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Almost each molecular aspect of life is controlled by a flow of information encoded in DNA 
to protein through an intermediary molecule called RNA. Some aspects of life are regulated 
by the RNA itself. This flow of coded information, from DNA to proteins, is called the ‘central 
dogma of molecular biology’(Crick, 1970). First reported as ‘invisible factor’ his work in 
heredity, Gregor John Mendel, discovered the basic unit of DNA that codes for a protein, 
now called a gene (Mendel, 1901). DNA, thus began to be called the genetic material (Griffith, 
1928). Later, it was demonstrated that RNA as well could serve as the genetic material in 
some viruses (Gierer and Schramm, 1956). The genetic material of a human diploid cell is 
about 6 billion base pairs (bp) of DNA which theoretically amounts to about 2 meters in length 
(Annunziato, 2008). How does the DNA of such length fit in the nucleus of a cell that is only 
few micrometres (µM) in diameter? The answer lies in the manner in which DNA is packaged 
with proteins called histones that allow super-folding of DNA such that it fits into the 
microscopically small nucleus of the cell. Histones are highly positively charged proteins that 
attract the negatively charged phosphodiester backbone in the DNA to form a histone-DNA 
complex. The DNA is wrapped, approximately 1.65 times, around the histone core octamer 
(two copies each of - H2A, H2B, H3 and H4) forming a structure that encompasses 146 or 
147 bp of DNA and is called a nucleosome (Figure 1.1A). 
 
The nucleosome forms the fundamental building block of the chromatin and it has been 
crystallized to give important structural details that help us in understanding how the 
chromatin is built (Figure 1.1A). The DNA in a cell is wrapped around millions of histone 
octamers separated by 10 to 90 bp linker DNA, giving rise to numerous nucleosomes that 
appear as ‘beads on a string’ of 10 nanometer (nm) diameter. This provides the first order of 
compaction of the DNA (Woodcock, 2006). Another histone protein, histone H1, binds the 
linker DNA at its entry and exit sites on the histone core. This causes the DNA to bend and 
allows further compaction of the chromatin (Xiao et al., 2012). Previous hypothesis had 
suggested that at the physiological state with 100-150 millimolar (mM) salt and 2-5 mM Mg2+, 
the nucleosome-nucleosome and nucleosome-DNA interactions allow the formation of 
secondary structures and further folding of the chromatin, leading to the formation of a 30-
nm fibre or solenoid. The fibre-fibre interactions were hypothesized to allow the formation of 
tertiary chromatin structures (Szerlong and Hansen, 2011). 
  Introduction 
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Figure 1.1 The structure of nucleosome 
 (A) The 2.8 Å (angstrom) crystal structure of the nucleosome core particle with histone 
proteins H2A (Magenta), H2B (Orange), H3 (Green) and H4 (Blue) in a left-handed superhelix. 
The 146 bp double-helix DNA is depicted in grey. The centre of the nucleosomal DNA – dyad, 
is indicated. Adapted from (Luger et al., 1997). (B) Schematic representation of chromatin  
organization depicting double helical DNA wrapped around histone octamers creating 
chromatin fibre that appear as ‘beads on a string’ with linker DNA. The chromatin fibers 
interact to form clutches on nucleosomes that are compacted by looping. Loops interact to 
  Introduction 
   
3 
form TADs which in turn lead to the formation of compartments in the nucleus. Adapted from 
(Misteli, 2020).  
 
However, the technological advancements over the last decade have helped to improve our 
understanding of the chromatin architecture. In fact, the existence of the 30-nm fibre and the 
higher order structures that were stipulated to form from fibre-fibre interactions have been 
challenged. The stochastic optical reconstruction microscopy (STORM) experiments show 
the presence of nucleosomes in ‘clutches’ instead. The clutches are several nucleosomes in 
a group and can have varying density of nucleosomes depending on the context and cell 
type. For example, in the transcriptionally silenced regions of chromatin, the clutches have a 
high density of nucleosomes while those clutches in actively transcribed regions have less 
nucleosomes. Similarly, the pluripotent stem cells have less density of nucleosomes in their 
clutches allowing access for several transcriptional factors to their binding targets. The 
differentiated cells, like fibroblasts, have higher density of nucleosomes in their clutches 
(Ricci et al., 2015). Another major technological advancement that improved our 
understanding of chromatin organization is the chromatin conformation capture (CCC) assay 
and its most recent iteration which couples it with high throughput sequencing (Hi-C). This 
technique makes use of chemical crosslinking of chromatin combined with sequencing to 
extract the information on the architecture of chromatin and has revolutionized our 
understanding of chromatin organization. Recent findings strongly support the existence of 
loops and domains. Chromatin forms loops and it has been proposed that these loops help 
to bring the enhancers in close proximity to the promoters that might otherwise be distant. 
Loops can be of different sizes, ranging from few kilo-bases to hundreds of kilo-bases and 
have been shown to form by a process called loop extrusion (Dekker and Misteli, 2015; 
Misteli, 2020). Loop extrusion involves a chromatin fibre looping out through the ring-shaped 
chromatin architectural protein – cohesin, helped by CTCF, among other proteins. CTCF has 
also been involved in chromatin domains, whereby, the regions of the genome that interact 
with each other are separated into a domain. Such domains that interact mostly within, but 
rarely with the surrounding regions, are called topologically associated domains (TADs). The 
TADs are usually several hundred kilo-bases in size and form by loop extrusion, wherein, 
once a loop is extruded it folds onto itself and forms distinct domains (Dekker and Mirny, 
2016). The genes within a TAD are regulated from within the TAD. It has been shown that 
disturbing a TAD boundary could affect the regulation of the genes within that TAD. 
Depending on whether the genes within a domain are actively transcribed or silenced, the 
TADs can interact to form higher-order chromatin compartments - A or B, which correspond 
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to euchromatin and heterochromatin, respectively. The compartment - A comprises of 
actively transcribed genes whereas silenced genes remain in compartment - B (Figure 1.1B) 
(Misteli, 2020). 
 
The major units of genome organization – chromosomes, exist in the form of chromosome 
territories. During interphase, each chromosome appears as a relatively compact and 
spatially restricted territory in the nucleus. Chromosome territories in mammalian cells are 
about 2-3 μM in diameter. The localization of chromosomes in the nuclear space also is a 
level of chromatin organization. The regions of chromosomes harbouring actively transcribed 
genes locate towards the inner nuclear space which corresponds to euchromatin or 
compartment – A. The parts of the chromosomes with silenced genes are arranged towards 
the nuclear periphery or the heterochromatin or compartment – B (Misteli, 2020). Recent 
studies indicate that phase separation, that is, distinct protein populations that preferentially 
interacts among themselves than with other types of biomolecules, upon reaching a 
threshold of saturation, separate into distinct and dynamic phases, play an important role in 
genome organization. For example, the protein involved in heterochromatin formation, 
heterochromatin protein HP1𝛼, phase separates both in vitro as well as in vivo leading to the 
belief that heterochromatin formation may be driven by phase separation (Banani et al., 2017; 
Misteli, 2020). 
 
1.1.1  Histones 
 
The core histone octamer consists of two copies each of histones H2A, H2B, H3 and H4. 
Histones contain a three-helix core domain, called the histone fold. These domains interact 
with each other in a ‘handshake’ arrangement that leads to the formation of H2A-H2B and 
H3-H4 dimers (Arents and Moudrianakis, 1993; Khorasanizadeh, 2004). These canonical 
histones are produced from highly regulated gene clusters during the S-phase of the cell 
cycle and are subsequently incorporated into the chromatin during the DNA replication 
(DeLisle et al., 1983). The core histone proteins have similar structural features and are highly 
conserved among the eukaryotes (Malik and Henikoff, 2003). Apart from the highly structured 
central region, each histone contains unstructured N-terminal and C-terminal tails which 
protrude from the nucleosome. The histone tails are post-translationally modified by histone 
modifying enzymes and these modifications are important for the formation of higher order 
chromatin structures that influence the dynamic nature of the chromatin. The core histones 
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can be replaced by histone variants, that along with the post-translational modifications of 
histone tails, contribute in regulating the gene expression (Fischle et al., 2003; Lawrence et 
al., 2016). 
 
1.1.2 Histone variants 
 
The variants of histones play an important role in the diversification of the nucleosome 
structure and the epigenetic regulation of the gene expression. Histone variants could attract 
variant-specific interacting proteins, thereby imparting certain genomic regions with unique 
characteristics to regulate the gene expression. For example, centromeric protein A (CENP-
A), a variant of histone H3, is specific to centromeres, and epigenetically marks them 
distinctly (Dunleavy et al., 2009; Foltz et al., 2009; Howman et al., 2000; Martire and 
Banaszynski, 2020). While the canonical histone genes have no introns and are transcribed 
from multiple histone gene clusters, the variant histones are transcribed from regions outside 
of the canonical histone clusters and often have introns that give rise to several splice 
isoforms. From amongst the histone variants, some are uniformly expressed while others are 
expressed in a tissue specific manner, particularly, in testis and brain (Maehara et al., 2015; 
Talbert and Henikoff, 2010).  
 
The variants of histone H3 include H3.1, H3.2, H3.3, H3.Y.1, H3.Y.2, H3.4, H3.5 and CENP-
A. Of these, H3.1, H3.2 and H3.3 are the most abundant variants of histone H3 while H3.4 
and H3.5 are testis specific variants. H3 variants - Y.1 and Y.2 are specific to primates 
(Gambogi and Black, 2019; Tachiwana et al., 2011; Wiedemann et al., 2010).  
 
The variants of histone H3 have subtle amino acid sequence differences (Figure 1.2A), yet 
their incorporation into the chromatin profoundly impacts the molecular processes. For 
example, there is a high degree of structural similarity between the nucleosomes containing 
H3.1 and H3.3 histones (Martire and Banaszynski, 2020). Nevertheless, nucleosomes 
containing canonical H3.1 are more stable than those nucleosomes that contain H3.3 variant. 
The few amino acid differences also impact the histone chaperones that interact with 
histones. For example, H3.1 histones interact specifically with chromatin assembly factor 1 
(CAF1) whereas H3.3 interacts with histone regulator A (HIRA) chaperone. The H3.1 histones 
which are only expressed during S-phase are incorporated during DNA replication and such 
nucleosomes are largely found at repressed chromatin regions that are enriched in histone 
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and DNA methylation. In contrast, the variant H3.3 are expressed throughout the cell cycle 
and nucleosomes containing H3.3 histones are largely distributed to active chromatin 
elements like enhancer, promoters and gene bodies (Conn et al., 2013; Martire and 
Banaszynski, 2020; Stroud et al., 2012). H3.3 histones are thus typically associated with the 
euchromatin. Similarly, the histone post-translational modification, H3K4me3, is more 
enriched among nucleosomes containing H3.3 variants than among histone H3.1 containing 
nucleosomes, further illustrating the molecularly distinct features that subtle differences in 
amino acid sequence in histone variants could yield (Maehara et al., 2015; Tagami et al., 
2004; Wong et al., 2010; Xiong et al., 2018).  
 
Similar to histone H3, other core histones also have variants that diversify the chromatin 
contexts and play specific roles in chromatin related processes. All the known histone 
variants and their domains are illustrated in Figure 2.2, however, detailing all of them would 
be beyond the scope of this thesis.  
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Figure 1.2: Core histones and their variants 
Illustration of core histone proteins and their variants.  The histone chaperone or chromatin 
remodeler complex associated with a particular histone variant is indicated. Colour shades 
of histone variants depict differences within domains relative to replication-coupled histone.  
 
1.2 Chromatin modifications and gene expression regulation 
 
The chromatin is maintained in a dynamic state where its structure is modified such that the 
gene expression can be regulated. This is achieved by chromatin modifying enzymes that 
post-translationally modify the histone globular domains or the histone tails that protrude out 
of the nucleosome; and by ATP-dependent chromatin remodelers. These remodelers use the 
hydrolysis of ATP to drive the changes in the conformation of the chromatin. 
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1.2.1 Histone modifications 
 
As mentioned above, histones are modified through covalent post-translational modifications 
(PTMs) (Allfrey et al., 1964). The highly basic N-terminal tails of the histones that protrude out 
of the nucleosomes make contacts with other nucleosomes in their vicinity. This influences 
the nucleosome-nucleosome interactions, and thereby, the chromatin structure. In addition 
to regulating the chromatin structure, the histone PTMs also influence the recruitment of 
certain chromatin modifying enzyme complexes including ATP-dependent chromatin 
remodelers and non-enzymatic proteins. Together, PTMs and chromatin modifying 
complexes influence the overall dynamic nature of the chromatin, its structure and the 
regulation of gene expression. Histone PTMs such as acetylation, phosphorylation, 
methylation and ubiquitination have been well studied (Figure 1.3). Other histone 
modifications that are beginning to be of interest include SUMOylation, deamination, ß-N-
acetylglucosamine, ADP-ribosylation, and several lysine modifications that have been 
discovered recently including its propionylation (Huang et al., 2014; Kebede et al., 2017; 
Sakabe et al., 2010). Such proteins that catalyse the deposition of histone modifications are 
termed ‘writers’ while the proteins that remove these modifications are called ‘eraser’ 
proteins. The proteins that recognize and bind to the histone PTMs are called ‘readers’ 
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Figure 1.3: Histone post-translational modifications.  
Histone are acetylated (ac), phosphorylated (ph), methylated (me) and ubiquitinated (ub1), 
besides other modifications. Positions of the amino acids modified are denoted by numbers. 
From (Bhaumik et al., 2007). 
 
  Histone acetylation 
 
The 𝜺-amino group of the lysine side chain in histones are acetylated by the transfer of an 
acetyl group (CO-CH3) from the acetyl coenzyme A (acetyl-CoA) co-factor (Wahab et al., 
2020; Xhemalce et al., 2011). This process is catalysed by a group of enzymes called histone 
acetyl transferases (HATs). HATs can be broadly classified into two categories – Type-A and 
Type-B. The Type-A HATs are mostly nuclear and highly diverse. Based on their amino acid 
sequence homology and structure, they can be further classified into five families - GNAT, 
MYST, CBP/p300, general transcription factor HATs (e.g. TAF1) and Nuclear hormone-
related HATs (e.g. SRC3) (Hodawadekar and Marmorstein, 2007; Xhemalce et al., 2011). The 
Type-A HATs are often present as part of multiprotein complexes and the other components 
of the complex influence their acetylation characteristics. For example, the purified yeast 
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GCN5 can acetylate free histones but is not able to acetylate those in a nucleosome 
(Bannister and Kouzarides, 2011). However, GCN5 present in the Spt-Ada-GCN5-
Acetyltransferase (SAGA) complex can efficiently acetylate histones in a nucleosome. The 
HATs not only acetylate the N-terminal histone tails but also the globular core of the histones. 
For example, the human GCN5 acetylates histone H3 at lysine 56 (H3K56) residue in the 
globular core (Grant et al., 1997; Miller and Grant, 2013; Tjeertes et al., 2009). 
 
The Type-B HATs, are mostly cytoplasmic, highly conserved and are involved in the 
acetylation of the newly synthesized histone H4 at lysine residues 5 and 12 (H4K5ac and 
H4K12ac) before their deposition into the nucleosomes (Parthun, 2007).  
 
The histones are rich in positively charged amino acids like lysine (K) and arginine (R) 
imparting a high affinity for the negatively charged DNA. The acetylation diminishes the 
histone-DNA interaction by neutralizing the positive charge inherent to histones, thereby, 
influencing the chromatin structure and conformation (Yang and Seto, 2007). The 
conformational changes in chromatin upon histone acetylation allow the transcription 
machinery access to its targets. Therefore, histone acetylation is generally associated with 
gene expression. A vivid example of this is provided by genes related to neuronal activity and 
memory: neural activity is accompanied by increase in acetylation levels of memory related 
genes so that the expression of certain genes is sustained for long-term memory and synaptic 
plasticity. Reduction in acetylation levels, therefore, have been proposed to be the underlying 
causes of several neurodegenerative diseases including Alzheimer’s disease and Rubinstein-
Taybi syndrome (Gräff and Tsai, 2013; Kandel, 2001).  
 
The acetylation by HATs is reversed by another set of enzymes called histone deacetylases 
(HDACs) which restore the positive charge on the histones and thereby, the affinity toward 
the DNA, tightening the chromatin. Thus, HDACs are generally repressors of transcription. In 
some cases of neurodegenerative diseases generated by the reduction of histone acetylation 
levels as mentioned above, a gain-of-function of HDACs has been found to be one of the 
underlying causes. Therefore, HDACs are therapeutically targeted by small molecule 
inhibitors called HDAC inhibitors (HDACi), to restore the acetylation levels necessary for 
memory and other neural activity. HDACs can be classified into four classes. The Class I, II 
and IV HDACs, which have a zinc metal ion dependent mode of action that does not involve 
the use of a cofactor (De Ruijter et al., 2003). On the other hand, the class III HDACs which 
are termed sirtuins, employ a NAD+-dependent catalytic mechanism (Saunders and Verdin, 
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2007). HDACs generally have a low substrate specificity, therefore, one HDAC enzyme has 
the capability to deacetylate several sites in histones. Often one HDAC enzyme is found 
within multiple distinct complexes, sometimes, working in cohort with other HDAC enzymes. 
For example, HDAC1, along with HDAC2, is present in NuRD, Sin3a and Co-REST complexes 
(Yang and Seto, 2007, 2008).  
 
HATs and HDACs have an opposite effect on the acetylation levels in the genome and 
thereby, on the transcription of multiple genes related to signal transduction, cell growth and 
cell death. Therefore, a fine balance between the two enzyme families is important for normal 
acetylation levels and genome stability. A loss in the balance has been associated with 
several cancers (Ceccacci and Minucci, 2016). Therefore, over the last few years both these 
enzyme families have been targeted in cancer therapies. However, the efficacy of HDACi on 
solid tumors has been challenged. Therefore, new strategies involve use of combinational 
therapies, that is, HAT or HDAC inhibitors in combination with other anti-cancer drugs 
(Francesco Fiorentino and Rotili, 2020; Park and Kim, 2020). 
 
  Histone Phosphorylation 
 
Histone phosphorylation was first reported nearly 40 years ago. The phosphorylation takes 
place majorly on the serine, threonine and tyrosine residues in the N-terminal histone tails 
(Shoemaker and Chalkley, 1978). The levels of phosphorylation are regulated by two sets of 
enzymes – kinases and phosphatases. The kinases are responsible for phosphorylation while 
the phosphatases remove this mark (Oki et al., 2007). During phosphorylation, a phosphate 
group from an ATP is transferred to the hydroxyl group of the substrate amino acid side 
chain. This leads to the addition of negative charge to the histone. Thereby, just like 
acetylation, phosphorylation weakens the histone-DNA contacts and influences the local 
chromatin structure (Rossetto et al., 2012). Importantly, phosphorylation provides a 
recruitment scaffold for other proteins including chromatin remodeling proteins or proteins 
that recruit chromatin remodelers, to help alter the chromatin conformation based on the 
cellular context. For example, during DNA damage response, the histone H2A.X is 
phosphorylated at its residues 139 and 142. These phosphorylation marks are recognized by 
microcephalin 1 (MCPH1) and is recruited to the damage sites. MCPH1, in turn recruits 
SWI/SNF chromatin remodeling complex that helps in DNA repair (Sawicka and Seiser, 2014).  
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Further, the phosphorylation of histones has been reported to be essential for mitosis, 
apoptosis, DNA repair, replication and transcription (Xhemalce et al., 2011). The most 
extensively studied histone phosphorylation is on serine 10 of histone H3 (H3S10) which is 
catalysed by the Aurora B kinase. This mark becomes detectable first during the late G2 
phase in the pericentric heterochromatin. Later, it spreads across the entire chromosome 
arm (Hsu et al., 2000). Several studies have demonstrated the direct correlation of chromatin 
compaction, during mitosis and meiosis, and H3S10 phosphorylation (H3S10ph). This makes 
H3S10ph a mark for these cellular processes (Hans and Dimitrov, 2001). During anaphase of 
the cell cycle, protein phosphatase 1 (PP1) dephosphorylates H3S10 and this is of critical 
importance for proper chromosome segregation (Hsu et al., 2000). While the H3S10ph plays 
pivotal roles during cell division in chromosome compaction and segregation, it also is 
important for transcriptional activation and cell growth. Therefore, mis-regulation of this mark 
(H3S10ph) has been identified in several cancers and associated with poor prognosis. In fact, 
higher levels of H3S10ph have been associated with invasive breast cancers, gastric 
carcinoma and glioblastoma among others (Khan, 2015; Komar and Juszczynski, 2020). The 
kinases that regulate H3S10 phosphorylation including aurora B and mitogen- and stress-
activated protein kinase 1 (MSK1), have therefore, been targeted to treat cancers (Bavetsias 
and Linardopoulos, 2015; Khan et al., 2016).   
 
  Histone methylation 
 
The histone methylations have been reported to occur on the side chains of arginine, lysine 
and histidine residues. One major difference between this modification and the earlier 
mentioned acetylation or phosphorylation modifications, is that, the methylation does not 
change the charge of the histones (Lan and Shi, 2009; Ng et al., 2009). The histone 
methylation marks are deposited by enzymes called histone methyltransferases (HMTs). 
HMTs catalyse the transfer of one, two or three methyl-groups from S-Adenosylmethionine 
(SAM) to the lysine residues in histones. Arginine residues as well can be mono- or di-
methylated and such methylations can be symmetrical or asymmetrical (Bedford and Clarke, 
2009). In the core histones, there are over twenty possible histone methylation sites and given 
the multiple methylation levels, this modification is the most complex of all the histone PTMs 
(Miller and Grant, 2013). The HMTs that methylate lysine residues (HKMTs) largely deposit 
the mark on N-terminal histone tails. Most HKMTs possess a SET domain which harbours 
the catalytic activity. One example for a HKMT that lacks a SET domain is the Dot1 enzyme 
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that methylates the histone H3 globular core at lysine 79 (H3K79) (Bannister and Kouzarides, 
2011). Of the several histone methylation sites, the methylation of Histone H3 at lysine 4 
(H3K4) is associated with active transcription (Wang et al., 2008). At enhancers, the mono-
methylation of H3K4 is highly enriched. At the body of actively transcribed genes, di-
methylation of H3K4 is enhanced. The tri-methylation of H3K4 has been reported to be 
enriched in the promoters, near the transcription start site (TSS) of the actively expressed 
genes (Pokholok et al., 2005; Santos-Rosa et al., 2002; Wang et al., 2005). The recruitment 
of some HMTs that methylate H3K4 is driven by RNA polymerase II. The RNA pol II is 
phosphorylated by TFIIH at serine-5 of its C-terminal domain (CTD) poising the RNA Pol II for 
active transcription. It is this poised RNA Pol II that recruits the Set1- containing H3K4 HMT, 
COMPASS, via RNA Pol II bound Paf1 complex (Bae et al., 2020; Ng et al., 2003; Phatnani 
and Greenleaf, 2006; Wood et al., 2003). Set1 is released when RNA Pol II is phosphorylated 
at serine 2 of its CTD during transcription (Martin and Zhang, 2005). Another histone 
methylation mark, H3K36me, is associated with active transcription. However, in contrast to 
H3K4 methylation, this mark (H3K36me) is enriched at the 3’- end of genes. It is catalysed 
by Set2 HMT which is recruited by serine-2 phosphorylated CTD as RNA Poll II approaches 
the 3' end of genes (Fong et al., 2017; Sun et al., 2020)).  
 
Unlike, methylation marks at H3- K4, K36 and K79, the methylation mark at K27 is a 
repressive mark. It is catalysed by the Set-domain containing Enhancer of Zeste 2 (EZH2) 
component of the Polycomb repressive complex 2 (PRC2) (Diehl et al., 2019). The 
transcriptional repression mediated by the methylation of H3K27 is crucial for X- 
chromosome inactivation (Inoue et al., 2017), suppression of homeotic genes and imprinting 
of genes at pericentric heterochromatin (Martin and Zhang, 2005; Wiles and Selker, 2017).  
 
The methylation at H3K9 is the most extensively studied PTM. Mono-methylation at H3K9 
(H3K9me1) is catalysed by HMT1C/G9a and is found at the 5’-UTRs of genes (Miller and 
Grant, 2013). Although, H3K9me1 has been implicated in the establishment of functional 
heterochromatin, not much is known about its role (Rivera et al., 2015). H3K9me2/3, on the 
other hand, have been extensively studied and are enriched at pericentromeric, sub-
telomeric and gene-desert regions. H3K9me2 co-localizes with Lamin B1 and is largely 
associated with inactive chromatin (Rosenfeld et al., 2009). Similarly, HP1𝜶  and HP1β 
interact with H3K9me3 through their chromodomains to establish pericentromeric 
heterochromatin indicating the importance of histone modifications in chromatin organization 
(Hyun et al., 2017).  
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Arginine residues are methylated by enzymes that can be classified into two types, type-I 
and type-II HMTs or Protein Arginine Methyltransferases (PRMTs). The type-I PRMTs are 
responsible for arginine mono-methylation (Rme1) and arginine asymmetric di-methylation 
(Rme2as). On the other hand, the type-II PRMTs lead to Rme1 and symmetrical di-
methylation (Rme2s). These two PRMT families comprise a total of 11 members. All the 
PRMTs catalyse the transfer of a methyl group from SAM to the 𝜔-guanidino nitrogen atoms 
of the arginine side chain (Bannister and Kouzarides, 2011; Bedford and Clarke, 2009). 
 
Like other histone PTMs, methylation is maintained in a dynamic state and the methylation 
marks are reversed by enzymes called histone demethylases. The demethylation by lysine-
specific demethylases, for example, LSD1, which catalyses the demethylation of lysine 
residues using flavin adenine dinucleotide (FAD) as a cofactor is well understood (Shi et al., 
2004). However, the demethylation at arginine residues is poorly understood. Two enzymes, 
peptidyl arginine deiminase 4 (PADI4) and JumonjiC-domain containing 6 (JMJD6) were the 
only proteins known to be involved in arginine demethylation (Rakow et al., 2020). PADI4 
demethylates mono-methylated arginine residues by conversion to citrulline. However, it 
does not act upon di-methylated arginine residues. The JMJD6, which was initially reported 
as a possible arginine demethylase, has turned to be a lysine hydroxylase (Chang et al., 2007; 
Rakow et al., 2020). Well established lysine demethylases, KDM4E and KDM5C, have 
recently been reported to also catalyse the demethylation of arginine residues in vitro (Rakow 
et al., 2020). However, both these enzymes demethylate arginine residues poorly compared 
with demethylation of lysine residues in vitro and this function has not been established in 
vivo yet (Bonnici et al., 2018; Rakow et al., 2020; Walport et al., 2016). Recently though, 
another lysine demethylase, KDM3B, was reported to act at the promoters of hematopoietic 
genes and mediate the demethylation of H4R3me2s and its intermediate H4R3me1 (Li et al., 
2018; Rakow et al., 2020). 
 
It is pertinent to mention that besides their bona fide functions, histone modifications cross-
talk with other histone modifying enzymes to regulate epigenetic processes. For example, 
the acetyltransferase activity of GCN5 at the tail of H3 histone is stimulated by the prior 
deposition of phosphorylation marks at H3S10 (Lee et al., 2010). 
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1.2.2 ATP-dependent chromatin remodeling enzymes 
 
As mentioned in section 2.1, the organization of DNA into chromatin with regularly 
interspaced nucleosomes allows tight packing of this long molecule into the nucleus. 
However, it renders the DNA sequences that are important for gene expression, DNA 
replication, repair and other processes, inaccessible to the regulatory proteins. Therefore, to 
circumvent this nucleosomal obstruction, the cell possesses specialized proteins that use 
the energy derived from the hydrolysis of adenosine triphosphate (ATP) to slide, reconstitute 
or eject the nucleosomes, such that the chromatin is maintained in a dynamic fashion. These 
proteins are called ATP-dependent chromatin remodelers (Narlikar et al., 2013). Not only do 
the ATP-dependent chromatin remodelers maintain proper density and spacing of the 
nucleosomes, but several of these remodelers work together with site-specific transcription 
factor and histone modification enzymes (Clapier et al., 2017). In recent years, several 
cancers have been found to be driven by mutations in certain ATP-dependent chromatin 
remodelers, highlighting the importance of their role in biological processes (Garraway and 
Lander, 2013; Wilson and Roberts, 2011). Based on their phylogenetic and functional 
characteristics, the ATP-dependent chromatin remodelers can be classified into four main 
families: imitation switch (ISWI), switch/sucrose non-fermentable (SWI/SNF), INO80 and 
chromodomain helicase DNA-binding (CHD) (Figure 1.4A). Among these subfamily 
members, there are common features like general affinity for nucleosomes and the presence 
of a Snf2-type ATPase motor. However, there are several differing aspects including the 
domains that confer specificity for the recognition of histone modifications and interactions 
with various proteins (Manelyte and Langst, 2013). 
 
  ISWI family 
 
The Drosophila Imitation Switch (ISWI) ATP-dependent chromatin remodeler was first 
identified on the basis of its sequence similarity to the Drosophila brahma and its mechanism 
of action has been extensively studied. Structurally, the ISWI remodelers contain two RecA-
like lobes in their ATPase domain that are separated by a small insertion sequence. It is this 
domain that hydrolyses the ATP. The C-terminal region possesses a HAND-SANT-SLIDE 
(HSS) domain which helps binding to unmodified histone H3 tail and the linker DNA flanking 
the nucleosome (Grüne et al. 2003; Boyer et al. 2004). The ATPase lobes are flanked on the 
N-terminal side by AutoN (autoinhibitory N-terminal) and on the C-terminal side by NegC 
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(negative regulator of coupling) domains that regulate the enzymatic activity of the ATPase 
domain (Clapier and Cairns, 2012).  
 
In Drosophila, ISWI is part of three multi-protein complexes: NURF (Nucleosome Remodeling 
Factor), ACF (ATP-dependent Chromatin assembly and remodeling Factor) and CHRAC 
(Chromatin Accessibility Complex) (Ito et al., 1997; Tsukiyama and Wu, 1995; Tsukiyama et 
al., 1995; Varga-Weisz et al., 1997). Some of the ISWI complexes have been reconstituted in 
vitro and their functional characteristics dissected. During in vitro remodeling assays with 
mononucleosomes that are end-positioned, that is, DNA wrapped around a core histone 
octamer on one end with another end of the DNA protruding freely, ISWI containing 
complexes were shown to re-position the histone octamer by sliding it to the centre of the 
DNA (Zhou et al., 2016). ISWI complexes use this ability of sliding the nucleosomes in vivo as 
well to regulate gene expression. For instance, the ACF complex which contains a 
heterodimer of ISWI ATPase and Acf1, uses this sliding ability to generate arrays of evenly 
spaced nucleosomes that give rise to transcriptionally repressed heterochromatin (Ito et al., 
1997; Wallrath and Elgin, 1995). Similarly, NURF, a multi-component complex, slides the 
nucleosomes in the promoter region of genes to make the transcription factor binding sites 
accessible and facilitate gene expression (Badenhorst et al., 2002; Tsukiyama and Wu, 1995). 
Furthermore, the CHRAC complex that includes ISWI, ACF1 and the two subunits CHRAC-
14 and -15, utilizes the hydrolysis of ATP, to assemble nucleosomes from free DNA and 
histones in vitro and to contribute to repressive chromatin in vivo (Scacchetti et al., 2018; 
Varga-Weisz et al., 1997). 
 
ISWI remodeler containing complexes have been implicated to play multiple roles in 
transcription, chromosome organization and DNA replication (Corona and Tamkun, 2004; 
Elfring et al., 1994). A recent high-resolution cryogenic electron microscopy (cryo-EM) 
structure of yeast ISWI in complex with nucleosomes has shed new light on the mechanism 
through which ISWI remodelers act. It suggests that in the absence of nucleosomes, ISWI 
remodeler remains inhibited and once it comes in contact with nucleosomes, there is a 
conformational change that allows it to proceed with its remodeling activity. In fact, the 
mechanism of action has revealed that it causes a local DNA distortion and translocation, a 
mode of action that is similar to snf-2 type remodelers (Yan et al., 2019).  
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Figure 1.4: Subfamilies of ATP-dependent chromatin remodelers and their roles.  
(A) Representation of domain organization of ATP-dependent chromatin remodeler 
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  SWI/SNF family 
 
The SWI/SNF (SWItch/Sucrose Non-Fermenting) ATP-dependent chromatin remodeling 
complex, was first identified in defective mutants of S. cerevisiae that were unable to ferment 
sucrose (Neigeborn and Carlson, 1984). Later in 1997, (Wu and Winston) reported that this 
defect is caused by the failure of the Snf2 mutant strains to remove the nucleosomes from 
the promoter of the SUC2 gene. This failure was attributed to the mutations in their snf2-type 
ATPase domain impairing their remodeling activity. Therefore, the transcription factor binding 
sites remained inaccessible and hence the gene responsible for proper sucrose fermentation, 
SUC2, remained transcriptionally repressed.  
 
Structurally, the SWI/SNF remodeler ATPase also has two RecA-like lobes that are separated 
by an insertion sequence. In the C-terminal region, there is a bromodomain that is unique to 
SWI/SNF remodelers and helps them to interact specifically with acetylated histones and 
hence the transcriptionally active chromatin (Gaspar-Maia and Sevilla, 2016).  
 
SWI/SNF containing complexes are highly conserved from fungi to plants and animals. They 
have been shown to play important roles in almost every nuclear process including gene 
expression regulation, DNA replication initiation, and homologous recombination (Euskirchen 
et al., 2012). The mammalian SWI/SNF complex contains 15 subunits. Some are core 
subunits that are required for basic remodeling functions and others are accessory subunits 
that are cell type specific and help in modulating the SWI/SNF functions (Alver et al., 2017). 
In Drosophila, the SWI/SNF-related Brahma (BRM) complex has two sub-types – BAP 
(Brahma associated factors) and PBAP (Polybromo-associated Brahma). These two sub-
complexes share some subunits including the brahma ATPase subunit. However, they also 
have sub-complex specific components. For example, BAP complex specifically has OSA 
component, a DNA binding protein that has target gene specificity and helps in the 
transcriptional activation of its target genes. Similarly, the PBAP sub-complex has two 
specific subunits – polybromo and BAP170. The sub-type specific components modulate the 
behaviour and localization of the BRM complexes. For example, on polytene chromosomes, 
OSA and polybromo immune-staining showed both overlapping as well as distinct 
localizations suggesting that to regions where distinct localization patterns were observed, 
BRM complex might be recruited by separate mechanisms. (Collins et al., 1999; Mohrmann 
et al., 2004). Functionally, OSA-containing BAP complex was shown to specifically regulate 
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the differentiation of Drosophila intestinal stem cells (ISCs) to enterocytes while the PBAP 
complex specifically regulates the maintenance of Drosophila ovarian germline stem cells (He 
et al., 2014; Zeng et al., 2013). 
 
Like ISWI remodelers, SWI/SNF remodelers also possess the capability to slide 
mononucleosomes in vitro. However, in contrast to the ISWI, SWI/SNF remodelers slide the 
nucleosomes towards DNA ends and cannot space the nucleosomal arrays evenly (Zhou et 
al., 2016). SWI/SNF complexes use this remodeling ability in diverse biological processes 
such as lineage specificity and the genome stability (Alver et al., 2017; Ribeiro-Silva et al., 
2019). Therefore, any mis-regulation of SWI/SNF complex leads to widespread effects and 
may for example, cause cancer. In fact, almost 25% of all cancers have mutations in subunits 
of SWI/SNF complexes. Therefore, SWI/SNF complexes are currently being targeted for 
therapeutic interventions in several cancers (Centore et al., 2020; Mittal and Roberts, 2020). 
 
  INO80 family 
 
The INO80 ATPases were first discovered as transcriptional regulators of inositol responsive 
genes in S. cerevisiae (Ebbert et al., 1999). The two RecA-like lobes in the ATPase domain of 
INO80 are separated by a large insertion sequence which can vary from about 250 amino 
acids in yeast to over 1000 amino acids in mammals. In yeast, this insertion sequence has 
been shown to bind the helicase-related AAA+ type ATP-binding protein chaperones Rvb1p 
and Rvb2p. These chaperones are components of the INO80 complex and also are essential 
in the assembly of a functional INO80 complex (Jha and Dutta, 2009; Jónsson et al., 2004; 
Watanabe et al., 2015).  
 
In yeast there are two INO80 ATPase containing complexes – INO80 complex and SWR1 
complex. In Drosophila, INO80 exists in INO80 complex and the SWR1 complex homolog 
Tip60/p400 complex. The dINO80 complex is a multi-subunit complex. The dINO80 complex 
has also been shown to interact with the DNA binding Pleiohomeotic (Pho) protein. The Pho 
component of this complex identifies the Polycomb responsive elements (PRE) and recruits 
the complex to regulate the transcription of homeotic genes that control the proper 
segmentation and patterning in Drosophila (Bhatia et al., 2010). However, dINO80 has been 
shown to function independent of Pho protein as well. For example, the Pho null mutants in 
Drosophila die at pharate adult stage. On the other hand, dINO80 null mutants die at the late 
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embryonic stage. This suggests that in addition to cooperative function, these two proteins 
also have their independent functions (Ghasemi et al., 2015). The Drosophila Tip60/p400 
complex contains the Drosophila homolog of SWR1 protein called Domino. Recent studies 
have shown that the ATPase containing remodeler Domino (Dom) has two splice isoforms – 
Dom A and Dom B. The Dom B isoform containing complex functions as the Drosophila 
homolog of SWR1 complex and performs ATP-dependent chromatin remodeling. The Dom 
A complex functions in an ATP-independent manner as an acetyltransferase, similar to the 
yeast NuA4 complex (Scacchetti et al., 2020). 
 
Similar to ISWI ATPases, INO80 ATPases can slide the end-positioned mononucleosomes to 
the central position in vitro. In fact, INO80 can remodel a tri-nucleosome array such that the 
nucleosomes are evenly spaced (Udugama et al., 2011). This nucleosome sliding ability of 
INO80 has been shown to play crucial roles in gene expression regulation, DNA repair and 
replication (Eustermann et al., 2018). The actively transcribed genes have nucleosome free 
regions (NFRs) in their promoters such that the transcription machinery can access the 
promoters. However, to set up the boundaries of the NFR, there are two nucleosomes that 
are positioned both upstream as well as downstream of the transcription start site. These 
nucleosomes are called -1 and +1 nucleosomes, respectively. The correct positioning of 
these nucleosomes is important for transcription as they regulate the binding of transcription 
factors as well as the passage of the RNA polymerase II through the gene body. INO80 
remodelers have been shown to be crucial for the correct positioning of these canonical -1 
and +1 nucleosomes (Brahma et al., 2017; Lai and Pugh, 2017). Besides this, INO80 is critical 
for the global genome distribution and exchange of histone variant H2A.Z and genome 
integrity (Papamichos-Chronakis et al., 2011).  
 
  CHD family 
 
The first member of the Chromodomain-helicase DNA binding (CHD) family of ATP-
dependent chromatin remodeling ATPase was identified in mice and named CHD-1. 
Subsequently, further family members were identified in other organisms including humans 
and Drosophila (Delmas et al., 1993; Platt et al., 2013). Structurally, CHD family members 
possess tandem chromodomains in their N-terminal part. The RecA-like lobes in the ATPase 
motor, just like in ISWI and SWI/SNF remodelers, are separated by a short insertion 
sequence. Based on the presence or absence of additional domains, this family of 
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remodelers is divided into three subfamilies. In Drosophila, the CHD family of proteins is 
comprised of four members, that is, dCHD1, dCHD3, dMi-2 and Kismet (Bouazoune and 
Brehm, 2006).  
 
The first CHD subfamily (subfamily 1) has a DNA binding domain in the C-terminal region that 
preferentially binds to AT-rich DNA sequences in in vitro binding assays. This subfamily 
includes yeast Chd1 (S. cerevisiae), yeast Hrp1 and Hrp3 (S. pombe) and CHD1 and CHD2 
in higher eukaryotes. The chromodomains in the human Chd1 interact with the H3K4me3 
mark and may help its recruitment to active genes. However, the Drosophila Chd1 does not 
seem to be recruited through this interaction as deletion of its chromodomains does not 
perturb its localization on polytene chromosomes (Murawska and Brehm, 2011). In yeasts, 
the Chd1 has been shown to co-localize with the transcription elongation factors at actively 
transcribed regions. However, its deletion does not yield a strong phenotype, perhaps 
because there are other chromatin remodelers that compensate for its loss (Simic et al., 
2003). Nevertheless, recent data suggests that the loss of Chd1 in yeasts specifically affects 
the intron containing and highly transcribed genes. Chd1 loss leads to severe perturbation in 
the nucleosomal arrangement at highly transcribed genes, particularly the +1 and +2 
nucleosomes. This indicates a role of Chd1 in nucleosome organization. Similarly, the loss of 
Chd1 leads to disruption of the serine-5 phosphorylated form of RNA pol II at highly 
transcribed genes, even though, the overall RNA Pol II occupancy remained unaffected (Park 
et al., 2014). Likewise, in Drosophila, the loss of Chd1 did not yield any dramatic phenotype 
such that the flies would die. However, its loss leads to defects in fertility and wing 
development indicating its non-redundancy in these aspects (McDaniel et al., 2008).   
 
Apart from its role in transcription, Chd1 is essential for the transcription-independent 
incorporation of H3.3 into the Drosophila genome and chromatin organization (Morettini et 
al., 2011). In fact, Chd1 also plays a role in nucleosome assembly and its loss or 
overexpression in the salivary gland cells of third instar larvae affects the higher order 
structure of the polytene chromosomes. The loss of Chd1 leads to increase in the expression 
of heterochromatin protein HP1a while the overexpression of Chd1 causes the reciprocal 
effect, leading to alterations in chromosome structure (Bugga et al., 2013). 
 
In vitro, Chd1 has been shown to slides the nucleosomes bi-directionally, that is, both 
towards, as well as, away from the DNA ends. It can also evenly space an array of 
nucleosomes. To investigate the details of the Chd1 remodeling process, its crystal structure 
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was solved which showed that in the absence of nucleosomes, the chromodomains inhibit 
the catalytic activity of Chd1 by contacting and thereby, occluding both of its ATPase lobes. 
Also, the DNA binding surface within the ATPase domain remains inaccessible as an acidic-
helix, the so-called chromo-wedge domain, packs against it. In presence of nucleosomes, a 
conformational switch takes places that releases the chromodomains from the ATPase lobes, 
thereby, making the ATPase domain accessible and ready for efficient hydrolysis of ATP and 
remodeling reaction (Hauk et al., 2010). 
 
The second subfamily of CHD proteins (subfamily 2) includes CHD3 and CHD4 (Mi-2𝜶 and 
Mi-2𝜷, respectively). Unlike the subfamily 1 proteins, they do not possess a DNA binding 
domain, instead they have PHD (Plant Homeodomain) fingers in the N-terminal region. These 
PHD fingers are the readers of the histone PTMs, particularly, binding to the methylated lysine 
in histone H3 (H3K4). They also bind to the unmodified histone H3 tails (Jain et al., 2020). The 
CHD5 protein may also be classified in this subfamily. Although, there is a discrepancy in its 
classification in either subfamily 2 or 3 because like CHD3 and CHD4, it possesses PHD 
fingers. However, unlike CHD3/4 and like subfamily 3 proteins, it possesses a SANT domain 
in its C-terminal region (Sims and Wade, 2011; Tyagi et al., 2016). Irrespectively, all these 
subfamily 2 members are alternative components of the Nucleosome Remodeling and 
Deacetylase (NuRD complex, see section 2.2.3) (Tencer et al., 2017). The two PHD fingers 
present in CHD3 protein have been shown to interact with methylated and acetylated forms 
of histone H3 tails at lysine 9 residue (H3K9). This ability of CHD3 to sense both methylated 
as well as acetylated histone tails gives the NuRD complex the ability to function in a dynamic 
fashion. It allows NuRD operation at H3K9me3-containing transcriptionally suppressed 
chromatin and H3K9ac-containing transcriptionally active chromatin. Perhaps, at the H3K9ac 
loci, the CHD3 mediated NuRD recruitment allows deacetylation through its HDAC 
components to control gene expression. Also, CHD3 driven recruitment of NuRD at 
H3K9me3 loci might mediate its role in heterochromatin formation (Tencer et al., 2017). The 
Arabidopsis thaliana homolog of CHD3 (PICKLE) associates with H3K27me3 enriched genes 
and contributes to the H3K29me3-related processes (Zhang et al., 2012). In Drosophila, 
dCHD3 has been shown to act as a monomer and associate with the actively transcribed 
genes. However, not much is known about its function in Drosophila. In cells, its depletion 
does not yield a drastic phenotype with insignificant effects on cell growth. It appears similar 
to dMi-2 protein with about 77% sequence similarity. However, dCHD3 possesses only one 
PHD finger and lacks the C-terminal region downstream of the ATPase domain that is present 
in dMi-2 (CHD4) (Murawska et al., 2008). Nonetheless, dCHD3, can bind to DNA and 
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nucleosomes. Its ATPase activity is stimulated by DNA as well as nucleosomes and it 
remodels mononucleosomes bidirectionally, that is, both towards as well as away from the 
DNA ends (Murawska et al., 2008). 
 
CHD4/Mi-2 was first identified in the serum of a dermatomyositis patient named Mitchell. It 
is a nucleosome stimulated ATPase and mainly takes part in the repression of gene 
expression through its association with the NuRD complex. It has been shown to be vital for 
proper lineage specification (Tyagi et al., 2016). In vitro CHD4 slides mononucleosomes away 
from the DNA ends. To investigate the mechanism through which CHD4 remodels chromatin, 
a crystal structure of human CHD4 (hCHD4) bound to nucleosomes was solved. It revealed 
that the hCHD4 binds to the nucleosomal DNA at super helical location (SHL) ± 2 and this 
causes a twist in the DNA. Subsequently, ATP binding then causes the closure of the ATPase 
motor and the propagation of the twist towards the dyad (see Figure 2.1A for nucleosome 
structure). Finally, the hydrolysis of ATP resets the ATPase motor and the remodeler can bind 
to the next DNA position (Farnung et al., 2020). 
 
Like hCHD4, the Drosophila homolog, dMi-2 protein has two chromodomains (CD), also in 
the N-terminus. The chromodomains of other proteins such as dHP1 bind to methylated 
histone H3 tails and help in its recruitment to the chromatin. However, the dMi-2 
chromodomains lack such a property but rather bind to DNA and this interaction has been 
proposed to be one of the ‘early steps’ in the remodeling process (Bouazoune et al., 2002; 
Jiang et al., 2009). Unlike dCHD3, dMi-2 has two PHD fingers which have been shown to 
read and bind to several PTM marks including acetylation and methylation. They can also 
bind unmodified histone tails. This binding is fundamental for gene expression regulation and 
nucleosome remodeling (Musselman and Kutateladze, 2011). Like hCHD4, dMi-2 also exists 
in NuRD complex (section 2.2.3), however, in addition to this it also exists in a dMEP-1 
containing dMec complex. dMec represses pro-neural genes in non-neuronal cells and 
mediates the SUMOylation-dependent gene repression. In fact, dMec complex is the major 
dMi-2 containing complex in Drosophila embryos and in Kc cells (Drosophila embryo-derived 
cells) (Kunert et al., 2009; Stielow et al., 2008).  
 
dMi-2 is important for somatic cell survival and germ cell development. Its interaction with 
Hunchback, a repressor of the HOX genes, has been implicated in the Polycomb-mediated 
gene repression of the homeotic genes (Kehle et al., 1998). Recent reports implicate dMi-2 
in repressing hormone regulated genes in Drosophila (Kreher et al., 2017). Apart from its role 
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in gene repression, dMi-2 also facilitates gene expression. For example, dMi-2 plays an 
important role in the efficient transcription of the heat shock (HS) response genes. dMi-2 is 
recruited to HS genes through its interaction with poly-ADP ribose (PAR) polymers and 
nascent HS transcripts that are produced from the heat shock gene loci (Mathieu et al., 2012; 
Murawska et al., 2011).  
 
Like hCHD4, recombinant dMi-2 is stimulated by nucleosomes and slides an end-positioned 
mono-nucleosome to the central position in vitro (Brehm et al., 2000). In fact, this property of 
mobilizing the nucleosomes allows dMi-2 to regulate the chromatin structure in vivo. For 
example, dMi-2 was shown to condense the polytene chromosomes and its over-expression 
or depletion disrupts their characteristic banding pattern (Fasulo et al., 2012). Mutations in 
the human homolog of dMi-2 have been associated with cancer. Recent findings suggest 
that analogous mutations disrupt the nucleosome remodeling function of dMi-2 by altering 
its ATPase activity, nucleosome -binding and -positioning. This indicates the importance of 
dMi-2 mediated chromatin remodeling for normal functioning of a cell (Kovač et al., 2018). 
 
The third subfamily of CHD proteins (subfamily 3) include CHD6 to CHD9 proteins. These 
proteins contain SANT or SANT-like or SLIDE domains or Brahma/Kismet (BRK) domains. 
Therefore, this subfamily is highly diverse. The SANT and SLIDE-domains bind to DNA and 
mutations in these domains of CHD7 have been associated with CHARGE syndrome (Asad 
et al., 2016; Ryan et al., 2011; Tyagi et al., 2016). Chromatin remodelers in this family 
contribute to a wide range of processes including DNA damage response (Kargapolova et 
al., 2020), neural crest migration and differentiation (Asad et al., 2016) and gene expression 
regulation (Alendar et al., 2020; Wilkinson et al., 2015). 
 
In Drosophila, the CHD protein containing a BRK domain is called Kismet. Kismet was first 
identified as a dominant suppressor of polycomb which represses homeotic genes in 
Drosophila (Daubresse et al., 1999). There are two isoforms of Kismet, one with a molecular 
weight of 574 kDa (kilo-Daltons) called KIS-L and another with a molecular weight of 225 kDa 
called KIS-S. The larger isoform contains an ATPase domain that catalyses ATP-dependent 
chromatin remodeling. Just like brahma, it possesses a 41 amino acid BRK-domain (BRM 
and KIS) in its C-terminal region which remains to be of unknown function. On polytene 
chromosomes, KIS-L co-localizes with RNA polymerase II (Pol II) on nearly all transcriptionally 
active sites. In fact, the loss of kismet leads to a dramatic reduction of elongating RNA Pol II 
and the elongation factor SPT6 and dCHD1 on polytene chromosomes. However, the 
  Introduction 
   
25 
recruitment of RNA Pol II to the chromatin is not affected suggesting that KIS-L plays a role 
in the early steps of transcription elongation (Srinivasan et al., 2005). Recent studies have 
shown that Kismet plays an important role in activating the transcription of the steroid 
hormone receptor gene – ecdysone b1 (ecr-b1), by promoting H3K36 di- and tri-methylation 
and H4K16 acetylation (Latcheva et al., 2019).  
 
1.2.3 Nucleosome remodeling and deacetylase (NuRD) complex 
 
As mentioned earlier, the chromatin is maintained in a highly dynamic fashion through 
compaction and decompaction by chromatin remodeling complexes allowing regulation of 
gene expression. One such complex combines the remodeling and deacetylation processes 
to give rise to nucleosome remodeling and deacetylase (NuRD) complex. NuRD is a 
macromolecular, highly conserved, multi-protein complex (Torchy et al., 2015; Zhang et al., 
1999). In mammals, the NuRD complex consists of at least six components, with each 
component having at least two paralogs. These include: 
 
- histone deacetylases – HDAC1 and HDAC2, 
 
- the ATP-dependent remodeling proteins – CHD4 and its paralogs CHD3 and CHD5, 
 
- the methyl CpG- DNA-binding domain proteins - MBD2 and MBD3, that can bind 
methylated and/or hydroxymethylated DNA, 
 
- the metastasis associated proteins - MTA1, MTA2 and MTA3, that are involved in 
nucleosome recognition, 
 
- the retinoblastoma binding proteins – RBBP4 and RBBP7, that can bind to histone tails, 
 
- GATAD2A and GATAD2B, which are known to interact with MBD2 and MBD3 and with other 
CHD proteins, however, their precise functions remain elusive (Low et al., 2020). 
 
NuRD complex was first described in 1998 by several groups reporting the coupled ATP-
dependent remodeling and deacetylase complex (Tong et al., 1998; Wade et al., 1998; Xue 
et al., 1998; Zhang et al., 1998). The only other complex that combines two different 
chromatin regulating functions is Tip60/p400 complex. In Tip60/p400 complex, Tip60 is an 
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acetyltransferase which acetylates N-terminal tails of H2A and H4. The p400 exchanges H2A-
H2B dimers for H2A.Z-H2B dimers within histone octamers (also see section 2.2.2.3) (Chen 
et al., 2013). One explanation proposed for such coupling of remodeling and deacetylase 
function is that the HDAC depends on ATP-dependent remodeling function for access to its 
targets. That is why, in the absence of ATP, only histone octamers can be deacetylated but 
not the nucleosomes (Torchy et al., 2015).  
 
Depending upon the cellular, tissue, physiological and pathological contexts, the 
components of the NuRD complex could vary giving rise to several coexisting complexes. In 
mammals, the variety of NuRD complexes is increased by the isoforms of its components 
some of which can be mutually exclusive. For example, MTA1, MTA2 and MTA3 are mutually 
exclusive to each other as are the isoforms of MBD.  To illustrate this, a NuRD complex is 
specifically found in mouse embryonic stem cells (mESCs) that contains MBD3C isoform of 
MBD, which uniquely has 50 amino acids in its N-terminal region allowing its interaction with 
WDR5, a histone H3 binding protein (Ee et al., 2017). This suggests that there is a great 
degree of heterogeneity of NuRD complexes with respect to all the alternative subunits and 
their cell-type-specific expression.  
 
The stoichiometry of subunit components and the assembly of NuRD complex has been a 
long running debate. Reports have suggested that CHD4, the ATPase motor component, is 
not a stable subunit of the complex and associates with it only peripherally (Zhang et al., 
2016). A recent study showed that, in mammals, a deacetylase module and a remodeling 
module form, which then combine to form the NuRD complex. The deacetylase module 
includes MTA, HDAC and RBBP components which have a stoichiometry of 2:2:4, 
respectively. The remodeling module includes MBD, GATAD2 and CHD components with a 
stoichiometry of 1:1:1, respectively (Low et al., 2020).  
 
In Drosophila, the corresponding NuRD components are Mi-2 (CHD), RPD3 (HDAC), p55 
(RBBP), MBD-like, MTA-like and Simjang/p66 (GATAD2). To measure the stoichiometry of 
the NuRD complex in Drosophila Schneider S2 cells, Ernest Laue and his colleagues 
performed label-free quantitative mass spectrometry based proteomic experiments. These 
revealed that MTA-like, Rpd3, MBD-like and p55 were present from single to several copies 
in different NuRD complexes whereas p66 (Simjang), Mi-2 𝛼 /β and Doc1 were sub-
stoichiometric components. MTA1-like, MBD-like and Rpd3 were found in the ratio of 2:2:1, 
respectively (Zhang et al., 2016). This suggests that both in mammals as well as in Drosophila, 
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the deacetylation unit is at the core of the NuRD complex and the remodeling motor 
containing module at the periphery.  
 
Functionally, NuRD complex was initially thought to be a bona fide transcriptional repressor 
because of its deacetylation activity. However, advances in the understanding of its role 
revealed that it plays a much more complex role in transcriptional regulation (Basta and 
Rauchman, 2015; Zhang et al., 1999). Genome-wide occupancy studies in mammalian cells 
showed that NuRD occupied most of the promoters and enhancers. At most of these loci, 
NuRD dampened the gene expression (Bracken et al., 2019). Soon it became clear that 
deacetylation was not the sole mechanism for NuRD to repress gene expression: NuRD 
increased the density of nucleosomes, thereby obstructing the transcription factors from 
binding their target sites, to represses gene expression at certain loci (Bracken et al., 2019). 
For example, a NuRD interacting transcription factor called Ikaros recruits NuRD to its target 
genes. At the target loci, NuRD induces a nucleosomal invasion resulting in eviction of RNA 
Pol II and a subsequent transcriptional repression. No deacetylation is required for this 
transcriptional shutdown, however, in the sequence of events, HDAC activity is later 
employed to maintain the target genes in a repressed state (Liang et al., 2017). Further, the 
genome-wide studies revealed association of NuRD with actively transcribed genes 
(Bornelöv et al., 2018). At the promoters of certain actively transcribed genes and regulatory 
regions, histone H3.3 is deposited. NuRD interacts with unmodified lysine residue 4 in histone 
H3.3 and this interaction was shown to be important for the expression of these genes 
(Kraushaar et al., 2018). Analysis revealed that NuRD played a role in fine-tuning of the 
expression of these genes. Thus, delineating from the earlier held assumption that suggested 
NuRD to be a canonical repressor of gene expression, recent models suggest NuRD to rather 
be a modulator of gene expression (Bracken et al., 2019).   
 
One of the best examples of NuRD’s fine-tuning role can be exemplified in the embryonic 
stem cells (ESCs) (Bornelöv et al., 2018). During the self-renewal state of ESCs, two naive 
pluripotency markers, Klf4 and Zfp42, are expressed while the primed pluripotency marker, 
Otx2, is repressed. For the differentiation to take place upon the removal of self-renewal 
factors, the Klf4 and Zfp42 genes are repressed while Otx2 is activated. NuRD complex is 
recruited to the enhancers of all the three genes in the self-renewal state. Upon removal of 
self-renewal factors, the cells that do not have NuRD complex recruited to the enhancers of 
these three genes, differentiate slower than wild type cells. The analysis revealed slower 
repression of Klf4 and Zfp42, and slower activation of Otx2 in the absence of NuRD on their 
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enhancers. There were distinct changes in the nucleosomal pattern of these enhancers upon 
loss of NuRD binding. These changes in the nucleosome patterning impaired the eviction of 
RNA Pol II from Klf4 and Zfp42 and recruitment of RNA Pol II at Otx2 genes. Hence, continued 
expression of pluripotency genes Klf4 and Zfp42 and impaired expression of primed 
pluripotency gene Otx2. This suggests that NuRD fine-tunes the gene expression at these 
loci by controlling the responsiveness of their enhancers (Bornelöv et al., 2018). 
 
Besides ESCs, Mi-2 subunit of the NuRD complex has been shown to regulate the gene 
expression of the hormone regulated genes in Drosophila. In the presence of the hormone 
ecdysone, hormone responsive genes are upregulated and there is increased occupancy of 
dMi-2 at these genes. In presence of hormone, dMi-2 constrains the expression of these 
genes. Therefore, if dMi-2 is depleted, hormone leads to super-activation of ecdysone 
responsive genes. This supports the model that NuRD complex acts as a fine-tuner or a 
modulator of the gene expression (Kreher et al., 2017).  
 
In addition to direct regulation of the gene expression, NuRD also facilitates the epigenetic 
regulation by other chromatin regulating complexes. For example, at certain pluripotency 
genes in ESCs, recruitment and trimethylation at H3K27 by polycomb repressive complex – 
2 (PRC2) is dependent on the prior deacetylation of H3K27 by NuRD, allowing for a proper 
exit from pluripotency into lineage specificity during differentiation (Kim et al., 2015; Reynolds 
et al., 2012). 
 
Owing to its critical role in gene expression regulation, several reports have implicated NuRD 
in cancer. The MTA1 component of NuRD has been found overexpressed in several cancers 
including breast, colorectal, oesophageal and prostate cancers. In fact, it has been noted 
that the higher the expression of MTA1 is, the more advanced is the grade of the tumor and 
the poorer is the prognosis (Lai and Wade, 2011). NuRD complex allows opening up of the 
chromatin at super enhancers in rhabdomyosarcomas, allowing binding of PAX3-FOXO1 
fusion proteins which are drivers of tumorigenesis, leading to the downstream cascade of 
tumor signaling. In fact, loss of CHD4, the ATPase motor of the NuRD complex, has been 
shown to re-compact the chromatin architecture around super enhancers and depletion of 
PAX3-FOXO1 proteins (Marques et al., 2020). Furthermore, as mentioned in section 2.2.2.4, 
the mutations in CHD4 subunit of the NuRD complex have been implicated in several 
endometrial cancers implicating aberrant NuRD activities or mutations in its components in 
cancer. 
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1.3 RNA binding proteins 
 
A large set of proteins have the ability to bind RNA and form a ribonucleoprotein (RNP) 
complex that have been shown to modulate the gene expression. Over 2000 such RNA 
binding proteins (RBPs) have been identified and the list is ever growing. RBPs identify a 
sequence or a structure in the RNA, often but not necessarily, through a well-defined 
structural motif called RNA binding domain (RBD). Several RBDs that have been extensively 
studied include RNA recognition motif (RRM), hnRNP K homology domain (KH domain) and 
DEAD-box helicase domain (Corley et al., 2020). However, several RBP complexes such as 
ribosome and spliceosome complexes lack such canonical RBDs indicating different 
mechanisms of protein-RNA interaction. RBPs have been termed as the ‘clothes’ of the 
mRNAs that help to cover or expose different regions, such as 5’- and 3’- untranslated 
regions (UTRs) and coding regions, within mRNAs, regulating their processing, stability, 
localization, translation and modification (Figure 1.5A) (Singh et al., 2015). Apart from RBPs 
exerting an influence on the RNAs, recent advances have shown that RNAs might as well 
exert their influence upon the RBPs in terms of their function, localization, stability and 
interactions (Figure 1.5B). Of late, several chromatin regulating proteins including ATP-
dependent chromatin remodelers have been identified to bind RNA which impacts their role 
in gene expression regulation leading to a growing interest in dissecting this aspect of their 
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Figure 1.5: Protein-RNA interactions.  
(A) RNA binding protein (RBP) can bind to RNA and regulate its different aspects of life (B) 
Conversely, RNA binds to RBP and regulates its function. From (Hentze et al., 2018). 
 
1.3.1 Chromatin regulators as RNA binding proteins 
 
A growing list of chromatin modifying proteins have been shown to be regulated by their 
interaction with RNA. Often, such proteins differ from the traditional RBPs, in that, they do 
not possess an established RBD or lack the specificity for RNA sequences or structures. 
Thereby, often such non-canonical RBPs are termed promiscuous in their RNA interactions 
(Hendrickson et al., 2016). Here, I detail some of the extensively studied non-canonical RBPs 
that are traditionally known for chromatin regulation.  
 
  MOF 
 
MOF (male absent on the first), a component of the MSL (male specific lethal) complex, is a 
histone acetyltransferase (HAT) that acetylates the lysine residue 16 in histone H4 (H4K16). 
It is of pivotal importance for the dosage compensation in Drosophila males and its loss is 
lethal specifically to male flies (Akhtar et al., 2000). To compensate for the lack of an X-
chromosome, the expression of the genes on the single X-chromosome in male (XY) flies is 
doubled to match the dosage of the X-chromosome related genes in the female (XX) 
counterparts. To achieve this, MSL complex is recruited specifically to the male X-
chromosome in flies where it causes the global acetylation of H4K16, inducing the 
transcriptional upregulation of X-linked genes in males (Kind et al., 2008). Notably, the 
recruitment of the MSL complex to the male X-chromosome is mediated by its interaction 
with male-specific non-coding RNAs called rox1 and/or roX2, including the interaction of 
MOF with roX RNAs (Franke and Baker, 1999). In fact, simultaneous deletion of the roX RNAs 
from Drosophila male embryos has been shown to disrupt the localization of MSL complex 
from the X-chromosome. Additionally, a depletion of RNAs in Drosophila Schneider 2 (S2) 
cells by treatment with RNase A has been shown to cause loss of MOF from the nuclear 
compartment. Upon in vitro analysis of the RNA binding properties of MOF, it was established 
that two amino acids - tyrosine 416 and tryptophan 426, in its chromo-barrel domain, mediate 
its RNA binding and mutations of these two amino acids lead to complete absence of male 
progeny. MOF provides an instructive example for the importance of RNA binding in directing 
the activity of a histone modifying enzyme (Conrad et al., 2012; Keller and Akhtar, 2015). 
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  PRC2 complex 
 
The polycomb repressive complex 2 (PRC2) has been extensively studied for RNA binding. 
Canonically known for its methyltransferase activity, where in, PRC2 complex marks lysine 
27 of histone H3 (H3K27me3) which plays a crucial role during development and malignancy. 
It is a multiprotein complex and three of its core components – EZH2 (enhancer of zeste 2), 
SUZ12 (suppressor of zeste 12) and EED (embryonic ectoderm development) have been 
shown to bind RNA directly (Yan et al., 2019a). The first reports of PRC2 interaction with RNA 
came from the studies on X-chromosome inactivation. In mammalian females (XX), one X-
chromosome is inactivated to account for the double copies of X-linked genes. In 1999, Xist 
(X inactive specific transcript) non-protein coding RNA was reported to be transcribed from 
the inactive X-chromosome and instead of its export from the nucleus, it was shown to act 
in cis and form ‘banded localization’ on the same chromosome it was transcribed from 
(Duthie et al., 1999). Soon after, in 2002, it was shown that PRC2 core component EED, stably 
associated with inactive X-chromosome in trophoblast stem cells (Mak et al., 2002). Several 
years later, in 2008, Jeanine Lee and her colleagues showed that short repeat RNA of 1.6 kb 
within Xist - called RepA, directly bound the EZH2 subunit of PRC2 complex and recruited it 
to the X-chromosome to induce the trimethylation of H3K27 and subsequent X-chromosome 
inactivation (XCI) (Wang et al., 2008).  
 
Soon the role of RNA interaction in the recruitment and modulation of PRC2 function at 
different loci across the genome began to be investigated. PRC2 was reported to bind a non-
coding RNA (ncRNA) that was transcribed antisense from the HOXC locus, hence called 
HOTAIR (HOX antisense intergenic RNA). This interaction of PRC2 with HOTAIR ncRNA was 
shown to have effects in trans and recruit PRC2 to the HOXD locus where PRC2 
subsequently trimethylates the H3K27 to repress the genes in the HOXD cluster. In fact, 
depleting HOTAIR ncRNA lead to a depletion of PRC2 complex on the HOXD locus and a 
subsequent depletion of H3K27me3 levels. This indicates the essential role played by this 
RNA-PRC2 interaction to localize PRC2 (Rinn et al., 2007). 
 
Reports of PRC2 interacting with several other ncRNAs such as Braveheart, MALAT1, PINC, 
Air, ANRIL among others suggested that although lacking a bona fide RBD, PRC2 might be 
a general RNA binding protein complex (Klattenhoff et al., 2013; Yan et al., 2019a). A large-
scale study confirmed this view by finding that about 20% of long intergenic ncRNA 
(lincRNAs) expressed in different mammalian cells were bound by PRC2 complex (Khalil et 
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al., 2009). More interest grew in the dissection of this RNA binding property of PRC2 and the 
roles it carries. It was shown that PRC2 lacks specificity and bound to a wide range of RNAs, 
however, it preferred binding to G-quadruplex (G-4) forming and G-rich RNAs. Therefore, 
PRC2 is neither highly specific nor highly unspecific in its RNA binding, thereby, promiscuous 
in nature (Davidovich et al., 2013, 2015; Kretz and Meister, 2014; Wang et al., 2017). 
Contradicting the earlier hypothesis that RNA interaction recruited PRC2 to chromatin, 
several reports suggested that RNA binding prevented PRC2 from interaction with chromatin. 
In fact, it was proposed that binding of PRC2 to RNA or chromatin is ‘mutually antagonistic’ 
and a depletion of RNA was shown to cause an increment in PRC2 occupancy on the 
chromatin. Not only did RNA evict PRC2 from chromatin but structural analysis showed that 
RNA interacted with the catalytic active center of EZH2 component of PRC2, occluding it 
and thereby, inhibiting its histone methyltransferase activity (Beltran et al., 2016, 2019; Riising 
et al., 2014; Zhang et al., 2019). Solving the puzzle, Thomas Cech and his colleagues showed 
in induced pluripotent stem cells (iPSCs), that PRC2 interaction with RNA is essential for its 
recruitment at PRC2 target genes, however, this interaction leads to its eviction from actively 
transcribing PRC2 non-target genes (Long et al., 2020). 
 
  dMi-2/CHD4 
 
In Drosophila polytene chromosomes, dMi-2 redistributes to the heat shock gene loci 87A 
and 87C, upon a heat shock, where it is necessary for efficient transcription of the heat shock 
response genes. Further analysis of this recruitment lead to the hypothesis that dMi-2 was 
recruited to the body of the heat shock genes in a two-step manner, wherein, dMi-2 first 
interacted with the poly-ADP ribose (PAR) polymers that are produced immediately after the 
heat shock and then the nascent RNA transcripts produced from the heat shock genes. 
During In vitro binding assays, recombinant dMi-2 also bound to an in vitro transcribed RNA 
derived from one of the heat shock genes (Mathieu et al., 2012; Murawska et al., 2011). Later, 
Ingrid Grummt and her colleagues showed that a hypo-phosphorylated form of CHD4 bound 
to a long ncRNA (lncRNA) called PAPAS which recruits CHD4 to rDNA (ribosomal DNA) 
promoters in a heat shock dependent manner. This recruitment of CHD4 is essential to 
repress the ribosomal synthesis in an event of heat shock (Zhao et al., 2018). Although, 
established for its role as an ATPase motor protein (see section 2.2.2.4), these results gave 
an indication that dMi-2 might have some ability to bind to RNA.  
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Several of the bona fide chromatin regulators lack a known RBD, yet there is a growing list 
of chromatin associated proteins that bind RNA and are regulated in both their localization 
as well as function by this interaction. The processes and the surfaces through which 
chromatin regulators that lack a RBD interact with RNA are poorly understood and remain a 
matter of investigation. 
 
1.4 How do proteins bind RNA? 
 
RNA binding proteins bind to RNA through highly diverse mechanisms involving different 
domains or surfaces. Various experimental techniques such as X-ray crystallography, nuclear 
magnetic resonance (NMR) and hydrogen-deuterium exchange mass spectroscopy (HDX-
MS) shed light on the interacting surfaces and the amino acids and nucleotides involved in 
RNA-protein interactions (Corley et al., 2020; Long et al., 2017). Generally, there are domains 
specialized in binding to RNA and these domains, forming stable secondary and tertiary 
structures, are called RNA binding domains (RBDs). Often an RBP could possess several 
such RBDs that mediate and enhance its RNA interaction (Cléry and Allain, 2012). However, 
lately a plethora of RNA binding proteins have been discovered which lack such canonical 
RBDs. Several of these RBPs contain intrinsically disordered regions (IDRs) that serve as 
RNA binding sites. However, due to their disordered nature, the structural details of their 
interaction with RNA remain poorly understood (Järvelin et al., 2016). Nonetheless, the 
structural details of several other protein-RNA interactions are available and selected 
molecular characteristics of these interactions and domain structures will be briefly discussed 
below. 
 
1.4.1 Molecular Interactions 
 
When a protein interacts with RNA, there is dynamic rearrangement at the local site of 
interaction in both RNA as well as protein. NMR and crystal structure studies of native and 
RNA bound proteins have shown that these rearrangements can be observed in the form of 
shifts in the RNA backbone and ‘flipping out’ of the RNA bases and amino acid residues. The 
sites of contact become rigid, locking the two molecules together while the adjacent regions 
loosen to absorb the changes in entropy (Corley et al., 2020; Leulliot and Varani, 2001; 
Matthews et al., 2016). At the local sites of interaction, there are different types of forces that 
bind the two molecules together, some of which are briefly discussed below. 
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  Hydrogen bonds and Van der Waals interactions 
 
Hydrogen bonds (H-bonds) are often the source of interaction between an RNA and a protein. 
The distances between H-bonds are 2.4-3Å and each bond carries 0.5-4.5 kcal/mol of energy 
(Auweter et al., 2006). The Van der Waals (VdW) interactions on the other hand, are the 
weakest of electrostatic interactions that form at a distance of above 3Å and carry forces of 
0.5-1 kcal/mol. In the context of protein-RNA interactions, H-bonds and VdW interactions 
can occur between the 2’-OH group of the sugar, any RNA base or phosphodiester backbone 
(phosphate) of the RNA, and protein (Figure 1.6) (Teplova et al., 2011). Upon large scale 
analysis of several protein-RNA data sets, it was found that the H-bonds with the RNA base, 
2’-OH group of sugar and phosphodiester backbone occur at an average frequency of 
35.5%, 23.5% and 41%, respectively. This suggests that on average, most of the RBPs that 
bind to RNA through H-bonds, do so by interacting with the phosphate backbone of the RNA. 
However, the VdW interactions were found to be highly variable. The analysis further revealed 
that in about 71.5% of H-bonds and 76% of VdW interactions, RNA was contacted by the 
side chains of amino acids indicating H-bonds and VdW interactions are largely driven by 
amino acid side chains of the RBPs (Corley et al., 2020; Han and Nepal, 2007).  
 
 
Figure 1.6: Protein-RNA interactions 
Human NOVA1 and U1A KH domains visualized with VMD zoomed-in (left) and zoomed-out 
(right). Protein in blue and RNA in red. (A) Hydrogen bonds (H-bonds) between adenine base 
and main-chain atoms of Leucine. (B) H-bonds bridged by a water molecule between 2’ OH 
in the sugar of RNA and glutamine. (C) H-bonds (two) between the phosphate backbone of 
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RNA (guanine) and serine and lysine residues. (D) Unpaired loop stacking interaction between 
adenine and cytosine nucleotides of RNA and aspartic acid and phenylalanine resides of 
protein. Adapted from (Corley et al., 2020). 
 
  Hydrophobic and 𝝅 (pi) stacking interactions 
 
Hydrophobic interactions that account for about 50% of the protein-RNA interactions, are 
the attractive forces that are created between nonpolar molecules in order to minimize the 
contact with the water molecules. Generally, these interactions occur at a distance of 3.8-
5.0Å and each interaction carries 1-2 kcal/mol of energy (Dill and MacCallum, 2012; 
Morozova et al., 2006; Onofrio et al., 2014). In the context of protein-RNA binding, 
hydrophobic interactions taking place between the RNA and the hydrophobic sidechain of a 
protein stabilize the protein-RNA interactions by forming a ‘hydrophobic core’ composed of 
hydrophobic amino acids and bases that are sequestered away from the solvent. For 
instance, the methionine-rich region of SRP54 protein, called M-binding domain, provides 
the hydrophobic surface for binding to SRP RNA (Akopian et al., 2013; Corley et al., 2020).  
 
𝜋 interactions are non-covalent interactions that occur between the ring of any nitrogenous 
base in the RNA and the 𝜋 containing amino acids in the protein. Aromatic amino acid 
residues – histidine, tryptophan, tyrosine and phenylalanine, and charged residues including 
arginine, glutamine and aspartate possess 𝜋 systems. 𝜋 interactions tend to stack, hence 
called 𝜋 stacking interactions (Figure 1.6D). These are generally strong, occurring over a 
distance of 2.7-4.3Å with 2-6 kcal/mol of energy per interaction. Analysis of the crystal 
structure data of several protein-RNA interactions has revealed that there can be several 𝜋 
interactions per structure, therefore, conferring considerable stability to the protein-RNA 
complexes. For example, in humans, U1A spliceosome protein is stabilized by several 
stacking 𝜋 interactions with the polyadenylation inhibition element of an RNA (Corley et al., 
2020; Wilson et al., 2016). 
 
1.4.2 RNA binding domains 
 
As mentioned earlier, canonical RBPs possess discrete RNA binding domains (RBDs). Often 
these RBDs are less than 100 amino acids in size and of those only few residues actually 
contact the RNA directly. However, a protein could possess several such RBDs that employ 
hydrogen bonds, 𝜋 stacking formation and/or other forces of interaction as mentioned above, 
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to stabilize the protein-RNA complexes (Cléry and Allain, 2012). While there is a large number 
of known RBDs, I have selected a few of the best-established RBDs and will briefly discuss 
them below. 
 
  RNA recognition motif 
 
The RNA recognition motif (RRM) is also called ribonucleoprotein domain (RNP). It is the most 
common RBD and is found in almost 0.5-1% of all human proteins. It is also the most 
extensively studied RBD and besides its RNA binding properties, it has been shown to also 
mediate protein-protein and protein-DNA interactions (Cléry and Allain, 2012). The total 
length of the RRM is 90 residues and it folds into two 𝛼-helices and four β-sheets with a 
topology of 𝛽1α1β2β3α2β4. Within β-sheets 1 and 3, there are two stretches of conserved 
amino acids, one eight residues and another six residues long, called RNP1 and RNP2, 
respectively. In the three-dimensional space, there are a total of three conserved aromatic 
residues between RNP1 and 2 that remain exposed and face the solvent. It is these residues 
that are involved in directly contacting the RNA (Cléry and Allain, 2012; Corley et al., 2020). 
In total, one RRM can contact 2-8 nucleotides of an RNA and even though each RRM can 
have different specificity, most prefer GU-rich RNA sequences. The RNP 1 and 2 within 
RRMs, form hydrogen bonds or stacking interactions to establish the contact often with 
nanomolar affinities. In some RBPs, there can be several RRMs which bind to RNA at the 
same time, increasing the affinity as well as specificity. For example, in heterogenous nuclear 
RNPA1 (hnRNPA1), there are two RRMs and both bind to RNA together (Beusch et al., 2017; 
Corley et al., 2020). 
 
  K homology domain 
 
K homology (KH) domain was first discovered in 1993 in heterogenous nuclear 
ribonucleoprotein K (hnRNPK) as a pre-mRNA binding motif. It was reported to ‘tenaciously’ 
bind C-rich RNA sequences (Siomi et al., 1993). Later research revealed that KH domain can 
interact with 4 nucleotides at a time and is about 70 amino acids in size. It folds in three 𝛼-
helices and three β-sheets. Based on the differences in folding, there are two types of KH 
domains, type I (eukaryotic) - that assumes a β1α1α2β2β’α’ topology and type II (prokaryotic) 
– that assume a α’β’β1α1α2β2 topology. Between the three α-helices of the KH domain, there 
is a conserved ‘GXXG’ motif that contacts the RNA through hydrogen bonds (Cléry and Allain, 
2012; Valverde et al., 2008). KH domains rarely employ stacking interactions, therefore, the 
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proteins that bind RNA only through KH domains do so with lesser affinity as compared with 
RRM mediated binding, often with micromolar affinities. However, proteins that possess 
multiple KH domains have higher binding affinity than those with only one KH domain. For 
example, in the human E3 ligase protein MEX-3C, there are two KH domains – KH1 and 2 
that mediate its binding to MEP10 RNA. The mutational analysis revealed that simultaneously 
perturbing the RNA binding ability of both the KH domains significantly decreased the binding 
affinity several folds compared to the effects of mutating only one KH domain suggesting a 
synergistic role in RNA binding (Yang et al., 2017).  
 
  Zinc Finger domain 
 
Zinc finger (ZnF) domains were initially reported to bind DNA, however, recent evidence 
suggests that several RBPs contact RNA through their ZnF domains. Typically, ZnF domains 
are about 30 amino acids long and fold in two β-sheets and one α-helix forming a simple ββα 
topology which is held together by a Zn2+ ion (Corley et al., 2020). Depending on the 
arrangement of cysteine and histidine residues that interact with the Zn2+ ion, there are three 
subtypes of ZnF domains that bind to RNA – zinc-knuckle (CCHC), CCCH, CCCC-type and 
CCHH-type. The zinc knuckles interact with the stem-loops in the RNA establishing contacts 
with the RNA bases in the loop and the phosphate backbone in the stem. The CCCH and 
CCCC-type ZnFs form hydrogen bonds with the RNA bases (Cléry and Allain, 2012). In fact, 
an RBP can have several such ZnFs and provide the specificity in RNA binding. For example, 
the structural analysis of an RBP called Muscle-blind-like 1 (MBNL-1) has revealed that it 
contains several CCCH-type ZnFs which can specifically recognize three nucleotide 5’-GCU-
3’ RNA sequences. The CCHH-type ZnFs can bind both single stranded as well double 
stranded RNA and DNA. It has been found in transcription factor TFIIIA (ZnF4-6) and it 
interacts with the phosphate backbone of the 5S rRNA (Cléry and Allain, 2012; Corley et al., 
2020). 
 
  Cold shock domain 
 
A large set of proteins that are involved in cold adaptation across different forms of life, called 
cold shock proteins (CSPs), possess cold shock domains (CSDs) that are involved in 
chaperoning of RNAs under a downward shift in temperatures (Corley et al., 2020).  Typically, 
CSDs are about 70 amino acids in length, however, could be longer in eukaryotic proteins 
and are highly conserved. These domains are folded into five anti-parallel β-strands (also 
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called β-barrels) that have been established as oligosaccharide and oligonucleotide-binding 
folds (OB-folds) (Amir et al., 2018). Within the CSDs, there are conserved RNP1 and RNP2, 
that are also found in RRMs as discussed in section 2.3.2.1. The binding to RNA takes place 
by sequential stacking interactions and formation of hydrogen bonds with RNA bases, often 
leading to nanomolar affinities. The human YB-1 protein contains the CSD that is well 
characterized. Although, it possesses ability to also bind single stranded DNA, however, it 
binds to RNA with at least 10-fold higher affinity and has been shown to be involved in the 
regulation of translation initiation (Kljashtorny et al., 2015). 
 
There are several other RBDs that have been well characterized and whose structural studies 
are available. However, it would be beyond the scope of this thesis to discuss each RBD. 
 
1.4.3  Intrinsically disordered regions 
 
As mentioned above, while several RBPs bind RNA through dedicated domain structures, a 
growing number of RBPs are identified that lack such structured domains. Most of these 
RBPs possess intrinsically disordered regions (IDRs) that mediate their RNA binding. These 
regions are unstructured and are often composed of amino acid repeats such as RS repeats 
(arginine and serine repeats), RGG repeats (arginine and glycine repeats), R/K basic patches 
(arginine- or lysine-rich patches) and other motifs (Hentze et al., 2018). There are a number 
of RBPs that contain disordered RG repeats and such proteins are called SR proteins or SR-
like proteins. The SR proteins are well characterized for their role in splicing but also mediate 
other RNA related processes such as export and translation. RS repeat elements are 
disordered, however, phosphorylation within the RS repeat residues reduces their structural 
flexibility. For example, the RS repeat elements in splicing factor SRSF1 (serine/arginine 
repeat splicing factor 1), adopt an arch-like rigid structure upon phosphorylation that 
provides a direct, non-specific, binding surface for RNA molecules. However, it is important 
to mention that IDRs do not necessarily require transition towards structural stability to bind 
RNA, as numerous IDRs bind to RNA despite the lack of any structural rigidity (Shepard and 
Hertel, 2009; Xiang et al., 2013). This is true for human nuclear ribonucleoprotein U (hnRNP-
U) which does not contain any canonical RBD, but instead possesses RGG repeat containing 
IDRs which bind to Xist and PANDA lncRNAs and mediate its role in epigenetic regulation 
(Hasegawa et al., 2010; Puvvula et al., 2014). Several RBPs contain IDRs in addition to their 
canonical RBDs. In several of such cases, IDRs have been shown to increase the efficiency 
of RNA interaction. For example, Fragile-X mental retardation protein (FMRP) has two 
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canonical KH domains and RGG repeat IDRs. It preferentially binds certain mRNAs mainly 
through its KH2 domain, however, loss of RGG IDRs leads to significant loss in RNA binding 
suggesting that the IDRs work in cooperation with the KH domains (Ascano et al., 2012; 
Järvelin et al., 2016).  
 
The IDRs in some proteins fold in a more structured manner once they come in contact with 
RNA. This has been observed with some of the RBPs that contain stretches of basic amino 
acids like arginine, called arginine-rich motifs (ARMs). Such IDRs provide a positively charged 
surface that faces the solvent and remains exposed for the negatively charged RNA to 
interact with. For example, the bovine immunodeficiency virus Tat proteins (Trans-activator 
of transcription) have ARMs which are disordered and bind to the 5’-end of the viral nascent 
RNA, called trans-activation response element (TAR). This binding induces the disordered 
Tat ARM to adopt a beta-turn structure (Puglisi et al., 1995). Similarly, IDRs can be composed 
of other basic amino acids like lysines. Such IDRs are called Poly-K or K-rich regions. Just 
like the ARM containing IDRs, poly-K IDRs provide a positively charged surface for RNA 
interaction. Of course, some IDRs contain a combination of lysine and arginine-rich residues 
(K/R-rich). Often IDRs have less sequence specificity but high affinity for RNA. In fact, the 
RNA binding mediated by IDRs can be as efficient as that mediated by a canonical RBD like 
RRM. For example, the homolog of protein SDA1 called SDAD1 has no RBD but in its C-
terminal is poly-K IDR and its binding to RNA is as efficient as an RRM containing RBP in 
vivo (Corley et al., 2020; Järvelin et al., 2016; Strein et al., 2014). Therefore, the RNA binding 
mediated by IDRs can be as efficient as those mediated by bona fide RBDs. Hence, the 
strong RNA interactions reported for several canonical chromatin regulators that lack RBDs 





During heat shock in Drosophila, dMi-2 is recruited to the heat shock genes where it supports 
their efficient transcription. Previous evidence has suggested that this recruitment takes 
place in two steps – dMi-2 first interacts with the PAR polymers which bring dMi-2 into close 
vicinity with the HS genes. In the second step, dMi-2 binds to nascent RNA transcripts from 
the HS genes and then gets recruited to the heat shock gene loci. In fact, recombinant dMi-
2 was shown to bind to a part of Hsp70 derived RNA in vitro (Mathieu et al., 2012; Murawska 
et al., 2011). In addition, mammalian CHD4 was shown to interact with an unrelated long non-
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coding RNA during heat shock. These isolated observations indicated the possibility of a 
conserved, general RNA binding function of dMi-2/CHD4. 
 
In this study, I asked if dMi-2 binds RNA also in the absence of heat shock and aimed to 
systematically characterize its RNA binding properties. I sought to use an unbiased approach 
(iCLIP) to identify novel dMi-2 associated RNAs in vivo and to characterise dMi-2 binding to 
selected RNAs in vitro. Finally, I aimed to identify the RNA binding domain of dMi-2 and to 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Cell lines  
 
Cell line Features Description 
Sf9 Immortalized ovarian cells Spodoptera frugiperda (Sf) 
S2 Drosophila melanogaster 
(late stage embryos, likely 
macrophage-like lineage) 
Schneider 2 (S2) 
S2 Cas9 Stably expressing Cas9, no 
protein tagged 
See S2 
S2 dMi-2-GFP S2 cells expressing GFP 




S2 cells expressing 
mCherry tagged dMof and 
GFP tagged dMi-2 
(Polyclonal) 
See S2 





2.1.2 Cell Culture 
 
Materials Supplier 
Sf-900TM SFM Thermo Fischer Scientific 
Fetal bovine serum (FBS) Sigma Aldrich 
Penicillin-Streptomycin (Pen: Strep, 10,000 
U/mL: 10,000 μg/mL 
Thermo Fischer Scientific 
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Baculovirus expressed protein; C-
terminal tag 
Source 
dMi-2 WT FLAG (pFastBac Dual) AG Brehm 
dMi-2 ∆N FLAG (pVL1392) AG Brehm 
dMi-2 ∆C FLAG (pVL1392) AG Brehm 
dMi-2 691-1271 FLAG (pVL1392) AG Brehm 
dMi-2 377- 483 FLAG (pFastBac1) This study 
dMi-2 484 – 690 FLAG (pFastBac1) This study 
dMi-2 1-376 FLAG (pFastBac1) This study 
dMi-2 ∆376 FLAG (pFastBac1) This study 
dMi-2 1-117 FLAG (pFastBac1) This study 
dMi-2 118-238 FLAG (pFastBac1) This study 




Plasmid Description Source 
pVL1392 dMi-2 WT (1-
1982) 
Encodes full length dMi-2 C-terminally 






Encodes full length dMi-2 C-terminally 





Encodes N-terminally truncated 
version of dMi-2, FLAG tagged on C-






Encodes C-terminally truncated 
version of dMi-2, FLAG tagged on C-
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Encodes C-terminally FLAG tagged 
ATPase region of dMi-2, for generation 





Encodes C-terminally FLAG tagged 1-
376 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 




Encodes C-terminally FLAG tagged 
377-1982 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 




Encodes C-terminally FLAG tagged 1-
117 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 




Encodes C-terminally FLAG tagged 
118-238 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 




Encodes C-terminally FLAG tagged 
239-376 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 
plasmid Gibson assembled. 
This study 
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Encodes C-terminally FLAG tagged 
377-690 amino acids of dMi-2, for 
generation of recombinant Baculovirus. 
The pFastBac1 vector was linearized 
with NotI restriction endonuclease and 
plasmid Gibson assembled. 
This study 
pRmHa-3 dMi-2 WT Encodes N-terminally FLAG tagged full 
length dMi-2 for Copper induced 
expression in S2 cells 
This study 
pRmHa-3 dMi-2 ∆376 Encodes N-terminally FLAG tagged 
377-1982 amino acids of dMi-2 for 
Copper induced expression in S2 cells 
This study 
pRmHa-3 dMi-2 ∆RRM Encodes N-terminally FLAG tagged 11-
238 fused with 377-1982 amino acids 
of dMi-2 for Copper induced 






Aprotinin (10 μg/μL) 
Used: 10 μg/mL 
AppliChem GmbH 
Leupeptin (10 μg/μL) 
Used: 10 μg/mL 
AppliChem GmbH 
Pepstatin A (10 μg/μL) 




Used: 0.2 mM 
Roth 
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2.1.6  Enzymes 
 
Enzymes Supplier 
DNase I VWR 
Proteinase K Roth 
RNase A AppliChem GmbH 
RNase I Thermo Fischer Scientific 
Superscript III Thermo Fischer Scientific 
TurboTM DNase  Thermo Fischer Scientific 




Custom unmodified DNA oligonucleotides were purchased from IDT. The stocks were 
dissolved in Tris-EDTA (TE) buffer pH 7.5 at 100 pmol/μL and stored at -20°C. 
 
 Oligonucleotides for generating templates for in vitro transcription 
 
The Oligonucleotides used to generate the templates for in vitro transcription contain a T7 
promoter sequence at the 5’-end of the forward primer. The oligonucleotides for generating 
templates for double stranded RNA additionally contain T7 promoter sequences at 3’-end 
of the reverse primer. The T7 promoter sequences are depicted in lowercase while the gene 
specific DNA sequence is shown in uppercase. 
 









Hsp70 230-merFwd  taatacgactcactatagggCCTACGGACTGGACAAGAAC 
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Pgant230-mer Fwd taatacgactcactatagggGTCATTGGTGCACGCGAGGC 
Pgant100-mer Rev CTTGATGAGGCGCAGCAG 
  
 Oligonucleotides for cloning in pFastBac1 vector to generate 
Baculovirus 
 
All clonings were performed by Gibson assembly. The sequences overlapping the vector 
are depicted in lower case while the gene specific DNA nucleotides are shown in upper 
case. The FLAG-tag coding sequences are underlined.  
 












  Materials and Methods 










  Oligonucleotides for sequencing 
 













dMi-2 WT Seq1R CAGAACTCACGCCACTTG 
pRmHa-3 Fwd GCAAAATCAAGTGAATCATCTC 
 
  Oligonucleotides for ChIP and qPCR 
 
Oligo name Sequence Source 
Hsp70 -154F TGCCAGAAAGAAAACTCGAGAAA  Boehm et al. 2003 
Hsp70 -154R GACAGAGTGAGAGAGCAATAGTACAGAGA  Boehm et al. 2003 
Hsp83 Total_F GGGTTTCTACTCCGCCTACC  Murawska et al. 2011 
Hsp83 Total_R CACGTACTGCTCGTCATCGT  Murawska et al. 2011 
Vrille_ChIP6_Fwd GTTTCTTCTGCCCCAATGC Kreher et al., 2017 
  Materials and Methods 
   
50 
Vrille_ChIP6_Rev CCTCTTTGGCCGAAAAATCT Kreher et al., 2017 
USP_Fwd (52) GCTCCTTTGAGCGACGAT  Kreher et al., 2017 
USP_Rev (53) CGAGAAGCTCTGGTTGAGGA  Kreher et al., 2017 
EcR_All_Fwd CAGGAGGACCAGATCACGTT  Kreher et al., 2017 
EcR_All_Rev TTCGCGAAGAATATTGAGTCC  Kreher et al., 2017 
Broad_ChIP1_fwd GCCGGCAATATTAGAAGTTCG Kreher et al., 2017 
Broad_ChIP1_rev ATTGGATTGGATGGTGCAG Kreher et al., 2017 
GAPDH1_F GAGCAAGGACTAAACTAGCCAAA Meier et al. 2012 
GAPDH1_R CAACAGTGATTCCCGACCA Meier et al. 2012 
Intergenic2R_F TGCTGACTGCCATCAAATTC  Meier et al. 2012 
Inregenic2R_R TACTGCTGTGACGGCTTTG  Meier et al. 2012 
 
2.1.8  Ladders and dyes 
 
Ladders and dyes Supplier 
GeneRuler 1kb DNA ladder Thermo Fischer Scientific 
GeneRuler 100 bp DNA ladder Thermo Fischer Scientific 
PageRulerTM Prestained Protein ladder Thermo Fischer Scientific 
6x Orange DNA loading dye Thermo Fischer Scientific 
2x RNA loading dye Thermo Fischer Scientific 
5x SDS loading buffer Thermo Fischer Scientific 
SpectraTM Multicolor High Range Protein 
Ladder 
Thermo Fischer Scientific 
 
2.1.9  Chemicals 
 
Chemicals Supplier 
Acetic acid Roth 
Acrylamide mix (30%, 40%) Roth 
Agarose Roth 
Ammonium persulfate (APS) Roth 
Bovine serum albumin (BSA) Thermo Fischer Scientific 
Bradford dye Bio-Rad Laboratories, Incorporated (Inc.) 
Coomassie Brilliant Blue R-250 AppliChem GmbH 
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Dimethyl sulfoxide (DMSO) Serva 
Dithiothreitol (DTT, 1M) Used: 1 mM Sigma Aldrich 
Ethylenediaminetetraacetic acid (EDTA) Roth 
Ethanol Roth 
Ethidium bromide Roth 
FLAG peptide Sigma Aldrich 




piperazineethanesulfonic acid (HEPES) 
CalBiochem 





PierceTM 10x WB Transfer Buffer Thermo Fischer Scientific 
Potassium chloride (KCl) Roth 
Powdered milk Roth 
RNase away Thermo Fischer Scientific Molecular 
Bioproducts 
Sodium acetate Roth 
Sodium dodecyl sulfate (SDS) AppliChem GmbH 
SYBRâ Gold Thermo Fischer Scientific  
Tetramethylethylenediamine (TEMED) Roth 
Triptolide Biomol 
Tris-aminomethane (TRIS) Roth 
TRIS-HCl Roth 
Tritonâ X-100 Roth 
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Kits Application Suppliers 
Bac-to-Bac Baculovrus 
Expression System 
Sf9 Cell transfection for 
Baculovirus generation 
Thermo Fischer Scientific 
DynabeadsTM MyONETM Silane 
cDNA Purification kit 
iCLIP2 Thermo Fischer Scientific 
Expand High Fidelity PLUS PCR 
system 
PCRs for CRISPR 
tagging 
Roche 
MEGAscriptTM T7 transcription 
Kit 
In vitro transcription Thermo Fischer Scientific 






QIAquick PCR purification kit DNA isolation after ChIP Qiagen 
QIAGEN Plasmid Maxi Kit DNA isolation Qiagen 
QIAquick Gel extraction kit DNA isolation from 
agarose gel 
Qiagen 
SensiFASTTM SYBRâ Lo-ROX 
kit 
qPCR Bioline 
RNeasy Mini Kit RNA isolation Qiagen 
SensiFASTTM cDNA Synthesis 
Kit 





Amiconâ Ultra Centrifugal Filters Merck 
25 mL Bio-Pure Reservior Diversified Biotech, Inc. 
Blotting paper sheets Sartorius Stedim Biotech 
10 mL and 20 mL Gravity Chromatogryphy 
Columns 
Bio-Rad Laboratories, Inc. 
Cuvettes Sarstedt 
15 mL and 50 mL Falcons Greiner Bio-One 
  Materials and Methods 
   
53 
Filter pipet tips Biozym Scientific GmbH 
Gel Cassettes (1.0 and 1.5 mm) Novexâ (Thermo Fischer Scientific) 
Gloves Sempermed  
Uniglovesâ 
LoBind Eppis Eppendorf 
Biozym 
96-well PCR plates Thermo Fischer Scientific 
Pasteur pipettes BRAND GmbH & Co KG 
Pipette tips Sarstedt 
Gilson 
10 cm and 15 cm plates Sarstedt 
T75 and T175 tissue culture flasks Sarstedt 
Rotiâ-PVDF (WB membrane) Roth 
Round bottom falcons Greiner Bio-One 





Cell culture laminar air filter hood Thermo Fischer Scientific 
Centrifuge Sigma Aldrich (Rotanta 460R) 
Thermo Fischer Scientific (Heraeus Fresco 
21) 
Thermo Fischer Scientific (HeraeusTM 
MegafugeTM 1.0) 
Thermo Fischer Scientific (Sorvall RC-5B) 
Ultracentriguge (Thermo Scientific) 
 
 
ChemiDocTM Touch Imaging System Bio-Rad Laboratories, Inc. 
Freezer (-20°C) Liebherr 
Freezer (-80°C) Thermo Fischer Scientific 
Fridge Liebherr 
Gel documentation Intas Scientific Imaging 
Incubator Binder HmbH 
Infors HT (Multitron Pro) 
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Light microscope (CK2) Olympus 
Confocal microscope Leica 
Medical Film Developer Konica Minolta 
Microwave LG 
Thermocycler (T3000) Biometra GmbH 
Pipettes Gilson 
Pipette device Heathrow Scientific 
qPCR machine (Mx3000P) Agilent Technologies 
Rotating Wheel (Multi-Rotator PTR-35) Grant Instruments Ltd. 
Plate rocker (ST5D Cat) Kobe 
Sonicator (Bioruptor) Diagenode 
Spectrophotometer (Genesys 10vis) Thermo Fischer Scientific 
Spectrophotometer (NanoDrop) Thermo Fischer Scientific 
Stratagene Stratalinker UV 1800 
Crosslinker 
Marshall Scientific 
Votrex Scientific Industries, Inc. 





GraphPad Prism GraphPad Software, Inc. 
Image LabTM 6.0.1 Bio-Rad Laboratories, Inc. 
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2.1.15 Antibodies and antisera  
 
 Primary antibodies 
 
Antibody Host origin Experiment Dilution Source 
αFLAG Rabbit, 
monoclonal 
WB 1:2,000 Sigma Aldrich 
αdMi-2 Rabbit, 
polyclonal 




WB 1:3,000 - 
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WB 1:10,000 - 
αH3 Rabbit WB 1:10,000 - 
αLSD1 Rabbit, 
polyclonal 








 Secondary antibodies  
 
Antibody Host origin Dilution Source 
αRabbit Polyclonal 1:30,000 GE Healthcare 
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2.2.1 Cell Culture 
 
 Culturing Sf9 cells  
 
Spodoptera frugiperda-9 (Sf9) cells were cultured in Sf-900™ II SFM (Thermo Scientific). The 
Sf9 culture medium was supplemented with 1% Penicillin-Streptomycin (Gibco) and cells 
were cultured at 26°C with 80 revolutions per minute (rpm) shaking. The cells were cultured 
from 0.5 million per millilitre (mil/ml) to 4 mil/ml. Cells were split every 3 days. 
 
 Culturing S2 cells 
 
Schneider-2 (S2) cells were cultured in Schneider’s Drosophila Medium Thermo Scientific) 
supplemented with 1% Penicillin-Streptomycin (Pen-Strep) and 10% Fetal Bovine Serum 
(FBS). 0.5 mil/ml cells were seeded in a flask and cultured at 26°C for 4-5 days and split in a 
ratio between 1:10 to 1:20. 
 
 Cell counting 
 
Cells were diluted 1:10 in respective medium. 10 μL cell suspension was transferred to the 
Neubauer cell counting chamber. Three of the four big squares, which are divided in 16 
smaller squares, were counted and the mean was calculated and multiplied by the dilution 
factor (10). To calculate the cell-count per milliliter, the final cell number was multiplied by 
104. 
 Freezing and thawing cells 
 
S2 or Sf9 cells were counted to 25 mil/ml in a 15 mL falcon, centrifuged to 1,000 relative 
centrifugal force (rcf) for 5 minutes at room temperature. The supernatant was discarded and 
the cell pellet resuspended in 500 μL of Freezing Buffer A. 500 μL of Freezing Buffer B was 
added dropwise while shaking the falcon. The cell suspension was transferred to a cryovial. 
The cryovial was placed in a 15 mL round bottom tube. This was then transferred to a 50 mL 
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Freezing Medium A 60% Sf9 or S2 medium supplemented with 
1% Pen-Strep + 40% FBS. Store at 4°C 
 
Freezing Medium B 60% Sf9 or S2 medium supplemented with 
1% Pen-Strep +  40% DMSO. Store at 4°C 
 
 
Frozen Sf9 or S2 cells were taken out of the –80°C freezer and quickly thawed in hands. The 
thawed cell suspension was washed by adding dropwise to a 15 mL falcon containing 14 mL 
respective culture medium. The cells were centrifuged at 1000 rcf for 5 minutes at room 
temperature. The supernatant was discarded and cell pellet again washed with 5 mL of 
respective medium. The centrifugation was repeated and final cell pellet was resuspended in 
5 mL of respective medium and transferred to 25 mL of Sf9 culture medium in a 250 mL flask 
(Sf9 cells) or 15 mL of S2 culture medium in a T75 flask. 
 
 Infection of Sf9 cells 
 
Proteins to be expressed in Sf9 cells were cloned in pFastBac1 vectors that provide a FLAG 
tag at the N-terminal of the protein of interest. The plasmid created as such were transformed 
into MAX Efficiency® DH10BacTM Competent E. coli. The Bacmids from these E. coli were 
extracted following the standard plasmid preparation protocol. The Bacmids were then 
transfected into Sf9 cells cultured in a 6-well plate using Cellfectin II reagent (Thermo 
Scientific). The cells were allowed to grow for 5-6 days. After visually inspecting the cells for 
signs of infection (cell lysis and increase in cell size), the supernatant containing the viral 
particles was saved as passage-1 (P1) virus. To amplify the P1 virus, Sf9 cells grown in a 10-
cm dish were infected with 100-200 μL of P1 virus and incubated for 5-6 days. Upon visual 
inspection of infection signs by using a light microscope, the supernatant was collected and 
saved as P2 virus. To amplify the P2 virus such that it has high viral titers, Sf9 cells were 
cultured in 15-cm dishes and infected with 100 μL of P2 virus. Upon visual confirmation of 
infection, cells were incubated for 5-6 days or till 50-60% cell lysis was observed. The 
supernatant (P3 virus) was collected, briefly centrifuged and stored at 4°C. 
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The P3 Baculovirus was used for protein expression. 1 litre Sf9 cell culture at a density of 1 
mil/ml were infected with 40-50 mL of P3 virus in a 5-litre flask and incubated for 48 hours at 
26°C with shaking. Cells were harvested and proteins extracted. 
 
2.2.2 Biochemical Methods 
 
 Bacculovirus protein extraction 
 
The Sf9 cells expressing the protein of interest were harvested by centrifugation at 3,200 rpm 
for 25 mins at 4°C using a swinging bucket rotor (Thermo Scientific, Heraeus). The 
supernatant was discarded and the cell pellet washed with 30 mL of cold 1XPBS (Phosphate 
buffer saline), pH 7.4. The centrifugation was repeated as earlier and supernatant discarded. 
The cellular pellet was resuspended and lysed in BC250 buffer supplemented with protease 
inhibitors and dithiothreitol (DTT), transferred to 50 mL falcons and incubated on ice for 15 
mins. The lysate was snap-frozen in liquid nitrogen and stored at -80°C. 
 
Buffer Composition 
1X PBS 140 mM NaCL 
2.7 mM KCl 
8.1 mM Na2HPO4 
1.5 mM KH2PO4 
pH adjusted to 7.4 with HCl (Thermo Fisher 
Scientific). Stored at 4°C. 
BC-250 0.4 mM EDTA pH 8.0 
20 mM HEPES mP 7.9 
10% Glycerol 
250 mM NaCl 
Dissolved in autoclaved Milli-Q Water, 
filtered and stored at 4°C. 
 
 
 FLAG-immunoprecipitation (FLAG-IP) 
 
The cell lysates of FLAG-tagged proteins were thawed from -80°C and the freeze-thaw cycle 
was repeated. The lysate was cleared by centrifugation at 10,400 rpm for 75 mins at 4°C in 
a sorval centrifuge (Thermo Scientific, Sorvall). The supernatant was transferred to pre-chilled 
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50 mL falcons and the cell debris was discarded. The protein concentration of the whole cell 
extract was determined by Bradford assay.  
An aliquot from the whole cell extract was taken as input, mixed with 5X SDS loading dye 
and stored at -20°C. To the rest of the extract, pre-equilibrated anti-FLAG M2 agarose (Sigma 
Aldrich) beads were added and incubated at 4°C for 4 hours on a rotator. After 
immunoprecipitation, the beads-protein solution was transferred to Bio-Rad Econo-pac 
gravity-flow columns, the flow-through was collected. The beads were washed with 40X bead 
volume of BC250, BC500, BC1000, BC500, BC250 and BC100 buffer, in that order. Each 
buffer was supplemented with protease inhibitor cocktail and DTT.  
The purified protein of interest was eluted with twice the volume of beads with elution buffer 
containing FLAG-peptide diluted in BC100 (1:20), supplemented with protease inhibitors and 
DTT. As soon as the elution buffer was added, the beads were properly resuspended and 10 
μL bead suspension was aliquoted out as Beads-IN. The elution was repeated once more. 
After collecting the elute twice, the beads were again resuspended in elution buffer and 10 
μL of beads were aliquoted out as Beads-OUT. To the beads-IN and OUT samples, 10 μL of 
2X SDS loading dye was added and samples stored at -20°C. The elutes were pooled and 
concentrated in pre-equilibrated centricons (Milipore). From the concentrated and purified 
protein, 21 μL were aliquoted out for analysis. The rest of the protein was aliquoted, snap 
frozen and stored at -80°C.  
 
Buffer Composition 
Buffering capacity (BC) buffers 0.4 mM EDTA pH 8.0 
20 mM HEPES mP 7.9 
10% Glycerol 
100 mM / 250 mM / 500 mM / 1000 mM 
NaCl. Dissolved in autoclaved Milli-Q 
Water, filtered and stored at 4°C. 
FLAG elution buffer (EB) FLAG peptide (5 mg/ml) diluted 1:20 in BC-
100 buffer. 
 
 Protein concentration estimation 
 
Protein concentration was estimated using Bradford Dye (Bradford, 1976). The Bradford dye 
was diluted 1:5 and a standard curve was generated using BSA standard. The protein to be 
estimated was diluted 1:10 in water, 1 mL of 1:5 diluted Bradford Dye was added and 
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incubated at room temperature for 5 mins. The absorption was measured at 595 nm against 
a blank solution containing the 1:10 diluted buffer of the protein of interest. The standard 
curve was used to estimate the final concentration of the protein. 
Reagent Composition 
Bradford dye Bradford reagent concentrate diluted 1:5 in 
autoclaved Milli-Q water. Filtered and 
stored at 4°C. 
In-gel estimation- Purified protein was loaded on a SDS polyacrylamide gel along with known 
BSA standards (Thermo Scientific) and electrophoresed. The gel was stained with Coomassie 
staining solution, destained, rehydrated and imaged with Bio-Rad ChemiDoc touch system. 
The protein bands were quantified along with the BSA standards using Image Lab software 
and concentration calculated against the BSA standards. 
 
  Sodium dodecyl sulfate Polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Polyacrylamide gels were poured with SDS and optimum concentration of acrylamide 
solution, depending on the size of the protein. The resolving gel was layered on top with 5% 
stacking gel. The gels were allowed to polymerise. Samples mixed with 5X SDS loading dye 
were denatured at 95°C for 5 mins and loaded on the SDS polyacrylamide gels and 
electrophoresed at 100 volts (V) till the bromophenol blue stain reached the resolving gel. The 
electrophoresis was then increased to 150V. The gels were run till the dye front reached the 
bottom of the gel. 
Solution Composition 
Resolving gel 6% / 8% % / 10% / 12% or 15% 
Acrylamide 





Mixed and poured 
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Stacking gel 5% Acrylamide 





Mixed and poured 
 
  Coomassie staining and imaging 
 
At the end of the electrophoresis, the gel was transferred to a Coomassie staining solution 
and incubated for 30 mins at RT while shaking. The gel was washed with de-ionized water 
thrice and destained using Coomassie destaining solution until the gel was ready for 
imaging. The gel was rehydrated in Coomassie storing solution for 30 mins at RT and 
imaged with Bio-Rad ChemiDoc touch system. 
 
Solution Composition 
Resolving gel 6% / 8% % / 10% / 12% or 15% 
Acrylamide 





Mixed and poured 
 
Stacking gel 5% Acrylamide 





Mixed and poured 
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  RNase A treatment and Cell Fractionation 
 
The protocol was provided by Manuel Beltran and adapted for S2 cells (based on Zoabi et 
al., NAR 2014, Mendez et al., Mol Cell Biol 2000 and Beltran et. al., Genome Res 2016).  
2-4 × 107cells per condition were aliquoted in 15 mL falcons. The cells were washed with 1X 
PBS at RT. Cells were permeabilized with 10 mL of 1X PBS supplemented with 0.05% 
Tween-20 and incubated at 4°C for 10 mins with intermittent agitation. The cell suspension 
was centrifuged at 1,200 rpm for 2 mins at 4°C and the supernatant was discarded. The cell 
pellet was resuspended in 950 μL of 1X PBS (RT). The sample was split into two vials, 450 
μL each. One was labelled as sample and another Mock. The sample vial was taken to a 
different room while the mock sample was processed on the normal RNase-free bench. To 
the sample vial, 50 μL of 10 mg/ml RNase A was added while to the Mock vial, 50 μL of 10 
mg/ml BSA was added. Each vial was incubated on separate rotating wheels at RT for 30 
mins. Both the vials were centrifuged at 1,200 rpm for 2 mins at 4°C. The supernatant was 
discarded. The cell pellet was washed by pipetting up and down with 10 mL cold 1X PBS. 
The cell suspension was centrifuged as earlier. The pellet was resuspended in 1 mL ice-cold 
buffer A supplemented with protease inhibitor and DTT (Care was taken to NOT mix by 
pipetting up and down as that could break the nuclei. The buffer was added to the wall and 
flicked gently). At this step and onwards, 2.5  𝜇L/mL	RNase inhibitor - RNaseOUT was added 
to the Mock sample. 
Triton X-100 was added to a final concentration of 0.1%, the tubes were flicked to mix and 
incubated on ice for 5 mins. To isolate the Cytoplasmic fraction (S1), the samples were 
centrifuged at 1,300 g for 4 mins at 4°C. The supernatant was separated, cleared by high-
speed centrifugation at 20,000 g for 15 mins at 4°C and stored at -20°C. The nuclei were 
washed twice with 1 mL Buffer A (without pipetting up and down, only by gently flicking). The 
nuclei were lysed with 250 μL of Buffer B (without pipetting up and down and only by gently 
flicking the tube as the chromatin is sticky and could stick to the pipette tip) supplemented 
with protease inhibitors and DTT. For the Mock sample, the Buffer B was additionally 
supplemented with RNaseOUT. Both samples were incubated on ice for 30 mins. The 
nucleoplasm (S2) was separated by centrifuged at 1,700 g for 4 mins at 4°C. The nucleoplasm 
was stored at -20°C. The chromatin pellet was washed twice with 1 mL of Buffer B and 
centrifuged at 1,700 g for 4 mins at 4°C (without pipetting up and down). The final chromatin 
pellet (P3) was resuspended in 200 μL of 1X Laemmli buffer supplemented with ß-
Mercaptoethanol (ß-Me). The chromatin samples were then sonicated for 7 cycles (30 sec 
ON, 30 sec OFF, at High output) in a Bioruptor (Diagenode). The samples were heated to 
  Materials and Methods 
   
66 
95°C for 5 mins and then stored at -20°C. The cytoplasm, nucleoplasm and chromatin 
fractions were loaded on 8-12% SDS PAGE. For the Mock sample, care was taken to clean 
the bench, the pipettes and all equipment with RNaseZap. 
Buffer Composition 
Permeabilization solution 0.05% Tween-20 in 1x PBS 
Buffer A 10 mM HEPES pH 7.9 
10 mM KCl 
1.5 mM MgCl2 
0.34 M Sucrose 
10% Glycerol 
1 mM DTT, supplemented with protease 
inhibitors 
Buffer B 3 mM EDTA 
0.2 mM EGTA 
1 mM DTT, supplemented with protease 
inhibitors and RNaseOUT (mock sample 
only) 
 
 Western Blot 
 
Samples to be analysed by Western blot (WB) were mixed with SDS loading dye, denatured 
at 95°C for 5 mins and loaded on SDS polyacrylamide gel along with a size marker and SDS 
PAGE was performed as described in 2.2.2.4. At the end of SDS PAGE, the proteins were 
transferred to a polyvinylidene difluoride (PVDF) membrane which was activated by brief 
exposure to methanol, at 400 mA (milliamperes) for 2 hr in cold conditions. The membrane 
was blocked with 5% milk in PBS-T for 30 mins at RT while shaking and then incubated 
overnight with primary antibody in 5% milk in PBS-T at 4°C on a shaker. The membrane was 
washed 3x with PBS-T for 5 mins each at RT on a shaker and incubated with the respective 
secondary antibody in 5% milk in PBS-T at RT for 2 hr on a shaker. The membrane was again 
washed 3x with PBS-T for 5 mins each at RT on a shaker. The secondary antibody is coupled 
with horseradish peroxidase (HRP) which reduces the peroxide from the WB detection 
solution. The reduction of peroxide provides the energy for the chemiluminescence of luminol 
in the WB detection solution. The chemiluminescence was detected by X-ray films which 
were developed by X-ray film processor (Kodak).  
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Buffer Composition 
10X SDS running buffer For 1 Litre (L): 
SDS 10 g (gram) 
TRIS base 30.3 g 
Glycine 144.1 g 
Dissolve in 800 mL Milli-Q water, adjust the 
vol. to 1L and store at RT 
Transfer buffer 10X PierceTM WB Transfer buffer diluted 
1:10 in Milli-Q Water. Store at 4°C 
PBS-T 1x PBS supplemented with 1% Tween-20 
Store at RT 
Blocking milk solution 5% milk powder in 1x PBS-T 
Store at 4°C 
WB detection solution 750 μL ImmobilonTM Western HRP 
Substrate Peroxide Solution 
750 μL ImmobilonTM Western HRP 
Substrate Luminol Reagent 
Freshly prepared, mixed before use. 
 
 
 Agarose gel electrophoresis 
 
DNA samples were verified for size and quality using agarose gels. The optimum percentage 
gels were prepared by dissolving DNA-grade agarose powder in 1x Tris-Acetic acid-EDTA 
(TAE) buffer, boiled briefly, supplemented with Ethidium bromide (EtBr) and poured in a 
chamber. The gel was allowed to polymerise. The DNA samples were mixed with DNA loading 
dye (1x final), loaded on the agarose gel along with a size marker and electrophoresed at 130 




TRIS-acetate-EDTA (TAE) buffer 40 mM Tris acetate pH 8.0 
1 mM EDTA pH 8.0 
Store at RT 
 
  Materials and Methods 
   
68 
  Electrophoretic mobility shift assay (EMSA) 
 
EMSAs were used to detected the binding of proteins with nucleic acids, DNA or RNA. When 
a protein binds DNA or RNA, the resulting protein-nucleic acids complex migrates slower this 
can be detected in native gels. In a 10 μL reaction, DNA/RNA was incubated with the protein 
of interest in EMSA buffer supplemented with protease inhibitors, DTT and RNase inhibitor 
(for RNA EMSA only) for 15 mins at RT. The samples were loaded on a pre-run 5% native 
polyacrylamide gel at 100 V for 1 hr. The gel was stained with 1x SYBR gold stain and 
processed as mentioned in 2.2.2.10. The intensity of the shifted and unshifted bands were 
quantified using Image Lab software. After subtracting the background intensity, the bound 
fractions were calculated as- 
Fraction bound = (Intensity of shifted band)/(intensity of unshifted band + intensity of shifted 
band) 
Percent bound was calculated as- 
Percent bound = (Fraction bound) × 100 
The dissociation constant (Kd) was calculated using the hill slope equation as 
Y=Bmax*X^h/(Kd^h + X^h) 
 
Where,  
Bmax = the maximum specific binding in the same unit as Y,  
Kd = ligand concentration needed to achieve a half-maximal binding at equilibrium in the 
same unit as X, and,   
h = hill slope. 
 
Buffer Composition 
EMSA buffer 40 mM KCl 
20 mM Tris pH 7.6 
1.5 mM MgCl2 
0.5 mM EGTA 
10% Glycerol 
BSA (200 ng/μl) 
0.4 Units (U) RNase inhibitor) 
1mM DTT, supplemented with protease 
inhibitors 
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  Native Polyacrylamide gel electrophoresis  
 
EMSA reactions were analysed by native polyacrylamide gel electrophoresis. A 100 mL 
solution of 5% native polyacrylamide gel was prepared by mixing 12.5 mL of Rotiphorese 
Gel 40 (19:1, Acrylamide:Bisacrylamide) (Roth) with 5 mL of 10x Tris-Boric acid-EDTA (TBE) 
buffer (Thermo Scientific), supplemented with ammonium persulfate (APS) and 
tetramethylethylenediamine (TEMED) and poured in a glass chamber. The gel was allowed to 
polymerise at RT for 30 mins, pre-run for 30 mins at 100 V. After the EMSAs samples were 
loaded, the gel was electrophoresed for 1 hr at 100 V at RT in 0.5x TBE buffer. The gel was 
incubated in a 1x SYBR gold staining solution (Thermo Scientific) for 5 mins at RT with 
shaking. The gel was washed 2x with deionized water and imaged with Bio-Rad ChemiDoc 
Touch system. 
Buffer Composition 
10x Tris-borate-EDTA (TBE) buffer 1 M Tris 
0.9 M Boric acid 
0.01 mM EDTA 
 
 Denaturing polyacrylamide gel electrophoresis (denaturing PAGE) 
 
RNA samples were loaded on denaturing PAGE to verify the quality of the RNAs. The gels 
were poured just like the native gels as described in section 2.2.2.10, however, additionally 
supplemented with 8% urea. The RNA samples were mixed with RNA loading dye, heated to 
65°C for 5 mins, instantly cooled for 1 min on ice and loaded on pre-run denaturing PAGE 
and electrophoresed at 100 V for 30 mins in 0.5x TBE buffer. The gels were processed as 
described in 2.2.2.10. 
 
 Circular dichroism (CD) spectroscopy 
 
CD spectroscopy was used to determine the secondary structures of RNAs. CD 
spectroscopy measures the difference in the absorption of the right and left – circularly 
polarised light. 10 micromolar (μM) RNA in 170 μL volume was allowed to fold as described 
in Wang et al., Mol Cell, 2017. CD spectra were measured in a 0.1 cm path-length quartz cell. 
The measurements were taken from 220 nanometer (nm) to 350 nm with a data pitch of 0.1 
nm and scanning speed of 50 nm/min and a band width of 1 nm. The cell holder temperature 
was regulated and the cuvette chamber was flushed with dry Nitrogen (N2) gas. Spectra were 
measured at temperatures indicated in the figures. 
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The CD spectroscopy data were analysed by using CAPITO CD analysis and plotting 
software (Wiedemann et al., 2013). The data were smoothened with Savitzky-Golay filter and 
CD values were plotted as mean residue ellipticity (q in grad cm2 dmol-1). 
 
Buffer Composition 
CD buffer 50 mM Tris-HCl pH 7.5 
100 mM KCl 
2.5 mM MgCl2 
0.1 mM ZnCl2 
2 mM 2-mercaptoethanol 
0.1 mg/mL BSA 
0.1 mg/mL fragmented yeat tRNA 
5% v/v Glycerol 
 
  in vitro transcription 
 
The in vitro transcription was used to produce some of the RNAs in this study. For any single 
stranded RNA to be produced, PCR template DNA was generated with T7 promoter 
sequence on its 5’-end (using forward primer with T7 promoter sequence). For double 
stranded RNA, the template DNA was produced using primers with T7 promoter sequence 
on both forward as well as reverse primers. In vitro transcription was set up using MEGAscript 
T7 transcription kit (Ambion) as- 
 
Component Amount 
ATP solution (75 mM) 2 μL 
CTP solution (75 mM) 2 μL 
GTP solution (75 mM) 2 μL 
UTP solution (75 mM) 2 μL 
10x Reaction buffer 2 μL 
DNA template (PCR products) 0.1-12 μg 
Enzyme Mix (T7 RNA polymerase, 1U/μL) 2 μL 
 
Samples were mixed thoroughly and incubated 37°C for 16 hrs. The DNA template was 
digested by adding 1 μL of TURBO DNase (2U/𝜇L) and samples incubated at 37°C for 15 
mins. The reactions were stopped by adding 30 μL of Nuclease-free water (Thermo 
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Scientific). To precipitate the RNA, 0.1 vols of 3M Sodium acetate and 2.5-3 vols of ice cold 
100% ethanol were added and samples incubated at -80°C for 1hr. Samples were 
centrifugated at 14,800 rpm for 30 mins at 4°C. The supernatant was discarded and RNA 
pellet was washed 2x with cold 75% ethanol. Supernatant was drained and RNA pellet air 
dried for 5-7 mins at RT and re-suspended in Tris-EDTA (TE) buffer pH 8.0. RNA was 
quantified by Nanodrop, quality checked by electrophoresis in denaturing-PAGE and stored 
at -20°C. 
 Nucleosome assembly 
 
Mononucleosomes were assembled on purified Drosophila histone octamers using 601 
nucleosomal DNA with 80 base pairs (bp) of flanking DNA. The nucleosomal DNA and histone 
proteins were mixed in a 0.8:1 ratio (determined empirically by test assembly) in 2M-TE buffer. 
The mix was pipetted in a low binding tube. A dialysis membrane was hydrated and 
equilibrated in 2M-TE buffer. The assembly mix was transferred to the dialysis membrane 
and incubated in 500 mL of 1x 2M-TE buffer for 40 mins. The assembly mix was dialysed to 
1M-TE buffer for 1 hr, 0.5M-TE buffer for 1hr and finally 0.05M-TE buffer for 1 hr. The dialysed 
nucleosome assembly mix was collected by poking the membrane at the top and pipetted 
out into a fresh low binding tube. The assembly was the concentrated in an equilibrated 
50,000 Dalton centricon (Milipore) by centrifugation at 3,000 rpm for 10 mins (until the 
assembly volume reaches about 200 μL). A glycerol gradient was poured with glycerol 
gradient buffer using AKTA prime. The nucleosome assembly was loaded carefully on the top 
of the glycerol gradient without disturbing the gradient. The tube was weighed and balanced 
and ultra-centrifuged (Thermo Scientific) at 35,000 rpm for 18 hrs at 4°C. 
The fractions were collected by poking a hole at the bottom of the gradient tube and about 
200 μL fractions were collected. 10 μL from each fraction were loaded on a 5% Native-PAGE 




(N)M-TE nucleosome assembly buffer 10 mM Tris-HCl pH 8.0 
1 mM EDTA pH 8.0 
2M / 1M /0.5 M or 0.05 M NaCl 
Glycerol gradient buffer A 50 mM Tris pH 8.0 
50 mM NaCl 
0.1% NP-40 
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10% Glycerol 
1 mM ß-Mercaptoethanol 
Glycerol gradient buffer A 50 mM Tris pH 8.0 
50 mM NaCl 
0.1% NP-40 
30% Glycerol 
1 mM ß-Mercaptoethanol 
 
 Nucleosome remodelling assay 
 
A typical nucleosome remodelling reaction was set in a volume of 10 μL. 50 nM end-
positioned mono-nucleosomes with 80bp flanking DNA were mixed with different 
concentrations of dMi-2 Wild type (WT) protein in BC-100 buffer. Reactions were incubated 
for 5 mins at 26°C, then, 2 mM ATP and 6 mM MgCl2 (final concentration) were added and 
reactions were incubated at 26°C for 45 mins. Reactions were stopped by adding competitor 
plasmid DNA (5 μg/reaction, nearly 6 Kbp plasmid) and samples were incubated on ice for 
10 mins and loaded on a 5% Native-PAA gel and run in 0.5x TBE buffer. Gels were stained 
with 1x SYBR gold staining solution, imaged with Bio-Rad ChemiDoc touch system and 
bands were quantified with Bio-Rad Image Lab software. For effects of RNA on remodelling 
activity of dMi-2, RNA was titrated in increasing concentrations before the addition of ATP 
and MgCl2. The IC50 was calculated in GraphPad Prism software using the following 
equation- 
                                       Y = Bottom + (Top-Bottom)/(1+(X/IC50)) 
Where, 
 
IC50 is the concentration of agonist that gives a response half way between Bottom and 
Top. Top and Bottom are plateaus in the units on the Y axis. 
 
 Reverse transcript- quantitative polymerase chain reaction (RT-qPCR) 
 
The gene expression levels were quantified using RT-qPCR. RNA was extracted from the 
cells using peqGold Total RNA extraction Kit (peqLab) following the Kit protocol. The RNA 
was reverse transcribed to cDNA using SensiFASTTM complementary cDNA synthesis Kit 
(Bioline) following the kit protocol in a thermocycler with the following program: 
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Temperature Time 
25°C 10 mins 
42°C 15 mins 
85°C 5 mins 
4°C ¥ 
 
The cDNA was diluted 1:5 before qPCR analysis. The qPCR allows the quantitative analysis 
using a double stranded (ds) DNA intercalating fluorophore. The cycle threshold (Ct) value is 
the number of cycles till the fluorescence reaches an indicated value. In the experiments in 
this thesis, since the Triptolide treatment downregulates the global gene expression including 
the expression of house-keeping genes. Therefore, expression was calculated relative to 
DMSO treated controls which were set to 1 using the equations- 
∆Ct = (Mean Ct of Triptolide treated sample – Mean Ct of DMSO control) 
Fold change = 2-∆Ct 
The standard deviation (SD) was calculated as- 
∆SD = √ (Mean SD of Triptolide treated sample)2 + (Mean SD of DMSO control)2 
Standard deviation = ((Fold change of sample ´ LN(2)2´ ∆SD2)) 
Where, LN(2) = Natural logarithm of 2 
 
  Chromatin immunoprecipitation-quantitative polymerase chain 
reaction (ChIP-qPCR) 
 
Chromatin preparation-    
ChIP-qPCR was used to quantify the abundance of proteins on chromatin. 100 million cells 
were seeded on a 15-cm dish and the protein-DNA contacts were crosslinked using 1% (final 
concentration, V/V) formaldehyde (Polysciences) for 10 mins at RT with shaking. The 
formaldehyde was quenched with 240 mM Glycine (final concentration) for 10 mins at RT 
with shaking. The cells were scraped and transferred to falcons and washed 2x with cold 
PBS, the supernatant was discarded. The cell pellet was lysed with 1 mL lysis buffer 
(supplemented with protease inhibitors and DTT) and incubated 10 mins on the ice. The cell 
lysate was sheared with sonication with 3 cycles of 30 seconds ON/OFF for 10 mins each at 
high power (Diogenode). The lysate was centrifuged at 14,800 rpm for 15 mins at 4°C. The 
supernatant (chromatin) was transferred to fresh tubes. 50 𝜇L of chromatin was aliquoted out 
for quality check. 
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Immunoprecipitation- 
The chromatin (140 μL per ChIP) was dilued to 1400 μL with ChIP-IP buffer and pre-cleared 
with pre-equilibrated and blocked (in blocking buffer) protein A beads (80 μL slurry) for 1 hr 
on a rotating wheel at 4°C. Pre-cleared chromatin was centrifuged 14,800 rpm for 10 mins at 
4°C. The chromatin was transferred to fresh tube, 14 μL aliquoted out as input (stored at -
4°C) and beads discarded. To the pre-cleared chromatin, 35 μL (1:1) pre-equilibrated and 
blocked, GFP-Trap beads (Chromotek) were added and samples incubated o/n on a rotating 
wheel at 4°C. 
 
Washing- 
The samples were centrifuged at 2000 rpm for 5 mins at 4°C, supernatant discarded and 
beads were washed 3x with low salt buffer, 3x with high salt buffer, 1x with LiCl buffer and 
1x with TE buffer. Each wash was incubated on a rotating wheel at 4°C for 10 mins. After the 
last wash, beads were resuspended in 700 μL of TE buffer and transferred to fresh tubes, 
centrifuged at 2000 rpm for 5 mins at 4°C. The supernatant was discarded. 
 
Elution- 
250 μL of elution buffer (EB) was added to each sample and incubated for 20 mins on a 
rotating wheel at RT, centrifuged 2000 rpm for 5 mins at RT. The supernatant was transferred 
to fresh tubes. To the beads, 250 μL of EB was added and incubated 20 mins at RT on a 
rotating wheel and then incubated 95°C for 10 mins, centrifuged full speed at RT for 5 mins. 








To each sample, 10 μL of 0.5 M EDTA, 20 μL of 1M Tris-HCl pH 6.8 and 2 μL of Proteinase 
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DNA purification- 
DNA was purified using Qiaquick PCR purification Kit (Qiagen) following the kit protocol. The 
DNA was eluted with elution buffer provided in the kit. The DNA was diluted 1:4 with the same 





5 μL of purified DNA was mixed with 15 μL of qPCR master mix as- 
 
qPCR Master mix per reaction- 
Component Concentration 
2x SensiFAST SYBR Lo-ROX mix 1x 
Forward primer 20 nM 
Reverse primer 20 nM 
Water upto 15 μL 
  
The master mix (15 μL) was pipetted in each well of a 96-well plate and 5 μL of purified DNA 
was then pipetted and mixed. The qPCR was performed with following program- 
   95°C    2 min 
    95°C    5 s 
    60°C    10 s 
    72°C    20 s 
    55°C    10 s 
     …. 
    95°C    10 s 
 
The Ct values derived from the qPCR were used for the quantification of the % input as- 
∆Ct = Mean Ct(input) – Mean Ct (elute) 
The percentage of input was calculated as- 
% input = 2^∆Ct 
The standard deviation (SD) was calculated as- 
SD = ln (2) × % input × √ SD (input)2 + SD (elute)2 
 
40 cycles 
Melting curve: temperature was 
increased in 0.5°C steps after 10 s 
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Buffer Composition 
Lysis buffer 50 mM Tris-HCl pH 8.0 
10 mM EDTA 
1% SDS 
ChIP-IP buffer 16.7 mM Tris-HCl pH 8.0 
1.2 mM EDTA 
167 mM NaCl 
1.1% Triton X-100 
0.01% SDS 
Blocking buffer 2 mG/mL BSA 
2% Fish skin gelatin 
2x low salt buffer (1x final) 
2x Low salt buffer 40 mM Tis-HCl pH 8.0 
4 mM EDTA 
300 mM NaCl 
2% Triton X-100 
0.2% SDS 
Low salt buffer 20 mM Tis-HCl pH 8.0 
2 mM EDTA 
150 mM NaCl 
1% Triton X-100 
0.1% SDS 
High salt buffer 20 mM Tris-HCl pH 8.0 
2 mM EDTA 
500 mM NaCl 
1% Triton X-100 
0.1% SDS 
LiCl buffer 10 mM Tris-HCl pH 8.0 
1 mM EDTA 
250 mM LiCl 
0.1% NP-40 
Elution buffer (EB) 100 mM NaHCO3 
1% SDS 
 
  Materials and Methods 
   
77 
 RNase A and Immunofluorescence 
 
300 μL of 1 mil/mL S2 cells expressing endogenously tagged dMi-2-GFP on the C-terminal 
were seeded on Concanavalin-A coated coverslips placed inside a 24-well plate and allowed 
to spread for 1 hr at 26°C. The medium was removed and cells washed twice with 1xPBS. 
The cells were permeabilized with 0.05 μg/μL Digitonin in 1x PBS for 15 mins at RT. The cells 
were washed twice with 1x PBS. The RNA was depleted by treating the cells with 10 ug/μL 
RNase A in 1x PBS for 10 mins at RT. The control cells were treated with 1x PBS alone. Cells 
were washed twice with PBS and fixed with 4% paraformaldehyde (PFA) for 15 mins at RT. 
The cells were again washed twice with 1x PBS. Since, dMi-2 is GFP tagged, it was visualized 
directly under a confocal microscope. However, to visualize the effects on a known RNA 
binding protein, MOF, which loses its nuclear occupancy upon RNA depletion, cells were 
treated with anti-Mof primary antibody after blocking with 3% BSA in a humidified chamber 
for 2 hr. The cells were incubated with secondary antibody against Rabbit primary antibody, 
incubated for 1 hr in humidified conditions. The secondary antibody solution (3% BSA in 
PBS) was supplemented with DAPI and Phalloidin stains. The coverslips were washed twice 
in 1x PBS and mounted on glass slides with Mowiol mounting media. Slides were allowed to 




Primary antibody solution Anti-Mof (1:1000, Rabbit) in 3% BSA 
Secondary antibody solution Alexa-633 anti-rabbit antibody (1:1000) 
DAPI stain (1:1000) 
Phalloidin-647 stain (1:1000) 
 
 Gibson assembly 
 
All the constructs in this study were generated by Gibson assembly as described in (Gibson 
et al., 2009). In brief, the insert DNA fragments were generated with primers having at least 
15-20 nucleotides over-lapping nucleotides at the selected site of insertion in the vector on 
either side. The vector was cut at the selected site with restriction enzymes and purified using 
Qiagen gel extraction kit following the kit protocol. The insert DNA fragments were also 
purified by gel extraction. The PCR generated insert DNA fragments and the restriction 
digestion generated vector DNA were mixed with 1.33x isothermal master mix as- 
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The 1.33x isothermal master mix (15 μL) was thawed on ice. To this 5μL of DNA (insert + 
vector) were added in equimolar amounts. Samples were incubated at RT for 2 mins and then 
immediately at 50°C for 60 mins in a thermocycler. 5 μL from the reaction were immediately 
transformed in competent E. coli. The transformed bacteria were then platted on Luria Broth-
Agar (LB-A) plates with specific antibodies and incubated o/n at 37°C. The plates were 
verified for colonies which were used for plasmid extraction. 
 
5x isothermal reaction buffer- 
Component Volume 
1 M Tris-HCl pH 7.5 3 mL 
1 M MgCl2 300 μL 
100 mM dGTP 60 μL 
100 mM dATP 60 μL 
100 mM dCTP 60 μL 
100 mM dTTP 60 μL 
1 M DTT 300 μL 
PEG-8000 (Polyethylene glycol) 1.5 g 
100 mM NAD (Nicotineamine adenine 
dinucleotide) 
300 μL 
Water 6 μL 
Aliquoted as 320 μL in 1.5 mL tubes and 
stored at -20°C. 
 
1.33x isothermal master mix- 
Components Volume 
5x isothermal master mix 320 μL 
T5 exonuclease (NEB) 0.64 μL 
PhusionTM High Fidelity DNA Polymerase 
(Thermo Scientific) 
20 μL 
Taq DNA Ligase (Thermo Scientific) 0.16 μL 
Water Up to 1.2 mL 
Aliquot as 15 μL in 0.2 mL PCR tubes and 
store at -20°C. 
 
  Materials and Methods 
   
79 
 individual nucleotide resolution cross-linking and immunoprecipitation-
2 (iCLIP2) 
 
The iCLIP2 protocol as described in (Buchbender et al. 2019) was used. Cells expressing the 
protein of interest which were seeded in 15 cm dishes were washed 2x with cold PBS and 
all liquid was discarded. Protein-RNA crosslinking was done with exposure to 254 nm UV 
light (300mJ/cm2) using a Stratagene Stratalinker while the culture dish was placed in ice-
cold water bath for cooling. The cells were harvested by scraping and collected in a vial and 
centrifuged for 5 mins at 2,000 rpm at 4°C. The liquid was discarded. The cell pellet was 
resuspended in 4 packed cell volumes of RIPA buffer supplemented with protease inhibitors 
and DTT, incubated for 10 mins on ice, mixed every 3 mins and centrifuged at 13,000 rpm 
for 20 mins at 4°C. Pellets were discarded and the whole cell extracts (supernatant) 
transferred to fresh tubes, quantified by Bradford assay and certain volumes selected for 
immunoprecipitation, three vials each condition and labelled 10-3, 10-4 and 10-5.  
 
Buffer Composition 
RIPA buffer 50 mM Tris-HCl pH 7.4 
1% NP-40 
0.1% SDS 
150 mM NaCl 
5 mM EDTA 
Store at 4°C (supplemented with protease 
inhibitor and RNase inhibitor on use). 
 
DNase and partial RNase digestion-  
To the whole cell extract, 2 volumes (vol) of RQ-1 buffer was added. Subsequently, TURBOTM 
DNase (1:500 vol.) and RNaseOUT (1:1,000 vol.) were added to the extract and mixed gently. 
RNase I was added to a final concentration of 10-3, 10-4 and 10-5 respectively. Samples were 
incubated at 37°C for 3 mins with 800 rpm shaking and immediately placed on ice for 3 mins. 
To each sample, 20 μL (1/50 vol.) of 5M sodium chloride (NaCl) was added and samples 
centrifuged at 16,400 rpm for 5 mins at 4°C. The extracts were transferred to fresh tubes. 
 
Buffer Composition 
RQ1 buffer 40 mM Tris-HCl pH 8.0 
10 mM MgSO4 
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1 mM CaCl2 
Store at 4°C (supplemented with 1mM DTT 
and protease inhibitors on use) 
TBS1000-T buffer 50 mM Tris pH 7.4 
1000 mM NaCl 
0.05% Tween-20 
Store at 4°C (supplemented with 1mM DTT 
and protease inhibitors on use) 
PNK Buffer 70 mM Tris-HCl pH 7.5 
10 mM MgCl2 
0.05% NP-40 
Store at 4°C (supplemented with 1mM DTT 
and protease inhibitors on use) 
 
Immunoprecipitation (IP)- 
Since our protein of interest was fused with GFP, the GFP trap beads were washed 2x with 
1 mL cold TBS-T. To each sample, the washed and equilibrated GFP-trap beads were added 
and samples incubated for 2 hrs at 4°C on rotation. After IP, the samples were centrifuged at 
2,000 rpm for 5 mins at 4°C and the flow through was discarded. The beads were washed 
4x with TBS1000-T (transferred to fresh tubes after third wash) and 2x with PNK buffer. 
 
On-bead phosphatase treatment 
1x phosphatase mix 20x 
4 μL 10x phosphatase buffer (Fermentas) 80 μL 
1.5 μL SAP (1U/μL, Fermentas) 30 μL 
 
 0.5 μL RNaseOUT (40U/μL, Invitrogen) 10μL 
 
43 μL DMPC-water 680 μL 
40 μL total vol. 40 μL each 
To the beads 40 μL of the 20x phosphatase mix was added and incubated at 37°C for 20 
mins. Beads were washed 2x with TBS400-T (eppis were changed in second wash) and 2x 
with PNK buffer. 
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On-bead 3’-end RNA linker ligation 
1x ligase mix: 20x 
1.5 μL 3’-linker (100 pmol/μL) 30 μL 
2.5 μL 10x T4 RNA-ligase buffer (Thermo) 50 μL 
0.65 μL RNA-ligase (10U/μL, Thermo) 13μL 
0.25 μL RNaseOUT (40U/μL, Invitrogen) 5 μL 
 
2.50 μL BSA (1mg/mL, The) 50μL 
17.60 μL DMPC-water 352 μL 
25 μL total vol. 25 μL each 
 
To the beads, 25 μL of 1x ligase mix was added and incubated at 16°C in a thermomixer o/n. 
Samples were washed 2x with PNK buffer. 
 
On-bead PNK treatment:                                                                    
1x PNK mix 20x 
2 μL 10x PNK buffer (NEB) 40 μL 
2 μL ATP (SCP801; 12.33 pmol/μL) 40 μL 
0.5 μL T4 PNK Enzyme (NEB) 10μL 
0.5 μL RNaseOUT (40U/μL, Invitrogen) 10 μL 
 
15μL DMPC-water 300 μL 
20 μL total vol. 20 μL each 
 
To the beads, 20 μL of 1x PNK mix was added and incubated at 37°C for 20 mins in a 
thermomixer. Beads were washed 1x with cold TBS-T and 1x with cold PNK buffer. 
 
SDS PAGE and Blotting- 
The beads were mixed with 20 μL of 2x LDS loading buffer supplemented with DTT. Samples 
were denatured for 10 mins at 70°C while shaking and loaded on 4-12% Bis-Tris gel along 
with a pre-stained size marker and electrophoresed at 200 V for 5 hrs. After this the proteins 
were transferred to a nitrocellulose membrane by blotting o/n at 15 V at 16°C. The protein 
size marker bands were drawn on a plastic bag using a radioactive pen after placing the 
plastic bag on top of the membrane. Expose the membrane whilst in the plastic bag to X-ray 
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film for 16 hrs. The X-ray films were developed and the autoradiograms were used to detect 
the protein-RNA complex of interest. The corresponding area was marked on the 
nitrocellulose membrane and further processed. 
 
RNA isolation- 
The selected area in the nitrocellulose membrane containing the protein-RNA complex of 
interest with intermediate RNase I (10-4) treatment was cut along with the corresponding area 
in the control lane. To the nitrocellulose membrane pieces, 400 μL of PNK buffer was added 
and 20 μL of Proteinase K (20 mg/mL). Samples were incubated at 37°C for 20 mins with 
1,000 rpm shaking. 400 μL of PK buffer and 7 molar (M) urea were added to each tube and 
incubated for a further 20 mins at 55°C with shaking at 1,000 rpm. 
 
CLIP-PK Buffer 
Buffer CLIP-PK Buffer (Final 
conc.) 
Volume (mL) 
1M Tris-HCl pH 7.4 100 mM 1.5 
5M NaCl 50 mM 0.150 
0.5M EDTA 10 mM 0.300 
10% SDS 1% 1.5 
 
CLIP-PK-Urea Buffer 
Buffer CLIP-PK-Urea Buffer 
(Final conc.) 
Volume (mL) 
1M Tris-HCl pH 7.4 100 mM 1.5 
5M NaCl 50 mM 0.150 
0.5M EDTA 10 mM 0.300 
Urea 7M 6.306 grams 
 
To each tube, 800 μL of RNA-grade phenol-chloroform-isoamyalcohol (25:24:1) was added 
and samples incubated at 30°C for 5 mins with shaking at 1,000 rpm. To separate the 
aqueous layer containing the RNA, samples were centrifuged at 13,000 rpm for 5 mins at RT 
using phase-lock gel (5PRIME). The aqueous layer was transferred to a new tube without 
disturbing the gel. RNA was precipitated by adding 1 μL glycoblue (Ambion, 9510), 80 μL of 
3 M sodium acetate (NaOAc) pH 5.5 and 0.7 vol. ice-cold isopropanol, mixed and incubated 
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o/n at -80°C. Samples were centrifuged at 14,800 rpm for 20 mins at 4°C, supernatant was 
discarded, RNA pellet washed with 0.9 mL of 80% ethanol, centrifuged again full speed for 
5 mins. The RNA pellet was air-dried for 3 mins and dissolved in 5 μL of RNase-Free water 
and transferred to a PCR tube. 
 
Reverse Transcription (RT)- 
To the RNA sample, 1 μL (0.5 pmol/μL) RT-oligo primer was added along with 1 μL (10 mM) 
dNTP mix. 
 
RT Thermal program 
Temperature Incubation time 
70°C 5 mins 
25°C Hold 
 




Water 7 μL 
5x RT Buffer 4 μL 




Superscript III 0.5 μL 
 
The reverse transcription reaction was set in a thermocycler with following temperature and 
time cycles- 
 
Temperature Incubation time 
25°C 5 mins 
42°C 20 mins 
50°C 40 mins 
80°C 5 mins 
4°C Hold 
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At the end of RT, 1.65 μL of 1 M sodium hydroxide (NaOH) was added and samples incubated 
at 98°C for 20 mins. To eliminate the radioactivity, 20 μL of 1 M HEPES-NaOH pH 7.3 was 
added. The samples were cleaned up using MyONE clean-up kit following the kit protocol 
which allows cDNA to bind the beads, beads are washed and then 5 μL of water was added 
directly without removing the beads. 
Second linker ligation to the 3’-end of the cDNA- 
To the cDNA-bead solution, 2 μL (10 μM) of second adapter and 1 μL DMSO (100%) were 
added. Samples were heated to 75°C for 2 mins and immediately cooled on ice for 1 min. 
We had a total of four tubes, therefore, we added four different second linkers as- 
 
Sample Linker sequence 
dMi-2-GFP replicate -1 NNNNNGCCTAANNNN (#3) 
untagged control replicate -1 NNNNNTCAAGTNNNN (#8) 
dMi-2-GFP replicate -2 NNNNNAAGCTANNNN (#10) 




Water 0.3 μL 
10x RNA ligase buffer (with DTT) (NEB) 2 μL 
100 mM ATP 0.2 μL 
50% PEG 8000 9 μL 
High conc. RNA Ligase 0.5 μL 
 
To the 8μL cDNA-second linker mixture, 12 μL ligation mix and an additional 1 μL of RNA 
ligase was added (final vol. 21 μL). Samples were mixed by stirring and agitation o/n at 22°C 
with 1,100 rpm shaking. The cDNA ligated to the second linker were cleaned up using MyONE 
clean up kit following the kit protocol. Like in the first MyONE clean up step, the cDNA were 
coupled to the beads, washed, air-dried and cDNA eluted in 23 μL of water. This time the 
elute was separated from the beads into fresh vials. 
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First Polymerase chain reaction (PCR, cDNA amplification) 
Sample Volume 
cDNA 22.5 μL 
P5Solexa_s and P3Solexa_s primer mix (10 
μM each) 
2.5 μL 
2x Phusion HF MasterMix 25 μL 
 










The excess primers and primer-dimers were removed in a subsequent size selection step 
using ProNex size selection kit following the kit protocol. The sample to ProNex bead ratio 
was determined (1:2.95) and this ratio was used for the samples. At this step, the cDNA 
fragments longer than 20 nucleotides (nt) were retained while smaller fragments were 
discarded. This allows unambiguous mapping of the resultant reads. A 20 nt cDNA fragment 
is extended to a length of 75 nt due the addition of two linkers. All the products below 75 nt 
were excluded from ProNex selection.  
 
















72°C 3 mins 
16°C Hold 
6 cycles 
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The cDNA fragments selected after first size selection were mixed with PCR mix as- 
Sample Volume 
Water 8 μL 
cDNA (³ 75 nts) 10 μL 
P5Solexa and P3Solexa primer mix (10 μM) 2 μL 
2x Phusion HF MasterMix 20 μL 
 










After the library preparative PCR, 4 μL of each library was loaded on a 6% native PAGE and 
stained with EtBr to verify the quality of the library. The library was again subjected to size 
selection using the ProNex size selection kit following the kit protocol. At this stage of 
amplification, the size of a 20 nt cDNA fragment is extended to 155 nt (P5Solexa and 
P3Solexa primers are each 60 nt). Therefore, fragments longer than 155 nt were retained 
and the shorter fragments were discarded along with primer-dimers and excess primers. 
The final library was quantified using a Bioanalyzer and sequenced. 
 
2.2.3  Bioinformatics Pipeline 
 
The raw iCLIP sequencing reads were assigned to the different libraries by the specific 
barcode part of the unique molecule identifier (UMI) and deduplicated based on total 
sequence identity with an in-house script. UMIs were removed from the read sequences and 
added to the read identifier. Additionally, poly(A) tails with at least eight consecutive A’s were 







72°C 3 mins 
16°C Hold 
11 cycles 
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Drosophila melanogaster genome (dm6) using bwa-mem (0.7.17-r1188, arXiv:1303.3997v2) 
with minimum score output (-T) set to 19. Alignments were deduplicated based on UMIs and 
mapping position using UMI-tools (1.0.1, doi:10.1101/gr.209601.116) dedup functionality 
with default parameters. Only reads mapping uniquely to the genome were considered for 
further analysis while the rest of the reads were discarded. The uniquely mapped reads were 
attributed to transcript annotations based on their genomic coordinates using featureCounts 
from the SubRead (v1.6.4, doi:10.1093/bioinformatics/btt656) software suite for non-
overlapping features (-O) and only counting strand specific alignments (-s 1). 
 
Sample Correlation- The read counts from the two biological replicates were checked for 
correlation by calculating the squared Pearson Correlation Coefficient for paired samples. 
For visualization a linear model was fitted using the same metric.  
 
Metagene Analysis- A metagene representation was generated based on read starts from 
both libraries using bamCoverage, calculateMatrix and plotProfile from the deepTools suite 
(3.4.3, doi:10.1093/nar/gkw257) with options “-bs 1 --ignoreDuplicates --minMappingQuality 
1 --exactScaling --Offset 1”. Additionally, a detail graphic for the TTS of all transcripts with 
iCLIP reads was generated by manually plotting cross link positions derived from alignment 
start position minus one within +/-500 nucleotides of the TTS. Transcripts were sorted by 
mapped number of reads and their proximity to TTS. Relative density of cross links was 
calculated for the respective region. 
 
Intron-Exon coverage- The cumulative coverage across the last intron-exon junction of all 
transcripts with at least two exons was determined using a custom script and plotted for +/-
10 nucleotides around the junction. 
 
DE-Seq analysis- To rule out abundant iCLIP targets due to overall expression in the cell, we 
used unbiased RNA-Seq libraries from the same cell line (lenz et. al., 2021) as a reference in 
a relative expression analysis. Reads were mapped identical to iCLIP reads but without prior 
trimming. Uniquely mapping reads were then counted using featureCounts as described 
above. In contrast to iCLIP, RNA-Seq read counts were normalized to FPKM (fragments per 
kilobase in transcript per million reads in library) to account for the difference in protocols 
(there is one read per cross-linked transcript molecule in iCLIP, while RNA-Seq can produce 
multiple reads per molecule especially for longer transcripts). 
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DESeq2 (doi:10.1186/s13059-014-0550-8) was used to identify mRNAs stably captured in 
iCLIP experiments than expected by proportional abundance in RNA-Seq. We chose a 
threshold for adjusted p-value of < 0.05 and putative log fold change > 4 to identify mRNAs 
that we regard as sufficiently enriched in iCLIP above expected abundance levels. 
 
Position relative to cross-link site- Genomic sequences +/-200 nucleotides around all 
identified cross-linking sites were extracted and absolute as well as relative base content 
per relative position to the cross-linking site calculated to identify base specific biases at 
the cross-linking site. Relative base content per position was converted to percent of the 
median content for each base within the 400-nucleotide window. Additionally, a sequence 
logo was generated with genomic sequences of +/-20 nucleotides around the cross-linking 
site using kpLogo (v1.1, doi:10.1093/nar/gkx323) and parameters “-gapped -startPos 21”.
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3 Results 
3.1 Chapter 1 
 
3.1.1 dMi-2 is an RNA-binding protein 
 
Murawska et al., 2011, suggested dMi-2 to be recruited to heat shock genes through a 2-
step mechanism in which a possible interaction with RNA in vivo is postulated to play an 
important role. dMi-2 was shown to bind RNA by Murawska et al., 2011, however, the 
molecular aspects underlying the binding to RNA were not studied in detail. I sought to 
characterize the molecular basis of dMi-2 interaction with RNA and started by re-producing 
the dMi-2 RNA binding experiment in Murawska et al., 2011. I generated the 230 nucleotide 
RNA fragment, used in that study, by in vitro transcription from Hsp70Aa gene. I infected 
Spodoptera frugiperda-9 (Sf9) cells with Baculovirus expressing N-terminally FLAG-tagged 
dMi-2. The recombinant FLAG dMi-2 was purified by FLAG-immunopurification using anti-
FLAG-M2 beads and the protein was eluted using FLAG-peptide. (Figure 3.1.1A, Lane 4). I 
performed an electrophoretic mobility shift assay (EMSA) using the recombinant dMi-2 and 
the RNA. If a protein binds the RNA, the protein-RNA complex that is formed is separated 
from the unbound RNA on a native gel wherein the bound complex appears as a 
shifted/retarded band. When I added dMi-2 to the RNA, I saw a shifted band (Figure 3.1.1B, 
lane 2, asterisk mark) and as I increased the amount of dMi-2, I observed an increased 
appearance of an RNA-dMi-2 complex confirming that, indeed dMi-2 is an RNA-binding 
protein in vitro (Figure 3.1.1B). 
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Figure 3.1.1: dMi-2 binds RNA in vitro 
A) FLAG Immunopurification of N-terminally FLAG tagged dMi-2 protein. 15 𝝁L of eluted dMi-
2 (lane 4) was loaded on an SDS gel along with 0.1% input (14.4 𝝁g) and 14.4 𝝁g of flow 
through (lanes 2 and 3, respectively) and electrophoresed. The gel was stained with 
Coomassie Brilliant Blue. The additional faint bands running below the main (dMi-2) band are 
likely the degradation products of dMi-2. Molecular weight marker was loaded in lane 1. B) 
Native polyacrylamide gel showing the EMSA of a 230-mer RNA fragment in vitro transcribed 
from Hsp70Aa gene. The asterisk in lane 2 marks the dMi-2-RNA complex. 160 ng 
(nanogram) of RNA in each reaction was incubated with 25, 50, 100 and 200 ng of FLAG-
dMi-2 in lanes 2, 3, 4 and 5, respectively, and loaded on a native polyacrylamide gel. RNA 
only was loaded in Lane 1 as free RNA control and samples electrophoresed. The gel was 
stained with 1X SYBR Gold stain and imaged with Bio-Rad ChemiDoc touch system. 
 
3.1.2 dMi-2 binds RNA promiscuously  
 
After confirming that in vitro dMi-2 binds to a 230-mer RNA derived from the Hsp70Aa gene, 
I asked if this binding was specific to only that region of the Hsp70Aa RNA or if dMi-2 could 
bind to different regions of the Hsp70Aa RNA. Also, I asked if reducing the length of the RNA 
impacted the binding. To answer this, I generated four RNA fragments from different regions 
of Hsp70Aa gene by in vitro transcription, named, Hsp70Aa #1, #2, #4 and #5), each 100 
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sequence, from the others and from the 230-mer RNA used in Figure 3.1.1B (Figure 3.1.2A, 
upper panel). The RNAs were loaded on a urea denaturing polyacrylamide gel and 
electrophoresed to verify the quality of the RNAs (Figure 3.1.2B, left panel, lanes 1-4), 
confirming that RNAs were of good quality appearing as a single band. The slight differences 
in running patterns between the RNAs could likely arise from incomplete denaturation of the 
secondary structures. The RNAs on the native EMSA gel appeared as multiple bands (Figure 
3.1.2C, lanes 1,3,5 and 7) rather than as single band seen in Figure 3.1.2B, lanes 1-4. This 
could be due to impurity, degradation or different secondary structure conformations of the 
RNAs. However, since, these RNAs form a single distinct band in the denaturing gel, we can 
conclude that the multiple bands on the native gel are very likely due to different 
conformations of the RNAs. Indeed, predicting the secondary structures of the RNAs using 
SPOT-RNA software suggests that they can form distinct folded structures (Supplementary 
Figure S3.1.2 A-D). Upon testing these RNAs in EMSA, dMi-2 bound to each of the RNAs 
(Figure 3.1.2C, lanes 2, 4, 6 and 8) irrespective of their sequence and predicted structural 
differences. These results suggest that dMi-2 can bind to different regions of Hsp70Aa RNA 
which are composed of different sequences and that reducing the length of RNAs from 230 
nucleotides to 100 nucleotides did not impact the binding of dMi-2 to RNA. 
 
Having established that dMi-2 binds to different regions within Hsp70Aa RNA, I asked if the 
binding of dMi-2 to RNA is specific to Hsp70Aa RNA only or if it binds to other RNAs as well. 
To answer this, I selected Pgant35a, an unrelated gene which produces a transcript of similar 
length as Hsp70Aa (Figure 3.1.2A, lower panel). I generated four RNAs from this gene, each 
100 nucleotides in length, by in vitro transcription and electrophoresed them on urea 
denaturing polyacrylamide gel to check their quality (Figure 3.1.2B, lanes 5-8). All the RNAs 
ran as distinct single bands on the denaturing gel suggesting the purity and good quality of 
the RNAs. Each RNA has a distinct sequence that is different from the other and from the 
RNAs that were generated from Hsp70Aa gene. I also predicted the secondary structures of 
these RNAs using SPOT-RNA software (Supplementary Figure S3.1.2 E-H). Each RNA also 
has a distinct predicted secondary structure. Similar to the RNAs generated from Hsp70Aa 
gene, the RNAs generated from Pgant35a gene, also formed multiple bands on the native gel 
(Figure 3.1.2C, lanes 9, 11, 13, and 15), indicating the possibility of formation of several 
conformations in native conditions as opposed to denaturing conditions. I tested dMi-2 for 
binding to these RNAs in EMSA (Figure 3.1.2C, lanes 9-16). Interestingly, dMi-2 bound to all 
of the RNAs generated from Pgant35a gene (Figure 3.1.2C, lanes 10, 12, 14 and 16), 
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suggesting the promiscuous nature of dMi-2 interaction with RNA which indicates that dMi-
2 could bind to a diverse set of RNAs. This hints toward the possibility of dMi-2 being a 
general RNA binding protein which could potentially bind to several RNAs in vivo as well.  
 
  Results 
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Figure 3.1.2: dMi-2 binds RNA promiscuously 
A) Schematics representing the regions of Hsp70Aa (upper panel) and Pgant35a (lower panel) 
genes from which RNAs were in vitro transcribed. The orange represents the Hsp70Aa 100bp 
double stranded DNA B) 150 ng of RNAs derived from Hsp70Aa and Pgant35a genes were 
loaded on urea denaturing polyacrylamide gels (Lanes 1-4 and 5-8, respectively) and 
electrophoresed. C) EMSAs showing that dMi-2 binds all the RNAs from (B) promiscuously. 
For EMSAs 150 ng of each RNA and 500 ng of dMi-2 was used per reaction. RNA only as 
control was loaded in lanes 1, 3, 5, 7, 9, 11, 13 and 15, and electrophoresed. Both the gels 
were stained with 1X SYBR Gold and imaged with Bio-Rad ChemiDoc touch system.  
 
3.1.3 dMi-2 binds some nucleic acids with higher affinity than others 
in vitro 
 
Having established that dMi-2 can bind to several RNA molecules in vitro, I asked if there are 
quantitative differences in binding affinity. To this end, I generated 100-nucleotide RNAs from 
Hsp70Aa and Pgant35a genes, named Hsp70Aa #3 and Pgant35a #3. (Figure 3.1.2A). Both 
of these RNAs were tested for quality (Supplementary Figure S3.1.3 A and B, respectively). 
Each RNA appeared as a single discreet band suggesting the purity of the RNAs. Hsp70Aa 
#3 RNA runs slightly higher than the 100-nucleotide single stranded RNA size marker, that 
could perhaps be due to incomplete denaturation which might allow some form of the 
secondary structure to form leading to an unexpected running behaviour.  I used 250 
nanomolar (nM) of each RNA and titrated dMi-2 from 0.1 to 1.5 micromolar (𝝁M) in the EMSA. 
As expected, dMi-2 bound to both the RNAs (Figure 3.1.3A, lanes 2-10 and lanes 12-20). In 
order to determine the quantitative differences in binding affinity of dMi-2 between these two 
RNAs I quantified the bound fraction and the unbound fraction of RNAs in each well using 
the Bio-Rad Image Lab quantification program. The binding affinity of each RNA was 
measured in terms of the approximate dissociation constant (app. Kd), which measures the 
concentration of the protein at which half of the RNA probe is bound by the protein. Hence, 
the lower the Kd value, the stronger the affinity of the protein to that RNA. The quantification 
of the EMSA results showed that dMi-2 bound the Hsp70Aa #3 RNA better than the Pgant35a 
#3 RNA (Figure 3.1.3B). The dissociation constant (app. Kd) of Hsp70Aa #3 RNA was 0.38 ± 
0.06 (𝝁M) while it was 0.63 ± 0.28 (𝝁M) for pgant35a #3 RNA, suggesting that dMi-2 has 
nearly 2-fold higher affinity for Hsp70Aa #3 RNA over the Pgant35a #3 RNA. From this data, 
I conclude that, indeed, dMi-2 could bind some RNAs with higher affinity over other RNAs in 
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vitro. This difference in the affinity could arise either from sequence of the RNA that dMi-2 
prefers binding to or their secondary structures.  
 
dMi-2 has been shown to bind to double stranded DNA (dsDNA) by (Bouazoune et al., 2002). 
I asked if dMi-2 binds double stranded RNA (dsRNA) as well and whether the binding affinities 
are different between dsRNA and dsDNA. To this end, I used the 100bp DNA sequence of 
Hsp70Aa #3 fragment from above as template to generate a double stranded RNA by in vitro 
transcription using two T7 promoters, one on each strand. The template DNA of this fragment 
without T7 promoters was used as double stranded DNA (Supplementary Figure S3.1.2C), 
hence, these two nucleotide fragments are analogous in sequence to each other. To ascertain 
the formation of double stranded RNA, I treated the dsRNA with or without RNase III. RNase 
III is a ribonuclease that specifically cleaves dsRNA. I used Hsp70Aa #3 single stranded RNA 
as a control (Supplementary Figure S3.1.2D). The RNase III specifically cleaved the dsRNA 
(Supplementary Figure S3.1.2D, lane 4) and expectedly had no effect on the ssRNA 
(Supplementary Figure S3.1.2D, lane 3). Having substantiated the double stranded nature of 
the Hsp70Aa 100bp dsRNA, I compared the binding of FLAG dMi-2 to dsRNA and dsDNA 
fragments with analogous sequences in EMSA experiments. I observed that dMi-2 binds to 
dsRNA (Figure 3.1.2C, lanes 1-10) in addition to dsDNA (Figure 3.1.2C, lanes 11-20). dMi-2 
bound to both the nucleic acids with similar dissociation constants (app. Kd) of 0.86 ± 0.01 
(𝝁M) for dsRNA and 0.82 ± 0.01 (𝝁M) for dsDNA (Figure 3.1.2D), suggesting that dMi-2 has 
similar binding affinity to both dsRNA and dsDNA of 100bp length in vitro. 
 
Table 1: Approximate dissociation constants for binding of various nucleotides to 
dMi-2 
 
Nucleic acids app.  Kd (𝝁M) 
Hsp70Aa 100-mer ssRNA 0.38 ± 0.06 
Pgant35a 100-mer ssRNA 0.63 ± 0.28 
Hsp70Aa 100bp dsRNA 0.86 ± 0.01 
Hsp70Aa 100bp dsDNA 0.82 ± 0.01 
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Figure 3.1.3: dMi-2 binds some nucleic acids with more affinity than others 
(A) EMSAs of ssRNAs Hsp70Aa #3 (lanes 1-10) and Pgant35a #3 (lanes 11-20). 250 nM RNA 
was used in each reaction and dMi-2 was titrated from 0.1 to 1.5 𝝁M. Representative image 
of 3 independent replicates is shown. B) Quantification of the EMSA in (A). Data points from 
three independent biological replicates are shown. C) EMSA of dsRNA  and dsDNA from 
Hsp70Aa (100bp) which are analogous in sequence. 250 nM dsRNA or dsDNA was used for 
each reaction and dMi-2 was titrated from 0.1 to 1.5 𝝁M. Representative image of two 
independent replicates. D) Quantification of the EMSA in (C). Data points from two 
independent biological replicates are shown. Each sample was loaded on a native 
polyacrylamide gel and electrophoresed. The gels were stained with 1X SYBR Gold and 
imaged with Bio-Rad ChemiDoc touch system. The image quantifications were performed 
using Bio-Rad Image-Lab software. The app. Kd were determined by using Hill Slope 
equation. 
 
3.1.4 dMi-2 binds RNA in high salt and detergent conditions 
 
The results above substantiate that dMi-2 is a general RNA binding protein in vitro. Next, I 
sought to determine if dMi-2 would be able to bind to RNA smaller than 100 nucleotides. I 
tested dMi-2 binding to 40-mer RNA, and it bound well, data not shown. Therefore, I decided 
to use 40-mer RNAs as well, henceforth. Next, I sought to determine the stability of the dMi-
2-RNA complex. The standard EMSA reaction buffer contains 40 millimolar (mM) potassium 
chloride (KCl); to determine the salt sensitivity of dMi-2 binding to RNA, I increased the salt 
concentration in the EMSA reaction buffers up to 800 mM KCl (Figure 3.1.4A). The formation 
of some RNA-protein complexes such as pentatricopeptide repeat protein-10 (PPR-10)-RNA 
complex was shown by (McDermott et al., 2018) to be highly sensitive to salt with dissociation 
constant increasing nearly 450-fold from 1.8 ± 0.2 picomolar (pM) at 75 mM salt to 800 ± 400 
picomolar (pM) at 300 mM salt. Similarly, Fox1, another RNA binding protein, was shown by 
(Auweter et al., 2006), to be influenced by salt in its RNA interaction with the dissociation 
constant (Kd) increasing over 300-fold from 0.06 nM at 75 mM salt to 18.7 nM at 500 nM salt. 
Likewise, PRC2, a chromatin modifying protein that has been extensively characterized for 
RNA binding, loses the crosslinking to HOTAIR 400 RNA at 400 mM salt, as reported by 
(Wang et al., 2017). Surprisingly, over 60% of dMi-2-RNA complex can withstand even the 
maximum amount of salt that I tested i.e. 800 mM KCl in the EMSAs (Figure 3.1.4A, upper 
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panel lane 7 and Figure 3.1.4C). The electrophoresis of the gels in such high salt conditions 
causes retardation of the nucleic acids which is the reason for the free RNAs running unevenly 
between low salt (Figure 3.1.4A, lanes 1-4) and high salt conditions (Figure 3.1.4A, lanes 5-
7). Also, the dMi-2-RNA complex is most stable at low to intermediate salt conditions i.e. 40 
mM to 150 mM (Figure 3.1.4A, lanes 2-4), after which the complex appears to gradually 
disintegrate, with increasing free RNA appearing as the salt is increased, however, still 
retaining stability to the extent that over 60% of the RNA remains bound to dMi-2 even at 
800 mM salt (Figure 3.1.4A and Figure 3.1.4C).  
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Figure 3.1.4: dMi-2 binds RNA in high salt and detergent conditions 
A) EMSA showing binding of dMi-2 to RNA in increasing salt conditions. 34.5 ng of Hsp70Aa 
#6 RNA (Figure 3.1.2A) and 1.12 𝜇g dMi-2 was used for each reaction. RNA only was loaded 
in lane 1 as free RNA control. B) EMSA showing binding of dMi-2 to RNA in increasing NP40 
conditions. 34.5 ng of Hsp70Aa #3 RNA and 763 ng of dMi-2 was used for each reaction. No 
NP40 was added in lanes 1 and 2. Lane 3 was left empty. C) Quantification of EMSA in (A). 
D) EMSA showing binding of dMi-2 to RNA in increasing SDS conditions. 34.5 ng of Hsp70Aa 
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#3 RNA and 763 ng of dMi-2 was used in each reaction. No SDS was added in lanes 1 and 
2. Lane 3 was left empty. Each sample was loaded on native polyacrylamide gel and 
electrophoresed. Gels were stained with 1X SYBR Gold and imaged with Bio-Rad ChemiDoc 
touch system.  
 
Further, I tested the effects of two detergents on the stability of dMi-2-RNA complex. I used 
NP40, a mild ionic detergent (Figure 3.1.4B) and sodium dodecyl sulfate (SDS), a harsher 
anionic detergent (Figure 3.1.4D). dMi-2-RNA complex could withstand 8% of NP40 in the 
reaction buffer. Beyond this concentration, the reactions became too viscous for proper 
pipetting. On the other hand, there was no formation of the dMi-2-RNA complex in presence 
of even 0.025% of SDS (Figure 3.1.4D, lanes 4-6). The possible explanation could be that 
the SDS either de-stabilized the complex or denatured the protein such that it no longer 
bound the RNA. To conclude, the data suggests that dMi-2-RNA interaction is very stable 
and the complex can withstand 800 mM salt and mild detergent conditions compared to 
several other RNA binding proteins including PPR-10, Fox-1, and PRC2, further 
substantiating that dMi-2 is a strong RNA binding protein. 
 
3.1.5 Mapping the RNA binding region of dMi-2 
 
The dMi-2 protein is 1982 amino acids long (Figure 3.1.5A and Supplementary Figure 
S3.1.5A). It has a N-terminal region that consists of several domains including plant 
homeodomain (PHD) and chromodomains (CD). The C-terminal part of the protein is 
separated from the N-terminal part by an ATPase or Helicase domain (Figure 3.1.5A). I 
sought to identify the RNA binding regions in dMi-2. To that end, I used three dMi-2 truncation 
mutants - dMi-2 ∆N, dMi-2 ∆C and dMi-2 (691-1271) from (Bouazoune et al., 2002) (Figure 
3.1.5A). All three mutant are N-terminally FLAG tagged. I infected Sf9 cells with Baculovirus 
expressing these truncation mutants and purified them by FLAG immunopurification. The 
proteins were eluted from the anti-FLAG beads using FLAG peptide (Supplementary Figure 
S3.1.5A). I performed EMSAs with these truncation mutants to test their binding to RNA. 
Often, protein-RNA complexes are resolved in the native polyacrylamide gel, however, with 
large proteins, there could be some complexes that do not enter the gel. Such complexes 
could be a result when two or more protein molecules bind the same RNA molecule. The 
resultant protein-RNA complex could be too large for gel resolution and therefore, such 
complexes remain stuck in the well. Such unresolvable complexes usually form with large 
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proteins. Indeed, we observe such complexes with FLAG dMi-2 wild type (WT), dMi-2 ∆N 
and dMi-2 ∆C, as pointed out by arrow heads (Figure 3.1.5B, lanes 2, 3 and 4). Therefore, 
it is important to consider the signal in the well as bound complex. The EMSA experiment 
shows that dMi-2 WT bound to RNA, as expected. The truncation mutant dMi-2 ∆C, which 
has the N-terminal region but doesn’t have the C-terminal, also bound to the RNA (Figure 
3.1.5B, lane 4, Figure 3.1.5C and Supplementary Figure S3.1.5B, lanes 5 and 6). 
Importantly, the dMi-2 ∆N mutant, which has no N-terminal part, largely lost binding to RNA 
with very faint signal from a gel resolved complex as pointed out by an asterisk (Figure 
3.1.5B, lane 3, asterisk mark, Figure 3.1.5C and Supplementary Figure S3.1.5B, lanes 3 
and 4) suggesting that the major RNA binding regions of dMi-2 reside within the N-terminal 
part of dMi-2. However, as marked by an arrow head, an unresolvable complex appears in 
the well (Figure 3.1.5B, lane 3). Also, since there is a loss of signal from the free RNA in lane 
4 as compared with the RNA only control in lane 1, this mutant might as well bind to RNA to 
some extent, suggesting that some RNA binding regions of dMi-2 might reside outside of the 
N-terminal region. In case of dMi-2 (691-1271), which has the ATPase domain, no binding to 
RNA could be detected (Figure 3.1.5B, lane 5 and Supplementary Figure S3.1.5B, lanes 7 
and 8) suggesting that this domain on its own does not bind RNA in vitro. From this data, I 
conclude that the major RNA binding regions of dMi-2 are within the N-terminal part of the 
protein. 
 
Having located the major RNA binding region of dMi-2 in its N-terminal part, I asked which 
region within the N-terminal part contributes to the RNA binding of dMi-2. The first 376 amino 
acids of dMi-2 contain several positively charged amino acids (22.34%). If the binding of dMi-
2 to RNA is entirely driven by charge, that is, interaction between positively charged amino 
acids with negatively charged nucleic acids, then the RNA binding region should be within 
the first 376 amino acids. To answer this, I created two new truncation mutants. First, I 
generated a truncation which consisted of only the first 376 amino acids, dMi-2 1-376 (Figure 
3.1.5A). This region includes the HMG-box domain whose function remains unknown and 
has several positively charged amino acids. Next, I generated another truncation mutant 
which lacked the first 376 amino acids, dMi-2 ∆376. This mutant contains the tandem PHD 
fingers and the chromodomains, the ATPase domain and the C-terminal part (Figure 3.1.5A) 
and it has only 15.81% positively charged amino acids. Both of these mutants were N-
terminally FLAG-tagged. I infected Sf9 cells with Baculovirus expressing these truncation 
mutants. The proteins were purified by FLAG immunopurification and eluted with FLAG 
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peptide (Supplementary Figure S3.1.5C and E, lane 2). Next, I tested these mutants in 
EMSAs for binding to RNA. dMi-2 (1-376) bound to RNA (Figure 3.1.5B, lane 6 and 
Supplementary Figure S3.1.5F, lanes 1-4). On the other hand, the dMi-2 ∆376 mutant also 
bound to RNA to some extent with a faint gel resolvable complex and an unresolved complex 
in the well (Figure 3.1.5B, lane 7, arrow head). The signal was stronger as compared to dMi-
2 ∆N suggesting that this mutant binds RNA better than the dMi-2 ∆N mutant (Figure 3.1.5C). 
This potentially implicates the additional PHD and chromodomains in dMi-2 ∆376 to play 
some role in RNA binding. These data suggest that the major RNA binding regions of dMi-2 
are within the first 376 amino acids and that some RNA binding regions may reside outside 
of this region. It also supports the hypothesis that the binding to RNA may be entirely charge 
driven. 
 
Since the above data indicate that the PHD fingers and the chromodomains (dMi-2 377-690) 
might as well bind to RNA in vitro. Therefore, to test that, I generated a N-terminally FLAG 
tagged dMi-2 (377-690) mutant and expressed this protein in Sf9 cells and FLAG 
immunopurified it (Supplementary Figure S3.1.5E, lane 3). I tested dMi-2 (377-690) for 
binding to RNA in EMSA. No RNA binding could be detected in the EMSA (Figure 3.1.5B, 
lane 8, Figure 3.1.5C and Supplementary Figure S3.1.5F, lanes 5-7), suggesting that dMi-
2 (377-690) might not bind to RNA on its own, however, it may contribute to the RNA binding 
when fused to the rest of the protein. Together, I conclude that the first 376 amino acids of 
dMi-2 which has 22.34 % positively charged amino acids, largely appear to be sufficient for 
RNA binding with possibly additional contribution by PHD fingers and chromodomains (377-
690).  
 
Having tracked a major RNA binding region of dMi-2 to the first 376 amino acids, I went on 
to further characterize the RNA binding regions within the first 376 amino acids. To that end, 
I generated mutants containing only the first 117 amino acids, dMi-2 (1-117); dMi-2 (118-238) 
which contains the HMG-box domain of unknown function and dMi-2 (239-376) (Figure 
3.1.5D). Each mutant was N-terminally FLAG tagged and expressed in Sf9 cells. The proteins 
were purified by FLAG immunopurification and eluted by FLAG peptide (Supplementary 
Figure S3.1.5G). Importantly, dMi-2 (1-117) and dMi-2 (118-238) contain similar numbers of 
positively charged amino acids, 17.94% and 17.35%, respectively, while dMi-2 (239-376) 
contains 26.08% positively charged amino acids. If the above hypothesis that the binding is 
entirely driven by charge is true, then dMi-2 (239-376) should bind to RNA the best while dMi-
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2 (1-117) and dMi-2 (118-238) should bind with equal affinity. Next, I tested these truncation 
mutant proteins for binding to RNA in EMSA. Interestingly, I observed that both fragments 
flanking the HMG-box domain bound to RNA while no RNA binding could be detected in 
dMi-2 (118-238) mutant in our assay (Figure 3.1.5E). This suggests that within the N-terminal 
region of dMi-2, the major contributors to RNA binding are likely 1-117 and 239-376 amino 
acids and that the binding to RNA is not entirely driven by charge. Several proteins, including 
chromatin regulators, bind to RNA without the presence of any canonical RNA binding 
domains. In such proteins, the presence of intrinsically disordered regions (IDRs) have been 
implicated in RNA binding. dMi-2 does not possess any canonical RBD binding domain and 
I observed that its RNA binding is not entirely driven by charge. Therefore, I asked if dMi-2 
possesses IDRs which may contribute to its RNA interaction. To this end, I predicted the 
presence of IDRs in the region that my experimental data showed to be majorly involved in 
RNA binding, that is, residues 1-376. I used Predictor of Natural Disordered Regions (PONDR) 
software with default settings. The HMG-box (118-238) folds into a defined structure (Figure 
3.1.5F). Indeed, the HMG-box was predicted as a well-defined structure with PONDR. The 
regions flanking HMG-box that appeared to bind RNA in the EMSA, that is, 1-117 and 239-
376 amino acids, were predicted as IDRs suggesting that the RNA binding of dMi-2 may be 
contributed by the IDRs in the N-terminal regions.  
  
Together, I conclude that major RNA binding sites of dMi-2 are in the first 376 amino acids 
in the N-terminal region and that 1-117 and 239-376 amino acids contribute to the RNA 
binding of dMi-2. The intrinsically disordered nature of these regions might play an important 
role in the RNA binding of dMi-2. This data does not rule out the possibility of some 
contributions to RNA binding outside of the N-terminal region. 
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Figure 3.1.5: Mapping the RNA binding region of dMi-2 
Schematics representing wild type and truncation mutants of dMi-2. High mobility group box 
(HMG), Plant homeodomains (PHD) and chromodomains (CD) and ATPase domains are 
marked (A). B) EMSA of dMi-2 WT and mutants. 250 nM RNA was used for each reaction 
against 500 nM of protein. RNA only was loaded as control in lane 1. Reactions were loaded 
on a native polyacrylamide gel and electrophoresed. The bound complexes are shown by 
arrows on the left. The unresolved complexes in the well are pointed out by arrow heads in 
lanes 2, 3, 4 and 7. Asterisk mark in lane 3 points out a gel resolved complex. C) 
Quantifications of the EMSA in (B). The bound fractions (gel resolved plus unresolved 
complex in the well) and unbound fractions were quantified using Bio-Rad Image Lab 
Software. D) Schematics representing the truncation mutants of first 376 amino acids. HMG-
box domain is denoted. E) EMSA of dMi-2 (1-117), (118-238) and (239-376). 250 nM RNA 
was used for each reaction with 1.5 𝜇M proteins. RNA only was loaded as free RNA control 
in lane 1. Arrows on the left show the bound complexes. EMSA samples were loaded on 
native polyacrylamide gel and electrophoresed. Each gel was stained with 1X SYBR Gold 
and imaged with Bio-Rad ChemiDoc touch system.  F) Software prediction of IDRs in the N-
terminal part of dMi-2. PONDR was used with optimal settings to predict IDRs. PONDR Score 
1.0 (y-axis) indicates highest score for prediction of IDR while PONDR Score of 0.0 indicates 
a well folded and structure prediction. HMG-box region is predicted as ordered and highly 
structured region while regions comprising (1-117) and (239-376) are predicted as disordered 
or IDRs. VL-XT is the combination of three predictors. One is trained on Variously 
characterized Long disordered regions. Two predictors are trained on X-ray characterized 
Terminal disordered regions.   
 
3.1.6 dMi-2 binding to homopolymer RNAs 
 
Next, I asked if dMi-2 had a specific binding preference to a certain nucleotide over the others 
i.e. if dMi-2 preferred binding to Adenine (A), Uracil (U), Cytosine (C) or Guanine (G) 
nucleotides. To answer this, I used homopolymers of (A), (U), (C) and (G), each 40 nucleotides 
long. The repeats of Guanines of such a length have been show by (Wang et al., 2017) to 
form a G-quadraplex structure. Therefore, I tested the Poly (G) RNA for the formation of G-
quadraplex structures by circular dichroism (CD) spectroscopy. The characteristic 
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absorbance pattern for a G-quadruplex structure are a negative peak between 237-241 nm 
(nanometre) and a positive peak between 260-265 nm. I used the Poly (U) RNA as a control. 
It is unstructured and has been shown to produce a negative peak between 240-250 nm and 
a positive peak at 270 nm in CD spectroscopy. The absorbance pattern of my Poly (G) RNA 
in CD spectroscopy supports that it indeed formed a G-quadraplex structure with the 
absorbance peaks that are characteristic of a G-quadraplex structure (Figure 3.1.6B). The 
structure was stable even at temperature as high as 90°C. On the other hand, the Poly (U) 
RNA absorbance peaks suggested an unstructured RNA (Figure 3.1.6A).  
 
Having established that my Poly (G) RNA formed a G-quadraplex structure, I tested the 
binding of dMi-2 to all homopolymer RNAs, including Poly (G) RNA, in EMSA. The structure 
of Poly (G) RNA doesn’t allow it to form a discreet band in a native gel, it rather runs as a 
smear as compared to other RNAs which form discreet bands. dMi-2 bound to Poly (A) and 
Poly (C) RNAs with very low affinities (Figure 3.1.6C – D, and 3.1.6G, quantification). On the 
other hand, dMi-2 bound to Poly (U) and Poly (G) RNAs with comparatively higher affinities 
(Figure 3.1.6E-F, and 3.1.6G, quantification). It bound to Poly (U) RNA at higher 
concentrations and with an approximate dissociation constant (app. Kd) of 787.8 nanomolar 
(nM). Importantly, dMi-2 bound to Poly (G) RNA with the highest affinity and had an 
approximate dissociation constant (app. Kd) of 40.88 nanomolar (nM) (Figure 3.1.6F-G). 
These data suggest that dMi-2 has low affinities for binding to Adenine and Cytosine 
nucleotides while it has higher affinities for binding to Uracil and Guanine nucleotides, and 
that it, particularly prefers binding to Guanines, perhaps due to the G-quadraplex structure. 
 
 
  Results 




  Results 
   
109 
 
Figure 3.1.6: dMi-2 binding to homopolymer RNAs 
CD spectroscopy of poly (U) and Poly (G) RNAs, each 40-mer (A) and (B). 10 𝝁M RNAs were 
allowed to fold in binding buffer and CD spectra measured between 220 to 300 nm. The data 
were analysed by CAPITO CD analysis and plotting software. The data were smoothened 
with Savitzky-Golay filter and CD values were converted to mean residue ellipticity (𝜃 in grad 
cm2 dmol-1). Poly (G) RNA forms a characteristic G-quadraplex absorbance patter with 
negative peaks between 237-241 nm and positive peaks between 260-265 nm. Poly (U) RNA 
was used as a control and it appears unstructured. The measurements were conducted at 
three different temperatures, 20°C (Blue), 30°C (Green) and 90°C (Red). At least 3 
measurements were taken at each temperature and mean values plotted. (C – F) EMSAs of 
Poly (A), (U), (C) and (G). 52.8 nM RNA was used in each reaction and dMi-2 titrated from 10 
nM to 900 nM. Samples were loaded on native polyacrylamide gels and electrophoresed. 
The gels were stained with 1X SYBR gold and imaged with Bio-Rad ChemiDoc touch system. 
(G) Quantification of EMSA gels in (C-F). The percentage of bound RNA fraction was 
quantified using Bio-Rad Image Lab Software. 
 
3.1.7 dMi-2 binds to G-rich RNA 
 
Some RNA binding proteins, PRC2, for example, has been shown to have higher affinity for 
binding to G-quadruplex forming RNAs including Poly (G) of the same size as Poly (G) used 
in this study i.e. 40 nucleotides. Since dMi-2 bound better to Poly (G) RNA compared to Poly 
(U), (C) and (A) RNAs (Figure 3.1.6), and since I showed that my Poly (G) RNA forms a G-
quadruplex structure, I asked if the better binding to Poly (G) RNA was because of its 
structure. To address this, I used two RNAs - (G4A4)4 RNA and (GA)20 RNA. Each of these 
RNAs are 40 nucleotides long. When two or more tetrads or blocks of G-nucleotides are 
regularly interspersed by other nucleotides, for example, Adenines, the G-nucleotide blocks 
form a G-quadruplex structure. Since, (G4A4)4 RNA has four G-repeat blocks separated by 
non-G nucleotides, it forms a G-quadruplex (also called a G4) structure. On the other hand, 
although, (GA)20 RNA has the same number of G-nucleotides as (G4A4)4 RNA, however, since 
it lacks the G-repeat blocks, it does not form a G-quadruplex structure.  
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I hypothesized that If the better binding of dMi-2 to Poly (G) RNA was entirely due to the G-
quadruplex structure of that RNA, then I should observe a similarly higher affinity for (G4A4)4 
RNA compared to (GA)20 RNA. To test this hypothesis, I first verified whether the (G4A4)4 RNA 
indeed forms G-quadraplex structures or not. I used CD spectroscopy to test the formation 
of the structures. The (G4A4)4 RNA absorbance patterns in CD spectroscopy determined a 
negative peak between 237-241 nm and a positive peak between 260-265 nm, a pattern that 
is characteristic of G-quadruplex structure (Figure 3.1.7D). I measured the absorbance at 
20°C, 30°C and 90°C to account for the stability of the structures. At 90°C, the structure was 
disrupted, suggesting that the G-quadraplex structure formed by (G4A4)4 RNA is less stable 
at 90°C compared to the G-quadruplex structure of Poly (G) RNA (data not shown). Since, I 
perform the binding experiments at room temperature i.e. 26°C, I therefore, can be sure of 
the formation of G-quadraplex structures as it remained stable between 20°C (data not 
shown) and at 30°C (Figure 3.1.7D). On the other hand, the control (GA)20 RNA had its own 
distinct absorbance pattern, confirming that it did not form a G-quadraplex structure (Figure 
3.1.7C). 
 
Next, I tested these RNAs in EMSAs for binding to dMi-2. dMi-2 bound to both the RNAs 
(Figure 3.1.7A-B and Figure 3.1.7E, quantification). The binding affinity of dMi-2 to G-
quadraplex forming (G4A4)4 RNA was 0.08 ± 0.00 µM while for control (GA)20 RNA, which does 
not for a G-quadraplex structure was 0.07 ± 0.01 µM (Figure 3.1.7E). Since, the binding 
affinities of G-quadruplex forming (G4A4)4 RNA and the non-G-quadruplex forming (GA)20 RNA 
are very similar, it suggests that the G-quadruplex structure does not conform an added 
advantage for binding to dMi-2. Therefore, the higher affinity of binding that was observed 
for Poly (G) RNA is unlikely due to its G-quadruplex structure and might be due to the G-
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Figure 3.1.7: dMi-2 binds to G-rich RNAs 
EMSAs showing the binding of dMi-2 to G-quadraplex forming (G4A4)4 RNA and to non-G-
quadraplex forming (GA)20 RNA (A - B). 250 nM RNA was used for each reaction and dMi-2 
was titrated from 10 nM (lanes 2) to 640 nM (lanes 8). Each RNA only controls was loaded in 
lane 1. Each EMSA is a representative figure of at least two independent replicates. The 
reactions were loaded on native polyacrylamide gels and electrophoresed. The gels were 
stained with 1X SYBR gold and imaged with Bio-Rad ChemiDoc touch system. Circular 
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dichroism (CD) spectroscopy of (GA)20 and (G4A4)4 RNAs (C and D, respectively). (G4A4)4 RNA 
forms G-quadraplex structures with absorbance spectra for negative peak between 237-241 
nM and positive peak between 260-265 nM. CD spectroscopy was performed at three 
different temperatures, 20°C (not shown), 30°C (Blue) and 90°C (not shown). The (GA)20 RNA 
does not form a G-quadraplex structure. The data were analysed by CAPITO CD analysis 
and plotting software. The data were smoothened with Savitzky-Golay filter and CD values 
were converted to mean residue ellipticity (𝜃 in grad cm2 dmol-1). The red-line denotes the 
zero (0) value on Y-axis. (E) Quantification of the bands in gels in (A), and (B). The bands were 
quantified using Bio-Rad Image Lab software. The data points of two independent biological 
replicates are plotted.  
 
Table 2: RNA sequences  
 
RNA Sequence 
Poly (A) (A)40 
Poly (U) (U)40 
Poly (C) (C)40 
Poly ((G) (G)40 
(G4A4)4 RNA A6(G4A4)4A2 
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3.2 Chapter 2 
 
3.2.1 dMi-2 Binds RNA in vivo 
 
My results in chapter 1 have established that dMi-2 has an inherent property to bind RNA in 
vitro. I hypothesized that dMi-2 might bind RNA in vivo as well. To answer this, I performed 
a partial individual-nucleotide resolution UV cross-linking and immunoprecipitation (iCLIP) 
experiment. The technique makes use of 254 nm (nanometre) Ultraviolet (UV) light 
(300mJ/cm2) to cross-link RNAs to protein in native physiological conditions. The cross-
linked protein-RNA complexes are immuno-precipitated using an antibody against the 
protein of interest. The RNAs are trimmed in a controlled fashion using RNAse I and any DNA 
contaminations are removed by DNase treatment. The 5’- end of the RNA is then 
phosphorylated with a radio-labelled phosphate, for example, 32P, using a kinase. The radio-
labelled RNA-protein complexes are resolved by electrophoresis in a gel and transferred to 
a nitrocellulose membrane. The membrane can be autoradiographed for the detection of RNA 
signals. If a protein binds RNA in vivo then there should be signal on the autoradiogram at 
the position at which the RNA-protein complex of interest runs.  
 
I used two Drosophila melanogaster Schneider-2 (S2) cell lines, one of which has the dMi-2 
protein endogenously tagged with green fluorescence protein (GFP) on its C-terminal end 
(dMi-2-GFP) and a control cell line that has no GFP tag, (untagged-dMi-2) (Lenz et al., 2020 
(in press)). As an additional control, I also included dMi-2-GFP cells without any UV treatment, 
that is, no cross-linking for protein-RNA complexes (minus UV dMi-2-GFP). I performed GFP 
immunoprecipitation, using GFP-trap beads to immunoprecipitate the GFP fused dMi-2. The 
partial-iCLIP was performed as mentioned above and samples were electrophoresed on a 4-
15% gradient polyacrylamide gel. The gel resolved protein-RNA complexes were transferred 
to a nitrocellulose membrane and the membrane was autoradiographed (Figure 3.2.1, upper 
panel). As expected, I observed no signal in the untagged-dMi-2 sample which lacks a GFP-
fusion protein (Figure 3.2.1, upper panel, lanes 2-4). dMi-2 has a molecular weight of nearly 
224 kilo Daltons (kDa) and the molecular weight of GFP is 27 kDa. Therefore, we expected 
dMi-2-GFP fusion protein to run above 250 kDa. We detected signals in UV treated dMi-2-
GFP cells at the expected molecular weight suggesting cross-linking of dMi-2 to RNA in vivo 
(Figure 3.2.1, upper panel, lanes 5 - 7). No signal was detected in the lane with highest 
concentration of RNase I (lane 5) suggesting complete digestion of RNAs. However, as the 
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RNase I concentrations decreased from 10-3 Units/μl in lane 5 to 10-5 Units/μl in lane 7, there 
appeared increased signals at the expected size (red closing bracket). This suggests that the 
signals that were detected are indeed RNA and not any contaminating DNA that survived the 
DNase treatment. There also appeared signals throughout in lanes 6 and 7. Those signals are 
very likely either from the RNA-binding proteins that co-purified with dMi-2-GFP or are the 
degradation products of dMi-2-GFP bound to RNA. No signal was detected in the (minus) -
UV dMi-2-GFP samples (Figure 3.2.1, upper panel, lanes 8-10). To establish that the signal 
was indeed coming from RNA cross-linked with dMi-2-GFP, I probed the nitrocellulose 
membrane with anti-dMi-2 antibody. As expected, no dMi-2 signals were detected in 
untagged-dMi-2 samples, lanes 2-4 (Figure 3.2.1, lower panel). On the other hand, dMi-2-
GFP signals were detected in lanes 5-10 suggesting that the signals in the autoradiogram 
were indeed a result of cross-linked RNAs that were closely associated with dMi-2 in vivo.  
 
                 
Figure 3.2.1: dMi-2 Binds RNA in vivo 
Partial-iCLIP showing that dMi-2-GFP binds RNA in vivo. Autoradiography of partial- iCLIP 
membrane (upper panel) and the Western blot (WB) against dMi-2 (lower panel). The dMi-2-
GFP cells were treated with UV radiation to crosslink the RNA bound by dMi-2-GFP in vivo. 
As controls, we similarly treated untagged-dMi-2 cells with UV and dMi-2-GFP cells were not 
treated with UV. The protein extracts, 3 mg each, were used for GFP-immunoprecipitation 
and partial-iCLIP was performed to capture the RNA - dMi-2-GFP complexes. The samples 
were treated with DNase, and RNA fragments were trimmed under a controlled RNase I 
treatment. The samples were loaded on a gradient gel and electrophoresed. The protein-
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RNA complexes were transferred to a membrane and autoradiographed. Red closing bracket 
indicates dMi-2-RNA complexes. Protein molecular weights are indicated on the left. 
 
3.2.2 dMi-2 iCLIP 
 
Having shown that dMi-2 binds RNA in vivo in an unbiased partial-iCLIP experiment, I next 
went on to identify the RNAs that dMi-2 binds to in the Drosophila S2 cells using iCLIP 
sequencing. The method is a continuation of the partial iCLIP whereby, the protein-RNA 
complexes resolved in a gel are retrieved from the membrane. The RNAs are purified and a 
cDNA library is prepared which is sequenced to identify the RNAs bound by the protein.  
 
The same cell lines and experimental setup as described above (3.2.1) was used. I performed 
an additional biological replicate for the iCLIP-seq. The protein-RNA contacts were cross-
linked by UV treatment and subsequently protein-RNA complexes were resolved on a gel 
and autoradiographed as in 3.2.1 (Figure 3.2.2 A and B). As expected, there were radio-
labelled-RNA signals from dMi-2-GFP samples in both of our replicates (Figures 3.2.2 A and 
B, lanes 4-6). As the RNase I concentrations decreased from lanes 4 to lanes 6, increased 
radio-labelled-RNA signals were detected, confirming that the signals were indeed from RNA. 
No signals were detected in untagged dMi-2 samples which do not have any GFP tag (lanes 
1-3) suggesting that the signals obtained in lanes 4-6 were specifically from dMi-2-GFP 
bound to RNA. Similarly, no signals were detected in dMi-2-GFP samples which were not 
treated with UV light (lanes 7-9), further substantiating that the signals are specific to dMi-2-
GFP. As was observed in 3.2.1, there were signals throughout the lanes 4-6 (right closing 
brackets), which could either come from RNAs cross-linked to proteins that co-purified with 
dMi-2 or RNAs that were bound to degradation products of dMi-2. Next, I selected the 
moderately RNase I treated (10-4 Units/μl) samples from dMi-2-GFP and untagged dMi-2 
samples in both replicates because the RNA fragments in these samples are of the optimal 
size, such that the RNA fragments are not too long, which could cause hindrances during 
immunoprecipitation, or too small, which do not allow proper alignment of the reads after 
sequencing (Huppertz et al., 2014). The region where dMi-2-GFP-RNA complexes were 
expected to run (Figure 3.2.1A and B, red boxes) and their corresponding regions in the 
untagged dMi-2 controls were selected and cut out from the membrane. 
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Figure 3.2.2: dMi-2 iCLIP-seq membranes 
iCLIP experiments of dMi-2-GFP replicate-1 (A) and replicate-2 (B). 26.10 mg of whole cell 
extract from each cell type or treatment were used for replicate-1 and 28.10 mg for replicate-
2. The dMi-2-GFP cells were treated with UV light to cross-link protein-RNA contacts. 
Untagged dMi-2 cells treated with UV and untreated dMi-2-GFP cells were used as controls. 
After GFP-immunoprecipitation and downstream steps, radio-labelled RNA-protein 
complexes were loaded on gradient polyacrylamide gels and electrophoresed. The 
complexes were transferred to membranes by blotting. The membranes were 
autoradiographed. Radio-labelled RNA signals were detected in dMi-2-GFP samples at the 
expected molecular weight of dMi-2-GFP (Figure 3.2.1A and B, lanes 4-6). No signals were 
detected at corresponding molecular weight in both the controls (lanes 1-3 and lanes 7-9). 
Signals below the dMi-2-RNA signals could be either degradation products of dMi-2-GFP or 
co-purifying protein that also bound to RNA (Right closing brackets). The red boxes indicate 
the region of the membranes that were cut out for library preparation. Molecular weight is 
indicated on the left by dots drawn on a plastic wrap using a radioactive pen while the 
membrane was placed inside the plastic wrap.  
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The regions cut out from the nitrocellulose membranes were treated with Proteinase-K to 
digest the proteins. The UV cross-linking causes the formation of a covalent bond between 
the RNA and the protein that were in contact with each other in physiological state. Therefore, 
the Proteinase-K, which exclusively hydrolyses peptide bonds, digests the protein up to the 
cross-link site, where it leaves a single amino acid attached to the RNA. Next the RNAs were 
eluted from the nitrocellulose membranes and precipitated using phenol-chloroform-
isoamyalcohol. The RNAs hence retrieved were reverse transcribed to cDNA.  
 
Next, we optimized library preparation with 6, 8 and 11 cycles of PCR amplification to 
generate a library that yields sufficient reads yet does not contain too many PCR duplications. 
The best results were obtained with 11 cycles (Figure 3.2.3A, lanes 10-13). Therefore, we 
performed 11 cycles in the library preparative PCR and loaded 4 𝝁L (microliter) of each library 
on a native polyacrylamide gel and electrophoresed to verify the quality of the iCLIP-seq 
library (Figure 3.2.3B). As expected, no products were detected in both the replicates of 
untagged dMi-2 samples (Figure 3.2.3B, lanes 2 and 4). PCR products suitable for library 
preparation (50-100 bp) were detected in dMi-2-GFP samples in both replicates (Figure 
3.2.3B, lanes 3 and 5). Primers and smaller PCR products were also detected. These 
unwanted products were removed in the subsequent size selection step. The final libraries 
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Figure 3.2.3: iCLIP library preparation 
Optimization of library preparation PCR (A). 10 𝝁L of PCR reactions were set up with each 
sample and both the replicates; 6, 8 or 11 cycles of PCR were performed and the entire 
reactions loaded on a 7.5% Native polyacrylamide gel along with a size marker and 
electrophoresed. The gel was stained with Ethidium bromide solution. The free primers and 
small PCR products are denoted. Amplimers best suited for library preparation (50-100 bp), 
denoted as library products were most prominent in PCR reactions with 11 cycles, lanes 11 
and 13. (B) Preparative PCR of replicate-1 and replicate-2 with 11 PCR cycles using P5 and 
P3-Solexa primers. 4 𝝁L out of each PCR reaction of a total of 40 𝝁L was loaded on a native 
polyacrylamide gel along with a size marker and electrophoresed. The gel was stained with 
ethidium bromide solution. The primers and small PCR products indicated on the right, were 
removed in the subsequent size selection step. The library products were observed in dMi-
2-GFP samples, each replicate, lanes 3 and 5, as indicated on the right. No products were 
detected in untagged dMi-2 control samples in either replicate, lanes 2 and 4.   
 
3.2.3 dMi-2-GFP promiscuously binds to different types of RNAs in 
vivo 
 
Next, the iCLIP data was analysed after sequencing. Combining the sequencing reads from 
the two replicates of dMi-2-GFP and untagged dMi-2 controls, we had a total of just over five 
million reads (Figure 3.2.4A). Of these, 41.8% came from replicate-1 of dMi-2-GFP and 
31.9% came from replicate-2. Further, 23.5% of the reads had no barcodes and hence their 
origin could not be determined. These reads were discarded from the downstream analysis. 
Our control samples for iCLIP, that is, untagged dMi-2 replicates-1 and -2, expectedly yielded 
very few reads, 1.1% and 1.7%, respectively. These were also discarded from any 
downstream analysis (Figure 3.2.4A). Next, we characterized the iCLIP sequencing reads 
into the types of RNAs they were emanating from. dMi-2-GFP replicates-1 and -2 produced 
a total of 161,569 and 160,021 reads mapping uniquely to RNAs, respectively. Of these, a 
majority of the reads stem from mRNAs - 86.3% and 90% in replicate-1 & -2, respectively, 
suggesting that dMi-2 is predominantly associated with protein coding RNAs (Figure 3.2.4B). 
The remaining reads mapped to tRNAs, rRNAs, snRNAs, snoRNAs and other non-coding 
RNAs, indicating that dMi-2-GFP might also be associated with these RNAs to some extent 
in vivo. 
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Of the 279,665 total mRNA reads, 49.2% were produced by replicate-1 of dMi-2-GFP while 
48.1% of the reads originated from replicate-2 (Figure 3.2.4C). The control samples, that is, 
untagged dMi-2 replicate-1 and -2, as expected produced only a comparatively small number 
of reads representing just 1.6% and 1.0% of the total mRNA reads (Figure 3.2.4C). Next, we 
went on to measure the strength of the relation between the two replicates of dMi-2-GFP by 
linear regression, comparing the mRNA read data sets of the two replicates. The closer the 
squared Pearson correlation coefficient (R2) is to 1, the greater is the correlation between two 
data sets. The mRNA data sets of dMi-2-GFP replicates-1 and -2 produced a squared 
Pearson correlation coefficient (R2) of 0.968, indicating that the two replicates are highly 
correlated (Figure 3.2.4D). 
 
Taken together, these data indicate that dMi-2-GFP promiscuously binds to several types of 
RNAs in vivo, however, it predominantly binds to mRNAs. Further, the sequencing data sets 
from our two biological replicates show a very similar relative representation of different types 
of RNA. Furthermore, both data sets are highly correlated which allowed us to pool the two 
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Figure 3.2.4: dMi-2 binds to different types of RNAs in vivo 
iCLIP sequencing data analysis (A). A total of 5.03 million raw reads from dMi-2 GFP 
replicates-1 and -2, indicated in orange and yellow, accounting for 41.8% and 31.9% reads, 
respectively. The control untagged dMi-2 replicates-1 and -2, indicated in green and violet, 
accounted for 1.7% and 1.1% reads, respectively. 23.5% of the reads, indicated in cyan, had 
no barcode and were thus not included in our downstream analysis. (B) The distribution of 
different types of RNAs represented in replicates-1 and -2 of dMi-2-GFP were plotted as pie 
charts, the total number of reads in each replicate are indicated below the pie charts.  Most 
of the reads in both the replicates, 86.3% and 90%, indicated in green, were mRNAs reads. 
(C) A total of 279,665 reads were mRNA reads. Of these, 48.1% originated from replicate-1 
of dMi-2-GFP, indicated in orange and 49.2% from replicate-2, indicated in yellow. The 
control untagged dMi-2 replicates-1 and -2, indicated in green and violet, represent 1.6% 
and 1.0% mRNA reads, respectively. (D) Squared Pearson correlation coefficient (R2) of the 
two-mRNA data sets from replicate-1, on x-axis, and replicate-2, on y-axis. The R2 = 0.968 
indicates high correlation between the two replicates. 
 
3.2.4 dMi-2 GFP binds 3’-ends of mature mRNAs 
 
iCLIP allows the precise determination of the cross-linked RNA nucleotide. Therefore, 
it is possible to analyse the distribution of dMi-2-GFP binding sites along the RNA 
molecules. To this end, we mapped the dMi-2-GFP cross-linking sites across a length 
normalized metagene. The distribution of the cross-linking sites showed a very 
specific pattern with few to no mapping towards the transcription start site (TSS) 
while most of the cross-linking sites accumulated towards the transcription end site 
(TES) (Figure 3.2.5A). This indicates that dMi-2 binds RNAs at the 3’-ends in vivo. To 
further confirm this, we aligned all annotated genes with the transcription end site 
(TES) at position zero (0) in their genomic context and visualized the cross-linking 
sites with varying intensities of blue (light blue: 1 supporting read; black: more than 4 
supporting reads) for 200 nucleotides up- and down-stream of the TES. The majority 
of all cross-linking sites indeed mapped towards the 3’-end of the transcripts, 
confirming that dMi-2-GFP predominantly binds the 3’- end regions of RNAs 
(Supplementary figure S3.2.5A, lower panel). We calculated the cumulative density 
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of the cross-linking sites around the TES and as expected from the alignment plot, 
we found a sharp peak towards the 3’-end of the RNAs (Supplementary figure 
S3.2.5A, density plot), indicating binding towards the end of RNAs.  
 
We found mRNAs from a total of 5,471 genes with at least 5 iCLIP cross-linking reads 
per mRNA across the two replicates of our iCLIP data. We asked whether dMi-2-GFP 
was bound to the genes of any of these RNAs that we found in our iCLIP data. To 
answer this, we used the dMi-2-GFP chromatin occupancy (ChIP-seq) data from Lenz 
et al., 2021 (in press). Our analysis showed that out of 5471 genes whose RNAs were 
bound by dMi-2-GFP, 2406 genes had significantly enriched dMi-2-GFP bound to 
their genes as well (Figure 3.2.5B). Next, we asked if RNA binding of dMi-2 plays a 
role in its recruitment to the chromatin. On chromatin, dMi-2 largely binds at the 
promoter regions, that is, towards the 5’-end of genes (Lenz et al., 2021 (in press)). If 
RNA binding plays a substantial role in recruiting dMi-2 to chromatin then we would 
expect the ChIP-seq profile of at least some of the above mentioned 2406 genes, to 
match their iCLIP profile. Using the above mentioned dMi-2-GFP ChIP-seq data set, 
we plotted the dMi-2-GFP chromatin binding sites of the selected 2406 genes which 
also had dMi-2-GFP bound to their mRNAs, across a metagene. Interestingly, we 
observed a sharp ChIP-seq peak at the 5’-end of the metagene (Figure 3.2.5C). This 
indicates that even on the genes whose RNA are bound by dMi-2-GFP, the dMi-2-
GFP is located at the promoter region which is in contrast to its occupancy on RNA. 
This does not support the hypothesis that RNA binding is involved in recruiting dMi-
2 to chromatin.    
 
Some RNA binding proteins bind to nascent RNAs, for example, PRC2. Others bind 
to processed and mature mRNAs, for example, cap-binding eukaryotic initiation 
factor 4F (eIF4F) (Pelletier et al., 2015). Some RNA binding proteins can bind to both 
nascent as well as to processed RNAs. We sought to determine whether dMi-2 binds 
to nascent RNAs or to processed RNAs. Since, dMi-2 predominantly cross-linked 
near the 3’-end of the RNAs, we therefore determined the average read coverage 
along the last intron-exon junctions of RNAs that had a minimum of two exons. We 
considered 15 nucleotides from either side of the intron-exon junction and plotted the 
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cumulative read coverage. We found low coverage across the intronic region, 
compared to the coverage in the exonic region (Figure 3.2.5D). While this finding 
does not rule out that dMi-2-GFP binds to introns and exons of nascent RNA, it is 
more compatible with the view that most binding events involve processed (spliced) 
RNA molecules.  
 
From the 5,471 genes which had a minimum of 5 iCLIP cross-linking reads in each of 
our replicate, we determined the high confidence genes as those that were present 
in both the replicates (Figure 3.2.5E). A majority of the genes, 5,411, were common 
to both of our iCLIP data sets. We used these high confidence genes for our further 
analysis. Next, we sought to identify the significantly enriched mRNAs from the dMi-
2-GFP iCLIP data sets. dMi-2 bound to RNAs promiscuously both in vitro as well as 
in vivo. Therefore, RNA concentration might be a major determinant for dMi-2-GFP 
binding. To account for that, we compared the iCLIP sequencing read counts for each 
identified RNA with the corresponding RNA sequencing read counts previously 
determined in S2 cells (Lenz et al., 2021 (in press)). We used the DEseq2 analysis 
platform with a fold change of greater than 4 (fold change > 4) and p-value less than 
0.05 (p-value ≤ 0.05) to determine the ‘significantly enriched’ RNAs. Of the 5,411 
high confidence genes in our iCLIP, 580 genes were detected as significantly 
enriched by DEseq2 analysis (Figure 3.2.5F, green dots). The genes that did not 
meet this criterion, that is, did not have 4-fold more iCLIP cross-linking counts over 
their RNA-seq read counts were distinguished as ‘not enriched’ (Figure 3.2.5F, blue 
dots). We selected a few genes from both - enriched as well as not enriched sets 
(Figure 3.2.5F, indicated by labelling), for validation through another approach (data 
not shown). Taken together, DEseq2 analysis revealed that indeed the binding of dMi-
2-GFP to a large portion of RNAs is driven by their abundance, however, there are 
some RNAs (580) which were bound by dMi-2-GFP preferentially. 
 
iCLIP favours cross-linking to Uridine nucleotides due to the usage of UV-C for cross-
linking  (Sugimoto et al., 2012). During the reverse transcription step of the iCLIP 
procedure, the reverse transcriptase enzyme does not readthrough the cross-linking 
site and dissociates due to the obstruction caused by a covalent bond created by the 
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UV cross-linking treatment between an amino acid and a nucleotide. Therefore, each 
iCLIP read lacks a single nucleotide upstream of its start (-1). It is this nucleotide at 
position -1, which can be identified from alignment of iCLIP reads to the respective 
genome, that is the actual cross-linking nucleotide and gives the single nucleotide 
resolution to iCLIP. In our in vitro RNA binding assays, we observed a preferential 
binding of dMi-2 to G-rich RNAs. We, therefore, asked whether dMi-2-GFP cross-
links to Guanine (G) nucleotides preferentially in vivo as well. To this end, we used 
KpLogo and aligned all the iCLIP reads relative to their cross-linking sites to the 
genome and detected the most frequently occurring nucleotide at the cross-linking 
site (position zero, 0) in our iCLIP data. We extended this analysis to nine nucleotides 
from either side of the cross-linking site. Expectedly, the Uridine nucleotides were 
detected as enriched at the cross-linking site (Figure 3.2.5F). However, since the 
cross-linking favours the U-nucleotides, we disregarded that and looked for the next 
significantly enriched nucleotide at the cross-linking site. Interestingly, we found G-
nucleotides enriched at the cross-linking site indicating that dMi-2 prefers cross-
linking to G-nucleotides which supports our in vitro data where we observed binding 
preference to G-rich RNA. Analysing the frequency of the nucleotides upstream and 
downstream of the cross-linking site, we observe that even though the G-nucleotides 
are enriched at the cross-linking site itself, the sequence surrounding the cross-
linking site is not G-rich. This might be due to the fact that dMi-2 is part of a multi-
protein NuRD complex or associates with dMep-1 in dMec complex. Therefore, the 
proteins that dMi-2 associates with might be involved in modulating the RNA binding 
of dMi-2 and influence the sequences of RNAs that it binds. From our KpLogo 
analysis we can estimate -GUNNACg- as the possible sequence that may be 
favoured for binding by dMi-2 in vivo.   
 
Taken together, our iCLIP data shows that dMi-2-GFP binds at the 3’- end of 
processed mature mRNAs. There are several mRNAs that are enriched over other 
RNAs, in our iCLIP, indicating a possible stronger interaction and dMi-2 shows a 
preference for cross-linking to G-nucleotides.  
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Figure 3.2.5: dMi-2 binds 3’-ends of mature mRNAs 
iCLIP cross-linking sites are predominantly located at the 3'-end of transcripts (A) Distribution 
of dMi-2-GFP cross-linking sites across a metagene indicating binding towards the 3’-end 
of RNAs. (B) Venn diagram showing the overlap between dMi-2-GFP -ChIP and -iCLIP genes 
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with 2406 genes having both. (C) Metagene analysis of 2406 genes from (B) showing the 
distribution of dMi-2-GFP on chromatin. dMi-2-GFP predominantly binds at the 5’-end of 
these genes. (D) iCLIP read coverage across the last intron-exon junction. All annotated 
genes with at least two exons are aligned at the last junction between intron and exon 
because the reads are almost exclusively situated towards the end of transcripts. The first 
base of the exon is at position zero. Even distribution across this junction would indicate 
bound nascent RNA while a sharp increase of coverage in the exon compared to the intron 
indicates fully processed RNA bound to dMi-2. (E) Venn diagram indicating the high 
confidence common genes between the two iCLIP replicates. 5,411 genes were found in 
both the replicates. (F) Some transcripts are highly enriched in iCLIP experiments compared 
to their regular RNA-Seq abundances. In order to rule out target transcripts bound in iCLIP 
are not solely over-represented due to their overwhelming global abundance, we correlated 
the number of cross-links per gene (iCLIP counts, y-axis) with RNA-Seq abundances (RNA-
seq FPKM, x-axis) in the same cell line. We used DESeq2 to determine robustly and 
significantly enriched mRNAs (green) across the two biological iCLIP replicates and three 
RNA-Seq replicates (fold change > 4 and p < 0.05) in contrast to mostly proportionally 
abundant mRNAs in both experiments (blue). We chose sufficiently conservative thresholds 
for enrichment to account for the poor overall correlation of the two different sequencing 
approaches. We selected some genes with decent expression and various enrichment for 
validation in further experiments (highlighted with labels). (G) KpLogo sequence plot around 
the cross-linking site indicating enrichment of G-nucleotides at the cross-linking site and a 
possible sequence preference to 5’- GUNNACg-3’ sequence. The size of nucleotide letters 
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3.3 Chapter 3 
 
3.3.1 RNA binding inhibits dMi-2 remodelling activity 
 
In chapters 1 and 2, I established and characterized the in vitro and in vivo RNA binding 
properties of dMi-2. Several chromatin associated proteins (CAPs) possess RNA binding 
properties and interaction with RNA influences both the recruitment to the chromatin as well 
as expulsion from the chromatin (Beltran et al., 2016; Zhao et al., 2008). Drosophila MOF 
(males absent on the first), which is a histone acetyltransferase (HAT), is recruited to the X-
chromosome in Drosophila males through its interaction with roX2 RNA (Akhtar et al. 2000). 
On the other hand, PRC2 (Polycomb repressive complex 2), a histone methyltransferase 
complex, is evicted from the chromatin via its interaction with RNA (Beltran et. al., 2016 and 
Wang et al., 2017).  
 
I asked what function does the interaction of dMi-2 with RNA entail. To answer this, I tested 
the effects of RNA on the remodelling function of dMi-2 in vitro. I used end-positioned 
mononucleosomes with 80 base pairs of flanking DNA. dMi-2 binds nucleosomes and in 
presence of ATP, slides such an end-positioned nucleosome to a more central-position. The 
centrally positioned nucleosome migrates slower than the end-positioned nucleosome in the 
gel. However, since dMi-2 binds the nucleosome to remodel it, and the binding of dMi-2 
retards the mobility of the nucleosomes to the extent that obscures the differences in the 
mobility of differently positioned nucleosomes. Therefore, at the end of the reaction, dMi-2 is 
competed off the nucleosome by competitor plasmid DNA. I tested the effects of three 
different RNAs in increasing amounts – (G4A4)4 RNA, a G-quadruplex forming RNA (Figure 
3.3.1A), (GA)20 RNA (Figure 3.3.1B) and Hsp70Aa #6 RNA (Figure 3.3.1C), each RNA 40 
nucleotide in length and each shown to bind dMi-2 in Sections 3.1.4 and 3.1.7. As expected, 
I observed remodelling of the nucleosome from end-position to central-position (Figure 
3.3.1A, B and C, lanes 1-2 and supplementary figure S3.3.1A, B and C, lanes 1- 2 in each, 
red arrow). Interestingly, with increasing RNA concentration, I observed a gradual decrease 
in the remodelling efficiency of dMi-2 (Figures 3.3.1A and B, lanes 3-10 and supplementary 
figure S3.3.1A and B, lanes 3-10) to the point where no centrally-positioned nucleosome 
was detectable on the gel (lanes 7-10, red asterisk marks), indicating complete inhibition. 
Interestingly, I observed no drastic effects of Hsp70Aa #6 RNA on the remodelling function 
of dMi-2 (Figure 3.3.1C and supplementary figure S15C, lanes 3-10), even at the highest 
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concentration of RNA used (lane 10, blue asterisk mark), indicating no apparent inhibition 
of remodelling activity of dMi-2.  
 
Next, I quantified the fraction of the centrally-positioned band against the end-positioned 
band in the gels in (Figure 3.3.1A, B and C) to calculate the apparent half-maximal 
concentration of each RNA at which 50% of the remodelling reaction is inhibited (IC50) (Figure 
3.3.1D). The IC50 for (G4A4)4 RNA was 140.1 ± 20.93 (nM) while that for (GA)20 RNA was 152.65 
± 52.25 (nM) (Figure 3.3.1D). As was evident from the gel image, there was no apparent 
inhibition by Hsp70Aa #6 RNA and hence the IC50 could not be calculated (Figure 3.3.1D). 
 
Inhibition of chromatin modifying enzymes by RNA could be due to the RNA interacting with 
the active site of the protein, thereby, blocking its enzymatic activity. This, for example, is the 
case for PRC2 (Zhang et al., 2019). Alternatively, RNA might compete off the protein from the 
nucleosomes. From my in vitro data in Chapter 1, I learned that the active site of dMi-2, that 
is, the ATPase region, does not bind to RNA on its own. This finding argues against inhibition 
of remodelling by RNA due to binding to the active site of the enzyme. Therefore, the other 
possible explanation is that the RNA competes dMi-2 off of the nucleosomes, thereby, 
causing inhibition in remodelling. 
 
Taken together, this data supports that binding to some RNAs can inhibit the remodelling 
function of dMi-2 and this inhibition is possibly due to a competition for binding to dMi-2 







  Results 




Figure 3.3.1: RNA binding inhibits dMi-2 remodelling 
Nucleosome remodelling assays with titrations of different RNAs (A) (G4A4)4 RNA, (B) (GA)20 
RNA and (C) Hsp70Aa #6 RNA. 15 nM of the end-positioned nucleosomes with 80 bp of 
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flanking DNA were used in each experiment as denoted by plus sign, except in controls 
(minus signs on the top). End-positioned nucleosome, lane 1 in each gel image, represented 
on the left (orange denotes the histone octamer positioned at the end of the nucleosomal 
DNA - in blue). 50 nM dMi-2 was added in each reaction (plus sign), except in controls (minus 
sign on the top). Remodelled nucleosome (represented on the left, orange denotes histone 
octamer positioned centrally on the nucleosomal DNA - in blue) can be observed in lanes 2-
6 of (A) and (B) and lanes 2-10 in (C). Free RNA in each gel can be observed at the bottom. 
Reactions were loaded on native polyacrylamide gels, electrophoresed, stained with SYBR 
gold and imaged with Bio-Rad ChemiDoc touch system. Red arrows point out the remodelled 
nucleosome band and red asterisk marks in lanes 7-10 of (A) and (B) point out the inhibition 
of remodelling. Blue asterisk in lane 10 of (C) points out remodelled nucleosome even at the 
highest concentration of Hsp70Aa #6 RNA. Representative images of at least three 
independent experiments. (D) Quantification of gel images in (A), (B) and (C) using Bio-Rad 
Image-Lab software and calculation of IC50 using linear regression (Blue: (G4A4)4 RNA, Red: 
(GA)20 RNA, and Green: Hsp70Aa #6 RNA). Individual data points of two independent 
biological replicates are plotted. 
 
3.3.2 RNAs that bind efficiently to dMi-2 inhibit remodelling 
 
In section 3.3.1, I hypothesized that perhaps the inhibition of remodelling is possibly by way 
of RNA competing dMi-2 off of the nucleosomes. If this hypothesis is the possible explanation 
for the remodelling inhibition of dMi-2 in presence of RNA; then the RNAs that bind to dMi-2 
efficiently should be able to inhibit better compared to RNAs that bind with less affinity. 
Perhaps that should also explain why Hsp70Aa #6 RNA failed to inhibit the remodelling. To 
test this hypothesis, I performed EMSA with the three RNAs used above in section 3.3.1 
(Figure 3.3.2A, B and C, and supplementary figure S3.3.2). dMi-2 bound to all the three 
RNAs albeit with evident differences in binding affinity. I quantified the RNA bound to dMi-2 
and the free RNA and calculated the approximate dissociation constant (app. Kd) to estimate 
the differences in the binding efficiency of the three RNAs (Figure 3.3.2D). The (G4A4)4 RNA 
and (GA)20 RNA (Kd = 0.08 ± 0.02 µM and 0.08 ± 0.001 µM, respectively) bound with at least 
3-fold higher efficiency compared with Hsp70Aa #6 RNA (Kd = 0.31 ± 0.1 µM). These results 
support the hypothesis that binding of RNA likely competes dMi-2 off of the nucleosomes. 
Therefore, the RNAs that bind with high affinity - (G4A4)4 RNA and (GA)20 RNA is able to 
compete dMi-2 away from the nucleosomes while the RNA that binds comparatively poorly 
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– Hsp70Aa #6 RNA, fails to compete dMi-2 off the nucleosomes, thereby, its failure to inhibit 
dMi-2 remodelling activity. To further support this mechanism of inhibition, another RNA of 
equal length as the three RNAs above, a (CA)20 RNA which also bound poorly to dMi-2 failed 
to inhibit its remodelling activity (data not shown). 
 
Taken together, this data supports the hypothesis that the RNAs that bind efficiently to dMi-
2 also inhibit its remodelling function likely by competing dMi-2 off of the nucleosomes. 
 
 
Figure 3.3.2: RNAs that bind efficiently to dMi-2 inhibit remodelling 
  Results 
   
131 
EMSA of (A) (G4A4)4 RNA, (B) (GA)20 RNA and (C) Hsp70Aa #6 RNA. 250 nM RNA was used 
in each reaction and dMi-2 titrated from 10 to 640 nM, lanes 2-8. Each reaction was loaded 
on a native polyacrylamide gel and electrophoresed. The gels were stained with SYBR gold 
and imaged with Bio-Rad ChemiDoc touch system. dMi-2 bound to RNA is denoted as bound 
complex. Free RNA is also denoted. Representative images of at least two independent 
experiments. (D) Quantification of the EMSA band intensities and calculation of (app. Kd) 
using Hill slope equation (Blue: (G4A4)4 RNA, Red: (GA)20 repeat RNA and Green: Hsp70Aa 
#6 RNA) indicating poor binding of Hsp70Aa #6 compared to (G4A4)4 RNA and (GA)20 RNA. 
Data points of at least two independent experiments are plotted.  
 
3.3.3 Loss of RNA causes increased association of dMi-2 with 
chromatin 
 
The data in sections 3.3.1 and 3.3.2 are indicative that RNA competes off dMi-2 from the 
nucleosomes by binding to dMi-2. This would suggest a decreased association of dMi-2 with 
chromatin upon RNA binding. I hypothesized that if RNA is degraded in the nucleus, then I 
should observe an increased association of dMi-2 with chromatin. To test this hypothesis, I 
permeabilized Drosophila S2 cells with Tween-20 and treated them with RNase A. The control 
cells were similarly permeabilized but instead of RNase A treatment, the cells were treated 
with BSA. The cells were then fractionated into cytoplasmic, nuclear and chromatin fractions 
and subjected to Western blot analysis (Figure 3.3.3A and supplementary figure S3.3.3A). 
I observed no significant leaking of the nuclear proteins into the cytoplasmic fractions. Also, 
the chromatin fraction, as detected by H3 signal, did not spill into either the cytoplasmic or 
the nuclear fractions, suggesting that the fractionation worked well under these conditions. 
Some proteins in the cell exist in both chromatin-bound and unbound state, such as dLSD1 
which was detected in both chromatin as well as nucleoplasm fractions. In a similar 
experiment in mammalian cells, EZH2 signal has been shown to increase in the chromatin 
fraction upon RNA depletion (Beltran et al. 2016). I tested the occupancy of the Drosophila 
homolog of EZH2, Enhancer of zeste (Ez), in my experiment. Indeed, my results in Drosophila 
S2 cells confirm that upon RNA depletion, Ez shows an increased association with the 
chromatin (Fold change = 2.63). Next, I looked at the effects of RNA depletion on dMi-2 and 
like Ez, dMi-2 signal decreased in the nuclear fraction (Fold change = 0.77) and increased in 
the chromatin fraction (Fold change = 2.59) suggesting an increased association with the 
chromatin upon RNase A treatment (Figure 3.3.3A, upper panel). RPD3, a component of the 
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NuRD (Nucleosome remodelling and deacetylase) complex to which dMi-2 also belongs, also 
showed a loss in the nuclear fraction upon RNase A treatment (fold change = 0.80) and a 
concomitant increase in the chromatin fraction (fold change = 1.96). This could be because 
RPD3 and dMi-2 interact and since dMi-2 recruits to chromatin upon RNA degradation, it 
could also carry RPD3 along. I detected no significant changes in the occupancy of dLSD1 
and H3, suggesting that the changes I observed in the occupancy of dMi-2, Ez and RPD3 
are not a general effect on all chromatin associated proteins upon RNA depletion. Taken 
together, this data suggests that upon depletion of RNA from the cell, dMi-2 shows an 
increased association with the chromatin as detected by this assay. 
 
dMOF which is recruited to chromatin by its interaction with RNA, has been shown to leave 
the nucleus upon RNA depletion (Akhtar et al. 2000). On the other hand, my fractionation 
analysis above indicates that dMi-2 is retained within the nucleus and that more dMi-2 
associates with the chromatin upon RNA depletion. To further establish that depletion of RNA 
results in an increased association of dMi-2 with chromatin by using an independent 
approach, I went on to use confocal microscopy. To this end, I used the dMi-2-GFP tagged 
cell lines, as used in chapter 2. As a control, I tracked the occupancy of dMOF using an 
antibody against dMOF. The cells were permeabilized with digitonin and treated with RNase 
A. The control cells were similarly permeabilized but mock treated. I used DAPI and Phalloidin 
conjugates to stain the nucleus and the actin filaments in the cell. The cells were fixed and 
imaged using a confocal microscope (Figure 3.3.3B and supplementary figure S3.3.3B). 
Indeed, dMOF was depleted from the nuclei upon RNA degradation (Figure 3.3.3B, dMOF 
panel), indicating a successful depletion of nuclear RNA. On the other hand, dMi-2 did not 
appear to leave the nucleus upon RNA degradation (Figure 3.3.3B, dMi-2-GFP panel). 
Whether the loss of RNA resulted in an increased association of dMi-2 with the chromatin 
remains uncertain in this assay due to the limited resolution afforded by the microscopy. 
However, the experimental setup may be applicable for future analysis with higher resolution 




  Results 




Figure 3.3.3: Loss of RNA causes increased association of dMi-2 with chromatin 
RNase A treatment and western blot  
(A) 3.5 × 107 cells were permeabilized by treatment with 0.05% of Tween-20 for 10 minutes 
at 4°C. Cells were treated with 10 (mg/ml) of RNase A. Control cells were similarly 
permeabilized but treated with equal amount of BSA. Cells were fractionated in cytoplasmic, 
nuclear and chromatin fraction. Each fraction was loaded on an 8-12% gradient denaturing 
polyacrylamide gel and electrophoresed. Western blot analysis was performed for the 
proteins indicated. Histone H3 was used as loading control. The western blot signals were 
quantified using ImageJ software. The BSA treated control signals were set to 1 and the fold 
change in the treated samples were calculated and numbers indicated below. (B) 1 × 106 
cells/mL each from dMi-2-GFP were seeded on concanavalin A coated glass coverslips, 
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permeabilized by treatment with 0.05 (𝝁g/𝝁l) of digitonin for 10 minutes. One set was treated 
with RNase A and another mock treated with PBS alone and cells were fixed. For MOF 
immunostaining cells were blocked with BSA, incubated with anti-MOF primary antibody and 
Alexa-547 secondary antibody. Fixed cells were stained with DAPI and Phalloidin stains just 
before mounting on a glass slide using mowiol as mounting media. The GFP signal emanating 
from dMi-2-GFP tagged cells was used to detect dMi-2. Cells were visualized under a 
confocal microscope and imaged. Representative images of several independent 
experiments.  
 
3.3.4 Binding to RNA prevents dMi-2 from interaction with chromatin 
 
The data in section 3.3.3 indicate that interaction with RNA could prevent dMi-2 from 
interacting with the chromatin. To further substantiate this, I hypothesized that a global 
inhibition of RNA polymerase II and the resulting decrease of RNA levels in close proximity 
to chromatin should cause increased association of dMi-2 to the chromatin. To this end, I 
treated S2 cells with 10 𝝁M Triptolide for 3 hours. Triptolide treatment induces proteasomal 
degradation of RNA polymerase II (Riising et al., 2014). As controls, I treated cells with an 
equal volume of DMSO for 3 hours. Next, I looked at the relative transcription levels of some 
genes to verify the effects of Triptolide. The RNA was isolated from Triptolide treated and 
DMSO treated cells, reverse transcribed and amplified by qPCR (Figure 3.3.4A). As 
expected, relative to DMSO treated controls, the Triptolide treatment lead to a sharp 
decrease in the gene expression (Figure 3.3.4A) suggesting a successful downregulation of 
global gene expression upon RNA polymerase II degradation by Triptolide treatment. 
 
After having established that Triptolide treatment depletes the RNA in the cell, I asked how 
that affects the occupancy of dMi-2 on the chromatin. To this end,  
I used dMi-2-GFP expressing cells and for controls I used untagged cells. As an additional 
control, I used a cell line expressing dLINT1-GFP from (MačInković et al., 2019). dLINT1 is a 
component of the LINT complex, a repressor complex that is also associated with chromatin 
(Meier et al., 2012). One set of cells from each type was treated with 10 𝝁M Triptolide for 3 
hours and the other set was treated with DMSO for the same amount of time. To quantify the 
occupancy of dMi-2-GFP and dLINT1-GFP across all treatments and controls, the chromatin 
was prepared and I performed chromatin immunoprecipitation (ChIP) using the GFP-Trap 
beads. I selected a few regions in the genome at which the occupancy of dMi-2 was 
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successfully quantified in ChIP assays (Kreher et al. 2017; Mathieu et al. 2012) to assess the 
changes in the occupancy of dMi-2-GFP and dLINT1-GFP upon inhibition of RNA Pol II 
transcription. As expected, since the untagged cells do not possess any GFP tag, low 
background signals were detected (Figure 3.3.4B, blue and red bars). I observed the 
occupancy of dLINT1-GFP at all the loci that I tested, however, I detected no significant 
changes in the occupancy of dLINT1-GFP upon the inhibition of transcription by Pol II 
degradation (Figure 3.3.4B, orange and black bars). Interestingly, however, there was a 
sharp increase in the occupancy of dMi-2-GFP at the promoters of Hsp70 and Broad genes 
upon Triptolide treatment. Similarly, I detected an increased occupancy of dMi-2-GFP at the 
promoter of Vrille gene (data not shown). I also tracked the changes at the gene body of Vrille, 
Hsp83 and ultraspricle (USP) genes and found an increment of dMi-2-GFP at each gene upon 
Triptolide treatment (Figure 3.3.4B, green and violet bars). On the other hand, no changes 
of dMi-2-GFP occupancy were detected at the Ecdysone receptor (EcR) and at an 
untranscribed intergenic region (2R). This could perhaps be because of inaccessibility for 
dMi-2 at these locations in the genome perhaps because other proteins are occupying these 
locations in the genome. 
 
Taken together, this data supports the hypothesis that interaction with RNA hinders dMi-2 
from interacting with chromatin and when there is a global depletion of RNA in the cell, dMi-
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Figure 3.3.4: Binding to RNA prevents dMi-2 from interaction with chromatin 
(A) S2 cells were treated with 10 𝝁M Triptolide or equal volume of DMSO for 3 hours. RNA 
was isolated from each sample and cDNA synthesized. qPCRs were performed using primers 
for GAPDH1, Vrille, EcR and Hsp83. The expression of each gene was measured relative to 
DMSO control which was set to 1. Individual data points of three independent biological 
replicates are plotted. Error bars indicate standard error between three biological 
experiments. (B) dMi-2-GFP, dLINT1-GFP and untagged cells were treated with 10 𝝁M 
triptolide or DMSO treated for 3 hours. Chromatin was prepared and immunoprecipitation 
was performed using GFP-trap beads. DNA was eluted and qPCRs performed for the genes 
indicated. Legend on the right indicates cell types and treatment conditions. Individual data 
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points of two independent experiments were plotted. Error bars indicate standard error 
between two independent biological experiments. 
 
 
  Discussion 




Recent studies have implicated several chromatin associated proteins, including ATP-
dependent chromatin remodellers, as RNA binding proteins. Interaction with RNA has been 
proposed to both help recruit some of the chromatin regulators to their target genes or expel 
them from chromatin. Thereby, RNA interaction has been implicated in modulating the 
function of chromatin regulators. In this study, I focus on dMi-2, an ATP-dependent chromatin 
remodeling enzyme which I show to possess broad RNA binding activity. I report the in vitro 
and in vivo characterization and the potential functional significance of the RNA binding 
property of dMi-2.  
 
Some of the RNA binding proteins (RBPs) specifically bind to RNAs that have distinct 
structural and sequence features (Hendrickson et al., 2016). For example, the phage MS2 
coat protein (MS2-CP) interacts with a stem-loop RNA called MS2-SL (He et al., 2016). 
Similarly, HuR (also called Elavl1), an RBP that is involved in stabilizing the RNAs has been 
established to preferentially bind AU-rich elements in mRNAs (Siang et al., 2020). Likewise, 
P40, a RBP that is encoded by human LINE-1 retrotransposons binds to L1Hs RNA in a 
sequence specific manner where it recognizes two regions within L1Hs RNA called site-A 
and site- B (Hohjoh and Singer, 1997). On the other hand, several of the RBPs bind to RNA 
with a more relaxed sequence specificity, that is, they can bind to a wide range of RNAs with 
different sequence and structural features. Most of such RBPs lack a canonical RNA binding 
domain. For instance, the heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) which 
binds to numerous RNAs and is involved in several RNA processing events such as splicing, 
stability, nuclear export and translation (Levengood and Tolbert, 2019). Similarly, 
polypyrimidine tract-binding protein (PTB), also called as hnRNP1, a well characterized RBP 
that regulates splicing, polyadenylation and initiation of translation, has been shown to bind 
numerous RNAs both in the nucleus as well as in cytoplasm (Xue et al., 2009). In in vitro 
experiments it was shown to bind to several RNAs indicating a relaxed sequence specificity, 
yet it bound to U-tract containing RNA with higher affinity (Pérez et al., 1997). In vivo it 
employs this degree of specificity to bind to U-tract containing mRNAs. In this study, I 
demonstrate that dMi-2 binds to RNA with a relaxed sequence or structural specificity. dMi-
2 was previously reported to bind to a 230-mer RNA fragment from the Hsp70Aa transcript 
(Murawska et al., 2011). Using electrophoretic mobility shift assays, I illustrate that dMi-2 can 
bind to several other regions within the Hsp70Aa RNA. I reveal its binding to several RNA 
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fragments transcribed from an unrelated gene - Pgant35a, and several other physiological 
and non-physiological RNAs of varying length, sequence and structure, in vitro. However, I 
observed quantifiable differences in the efficiency between some RNAs for binding to dMi-2. 
For example, a 100-nucleotide long RNA from Pgant35a gene bound with less affinity than 
the RNA of equal length from Hsp70Aa gene. This points to dMi-2 possessing ability to bind 
several RNAs and yet possess some degree of specificity to bind certain RNAs better, just 
like PTB.  
 
Several protein-RNA interactions are highly salt sensitive, such proteins often lose or have a 
highly diminished RNA binding in higher salt conditions. Protein-RNA complexes of P40 
(Hohjoh and Singer, 1997), Pentatricopeptide repeat protein 10 (PPR10) (McDermott et al., 
2018) and Fox1 (Auweter et al., 2006) are highly salt sensitive. Similarly, PRC2 RNA 
interaction is sensitive to salt with loss in crosslinking to HOTAIR RNA at 400 mM salt (Wang 
et al., 2017). In contrast, I found that dMi-2 interacted with RNA in the presence of 
significantly higher salt concentrations and in the presence of high concentrations of 
detergent. These findings suggest that dMi-2 is a robust RNA binding protein and that 
stronger non-ionic interactions between the base or sugar-phosphate backbone of RNA and 
dMi-2 might play the major role in its RNA binding (detailed below). 
 
In this study, I map the major RNA binding region of dMi-2 to the first 376 amino acids. The 
ATPase domain, the chromodomains, the PHD fingers or the C-terminal portion revealed no 
significant RNA binding in my assays. The HMG-box domain in the N-terminal portion which 
lies within the first 376 amino acids also did not bind RNA on its own in my assay. This study 
presents the regions flanking the HMG-box on either side, 1-117 and 238-376 amino acids, 
as major RNA binding regions in dMi-2. The amino acid sequence between 1-117 and 238-
376 is rich in positively charged amino acids such as lysine (K) and arginine (R). Perhaps, the 
positive charge in these regions plays some role in RNA interaction, however, it is important 
to note that the HMG-box which did not show any RNA binding on its own, also contains few 
of the K and R stretches. Therefore, it is improbable that the charge alone drives the RNA 
binding properties of 1-117 and 238-376. This hypothesis is supported by the ability of dMi-
2 to bind RNA in the presence of high salt concentrations (see above). In several non-
canonical RBPs that do not possess any bona fide RNA binding domain (RBD) like an RNA 
recognition motif (RRM), K homology (KH) domain or a cold shock (CD) domain, the 
intrinsically disordered regions (IDRs) have been observed to be key determinants in RNA 
interaction (Castello et al., 2013; He et al., 2016). Both of these regions in dMi-2, 1-117 and 
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239-376 amino acids, are predicted to be intrinsically disordered. In fact, some reports 
suggest that the IDRs which are often rich in K, R and G (Glycine) amino acids, could directly 
interact with RNA (Castello et al., 2016). The mechanisms of such interaction, however, 
remains elusive, partly due to the challenge that the IDRs confer in X-ray crystallography and 
other structural studies. In case of dMi-2, however, it would not be wrong to dismiss the ionic 
interactions as the major mechanism of its interaction with RNA because, I observe strong 
RNA binding at salt concentrations at which the ionic interactions are largely inhibited. 
Therefore, perhaps the IDRs in dMi-2 directly interact with the RNA through more stronger 
hydrogen bond interactions or 𝜋 - stacking interactions. The dMi-2 could directly contact the 
sugar-phosphate backbone or bases of the RNA through hydrogen bond formation leading 
to a stable complex. Or perhaps the R-residues, which are known to form the strong 𝜋 - 
stacking interactions, within the IDRs contact the bases in the RNA to form a highly stable 
complex. There is also a possibility that the IDRs of dMi-2, upon interaction with RNA, fold in 
a best-fit pocket for the RNA and the combined effect of the charge and spatial arrangement 
allows the interaction of dMi-2 with RNA to be strong to resist high salt conditions. Needless 
to say, these models are speculative and would need thorough studies such as Nuclear 
Magnetic Resonance (NMR) or X-ray crystallographic analysis for substantiation.   
 
Using iCLIP, this study illustrates the RNA binding characteristics of dMi-2 in vivo in an 
unbiased manner for the first time. The in vivo data from iCLIP unveils interaction of dMi-2 
with a large number of RNAs, in agreement with the promiscuous binding character of dMi-
2 that was found in vitro. In a heat shock state, dMi-2 interacts with the nascent RNA 
fragments transcribed from the heat shock genes (Murawska et al., 2011). The genome-wide 
RNA binding data of  CHD4 has reported its interaction with processed mRNAs (Hendrickson 
et al., 2016). The iCLIP data from this study agrees with the CHD4 RNA binding profile and 
shows that dMi-2 interacts with the mature mRNAs, almost exclusively. This indicates an 
evolutionarily conserved RNA binding property between Drosophila dMi-2 and human CHD4. 
Furthermore, the iCLIP data indicates that the interaction takes place at the 3’-end of the 
mRNAs. This is opposite to the interaction of dMi-2 to its target genes where it largely 
localizes towards the promoter region. This indicates that the interaction of dMi-2 with RNA 
might not lead to its recruitment to the genome and that the recruitment mechanism on heat 
shock genes, in heat shock condition, might not be a general role of the RNA binding function 
of dMi-2. Perhaps, the interaction of dMi-2 at the 3’-end of the RNAs is due to the prevalence 
of highly folded structures at the 3’-ends of RNAs or conceivably dMi-2 plays a role in the 
processing of the 3’- ends of RNAs during polyadenylation. The polyadenylated mRNAs are 
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exported out of the nucleus for translation to take place. For such a process, the mRNA is 
made competent for export by disassembly of the polyadenylation factors (Casañal et al., 
2017; Qu et al., 2009). It is possible that dMi-2 either helps in the disassembly of the 
polyadenylation factors or prepares the mRNAs for the nuclear export. However, in depth 
analysis into the role of dMi-2 at the 3’-end of RNAs need to be carried to ascertain the exact 
function. A logical experiment to address this question would be to monitor the mRNA 
nuclear export under dMi-2 depleted condition.  
 
I found that dMi-2 preferentially binds to Guanine-rich RNAs in vitro. The iCLIP data presents 
the Guanine nucleotide as the most frequently cross-linked nucleotide after Uridine, however, 
the Uridine enrichment at the cross-linking sites could very likely arise from the inherent 
positive bias due to the use of UV-C in the iCLIP procedure (Sugimoto et al., 2012). Therefore, 
the in vivo results complement the in vitro results in this study. However, even though 
Guanine nucleotide appeared enriched at the cross-linking site, the RNA reads bound by 
dMi-2 did not appear to be significantly rich in Guanine content in vivo. This could possibly 
arise from the differences between the physiological environment and the in vitro conditions. 
For the in vitro experiments, I used purified dMi-2, however, in vivo, dMi-2 exists in two 
complexes – the multi-subunit Nucleosome remodeling and deacetylase (NuRD) and dMep-
1 containing, dMec complex. It is plausible that the other components in the NuRD complex 
or dMep-1 in the dMec complex, exert some influence in determining the RNA fragments that 
the dMi-2 binds to. This could be either by influencing the spatial arrangement of dMi-2 or 
because some of the other proteins with which dMi-2 associates, bind to RNA themselves, 
thereby, cooperatively determining the RNAs that the complex interacts with. One approach 
to determine this would be to express each of the NuRD components and dMep-1 
individually and test their RNA binding abilities independently. The second approach would 
be to express all the dMi-2 associated proteins and reconstitute the NuRD complex and 
dMec complex in vitro. The RNA binding profile of such a complex would presumably be 
closer to what appears in our iCLIP data. 
 
Furthermore, this study reveals that interaction with RNA inhibits the remodeling activity of 
dMi-2. I used in vitro remodeling assays to detect the effects of different types of RNA on the 
remodeling function of dMi-2. While two Guanine-rich RNA fragments ((G4A4)4 and (GA)20) 
inhibited the remodeling of dMi-2, another RNA fragment (Hsp70Aa #6) of equal length but 
with less Guanine content (30% compared with 40% and 50% in (G4A4)4 and (GA)20, 
respectively), had no apparent effect on the remodeling activity. Further analysis revealed 
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that Hsp70Aa #6 RNA bound dMi-2 with much less affinity (in EMSAs) compared with the 
RNAs that inhibited the remodeling. Perhaps, the inhibition of remodeling activity is brought 
about by a mechanism that depends on strong RNA binding. The affinity of binding to dMi-2 
might depend on the Guanine-richness of the RNA. However, the differences in Guanine 
content are similar (10%) between (GA)20 RNA and (G4A4)4 RNA, and between (G4A4)4 RNA 
and Hsp70Aa #6 RNA (10%). Yet, Hsp70Aa #6 RNA bound poorly compared with the other 
two RNAs and had no apparent effect on remodeling. This could arise from three possibilities 
- a) dMi-2 requires a minimum threshold of Guanine nucleotides which could be more than 
30% for it to bind an RNA fragment with high affinity, b) the pattern of Guanine nucleotides 
in an RNA might influence its interaction with dMi-2. In (G4A4)4 RNA, Guanine nucleotides are 
regularly interspersed as blocks of four nucleotides separated by four non-Guanine 
nucleotides. Similarly, in (GA)20 RNA, Guanine nucleotides are regularly interspersed with 
every second nucleotide being a Guanine nucleotide. This is not the case for Hsp70Aa #6 
RNA where Guanine nucleotides are more randomly distributed, and/or c) there are structural 
differences between the RNAs and that dMi-2 binds better to the secondary structures 
formed by (G4A4)4 RNA and (GA)20 RNA but not to the structure formed by Hsp70Aa #6 RNA. 
Although, there is a clear impossibility of secondary structures formed through canonical 
base-pairing due to unavailability of Cytosine (C) and Uracil (U) nucleotides in (GA)20 RNA, 
however, a similarly Guanine-rich RNA with same Guanine-content and length - (GU)20 RNA, 
has been shown to fold into its own secondary structures (Wang et al., 2017). In fact, the 
(GA)20 RNA used in this study, indeed appeared to fold in its own distinct structure, different 
from a G-quadruplex structure of (G4A4)4 RNA in the CD spectroscopy analysis. Just, like the 
stretches of Guanine-nucleotides in (G4A4)4 RNA exert their influence on the folding, perhaps 
the Guanine-nucleotides in (GA)20 RNA also exert a folding pressure resulting in a structure 
that is distinct, yet has features that are recognized by dMi-2 preferentially. 
 
The RNA binding of several chromatin modifying proteins has been proposed to either aid 
their recruitment to the chromatin or antagonize their association with chromatin. However, 
depending upon the context, RNA binding can exert both effects as well. This is vividly true 
for PRC2 as its interaction with RNA has been proposed to recruit it to the PRC2 target genes 
while the RNA binding evicts PRC2 from PRC2 non-target genes (Beltran et al., 2016; Long 
et al., 2020; Riising et al., 2014). In this study, I found that binding to RNA possibly 
counteracts the association of dMi-2 to chromatin. The RNase A mediated degradation of 
cellular RNA leads to increased association of dMi-2 with chromatin in vitro. To support this 
view, I illustrate that inhibition of transcription also leads to an increased occupancy of dMi-
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2 with certain chromatin loci in vivo. It seems that the RNAs in the cell act as a sponge for 
dMi-2 to bind to, preventing unwanted dMi-2 interaction with chromatin and thereby aberrant 
gene repression. It is likely that this function of RNA binding works in cue with other gene 
expression signals. I propose that in a repressed state when there is no signal for transcription 
at a locus, therefore, low to no mRNA is available for dMi-2 to interact with, allowing dMi-2 
to interact with the chromatin and maintaining the repressed state. However, when there is a 
gene activation signal for example, recruitment of TATA-binding protein (TBP) to the 
promoters of respective genes leading to gene expression cue and subsequent production 
of RNA from the locus (Coleman et al., 1999), dMi-2 is competed off from the chromatin by 
its interaction with RNA and an activated state is maintained (Figure 4.0, Model). It is 
pertinent to mention that RNA competes off dMi-2 from DNA in vitro (Murawska et al., 2011). 
In addition, CHD4, the human homolog of dMi-2, is competed off from the nucleosome by 
RNA in vitro (data not shown), supporting the proposed model.  
 
This study characterizes the RNA binding of dMi-2 and mainly uses EMSA to detect the 
binding. While as such EMSA is a robust assay, the chemical equilibrium of binding reactions 
is not maintained during electrophoresis (Hellman and Fried, 2007). Such a caveat could miss 
protein-RNA complexes that dissociate rapidly. Therefore, the approximate dissociation 
constants determined in this study might differ from the dissociation constants in the solution. 
An alternative to electrophoresis dependent binding quantifications is the use of fluorescently 
labelled probes (RNA) and measurement of the dissociation constants in-solution by using 
techniques such as fluorescence polarization (FP) assays. Also, the in vitro RNA binding 
assays lack the exact physiological conditions, therefore, inside a cell, the binding patters of 
dMi-2 could be slightly different. This was evident in dMi-2 preference for binding to Guanine-
rich RNA in vitro and its lack thereof in vivo. Therefore, as stated above, reconstituting the 
complexes in which dMi-2 exists in the cell would recapitulate its physiological state and 
provide a more accurate RNA binding profile of dMi-2. Additionally, I have stained the EMSA 
gels with SYBR gold stain. The sensitivity of SYBR gold for in-gel detection is at least 10 
times more than ethidium bromide, however, it was not able to stain Poly (G), Poly (U) and 
(CA)20 RNAs properly. Therefore, in such cases a different stain or the detection mechanism, 
such as radio-labelling could be done to improve the detection as well as accuracy of the 
dissociation constants. Furthermore, this study indicates the RNA binding regions as 1-117 
and 238-376 amino acids in the N-terminal region of dMi-2. Further truncations within these 
regions must be performed to determine the minimal RNA binding motifs. Also experiments 
such as Hydrogen deuterium exchange mass spectrometry (HDX- MS) or Nuclear magnetic 
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resonance (NMR) of dMi-2-RNA complexes could be conducted to detect the precise RNA-
protein interacting surfaces. The details of the precise amino acids involved in RNA binding 
that are revealed through such data should be used to dissect the exact RNA binding function 
of dMi-2. This can be achieved by creating the dMi-2 loss-of-RNA-binding mutant flies and 
analysis on the phenotypes. Such RNA binding mutant dMi-2 can also be created in 
Drosophila cells and analysis of gene expression through RNA-sequencing could be done to 
inform on its role in gene expression regulation. 
  
In-depth studies into the dMi-2 interaction at the 3’- end of mRNAs should be conducted to 
unveil the role of this interaction. As suggested above, perhaps dMi-2 plays a role either in 
the 3’-end processing or the nuclear export of mRNAs. Therefore, to substantiate these 
possibilities two strategies could be adopted: a) monitoring the 3’-end processing and 
nuclear transport in a dMi-2 knockdown situation or a dMi-2 RNA binding mutant condition 
and b) establishing whether dMi-2 physically interacts either with the 3’-end processing 
machinery or the nuclear export machinery by performing protein-protein interaction analysis 
such as mass spectrometry. Protein-protein interaction assays based on 
immunoprecipitation experiments are generally conducted after depletion of DNA and RNA 
that could mediate protein-protein interactions. However, if dMi-2 plays a role in 3’-end 
processing, then its interaction with the 3’-end processing machinery may be mediated by 
mRNA. Therefore, care must be taken to not deplete RNA while conducting such an 
experiment.  
 
The RNAs that were identified as bound by dMi-2 in vivo in this study should also be studied 
in detail to dissect how dMi-2 interaction affects their biological functions. For example, if 
dMi-2 binds an RNA which codes for an enzyme involved in a cellular process such as 
glycolysis. Loss of dMi-2 RNA binding function may impact the processing, stability or 
translation of this RNA. Such effects of dMi-2 on its RNA partners must be studied to provide 
a more in-depth role of dMi-2 RNA binding function. This can be achieved by a) monitoring 
the changes in the expression levels of these RNAs between a wild type condition and a dMi-
2 RNA binding mutant condition using RNA sequencing analysis, b) monitoring the protein 
levels coded by the RNAs found in dMi-2 iCLIP in a wild type and dMi-2 RNA binding mutant 
condition by proteomic studies. 
 
This study proposes that the RNAs that bind to dMi-2 with high affinity also inhibit its 
remodeling activity. This is based on our in vitro remodeling assays. However, it is important 
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to note that a) the in vitro environment does not recapitulate the exact physiological state and 
b) I use mononucleosomes in my assays. In the physiological state, the dMi-2 deals with 
arrays of nucleosomes and this might affect its in vivo behavior to be slightly different from 
the in vitro observations. However, despite these caveats, the inhibition of remodeling by 
RNA interaction provides a mechanism for maintaining gene expression of actively 
transcribed genes.  The depletion of RNA led to an increased association of dMi-2 to 
chromatin. A thorough genome-wide analysis of that aspect could be conducted to detect 
the exact location of the newly chromatin-associated dMi-2, perhaps by ChIP-seq of an RNA-
binding mutant version of dMi-2. It is likely, that such a mutant dMi-2 causes an aberrant 
gene expression repression of the loci to which it binds upon loss of its RNA interaction 
properties.       
 
In conclusion, this thesis establishes the RNA binding role of the canonical chromatin 
remodeler – dMi-2. This study provides evidence that the intrinsically disordered regions 
(IDRs) in the N-terminal regions of dMi-2 mediate its RNA binding. It establishes the 
promiscuous RNA binding nature and identifies thousands of RNAs that dMi-2 binds in 
Drosophila S2 cells. The findings here establish, for the first time, an inhibitory role of RNA 
binding on the remodeling activity of dMi-2. Finally, this thesis proposes a model that 
suggests RNA binding antagonizes dMi-2 association with chromatin which may provide a 
mechanism to maintain the expression of actively transcribed genes. 
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Figure 4.0: Model 
dMi-2 interacts with chromatin at transcriptionally repressed loci. Upon transcriptional 
activation, dMi-2 interacts with the mRNA produced from the actively transcribed genes. 
RNA interaction competes dMi-2 off from the chromatin, acting as a ‘sponge’. At actively 
transcribed genes, RNA interaction with dMi-2 provides a mechanism of maintaining the 
gene expression.   
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5 Summary 
5.1  Summary 
 
Chromatin is maintained in a dynamic relaxed or repressed state such that DNA binding sites 
for the transcription machinery are either accessible or occluded. This way the gene 
expression is regulated. There are several chromatin regulators including ATP-dependent 
chromatin remodelers that help change or modulate the conformation of the chromatin to 
repress or to facilitate gene expression. Recent studies have implicated several chromatin 
remodelers in RNA binding. However, the precise function of this RNA binding property is 
intensively debated due to our limited understanding of its function. In this thesis, dMi-2, an 
ATP-dependent chromatin remodeler, has been studied for its interaction with RNA and a 
model is proposed for the effects of RNA binding on its function that supports the hypothesis 
that RNA binding modulates the function of chromatin remodelers. 
 
In the first part of this thesis, the RNA binding properties of dMi-2 were characterized in vitro. 
dMi-2 formed biochemically stable complexes with several RNAs of varying sequences. This 
suggested a binding of promiscuous nature. However, dMi-2 bound some RNAs with higher 
affinity compared with others. Further, the RNA binding regions in dMi-2 were mapped. The 
major RNA binding regions of dMi-2 were located in its N-terminal part. Analysis of the type 
of sequences that dMi-2 bound to revealed a preference for G-rich RNA. 
 
In the second part of this study, in vivo RNA binding of dMi-2 was characterized in an 
unbiased genome-wide manner. The individual nucleotide-resolution crosslinking and 
immunoprecipitation (iCLIP) experiment recapitulated the promiscuous nature of RNA 
binding that was found in in vitro assays. iCLIP revealed thousands of different dMi-2-binding 
RNAs. Further analysis revealed that dMi-2 interacted almost exclusively near the 3’-end of 
the mRNAs. At the cross-linking site, G-nucleotides were enriched. 
 
In the third part of this thesis, the effects of RNA binding on the function of dMi-2 were 
studied. It was shown that RNA binding inhibits the remodeling activity of dMi-2. Further 
analysis illustrated that the RNAs that bound dMi-2 with higher affinity also inhibited its 
remodeling better compared with the RNAs that bound with lower affinity. Biochemical 
analysis revealed that the depletion of RNA led to an increased chromatin occupancy of dMi-
2. Likewise, inhibition of transcription in vivo also resulted to an increased chromatin 
occupancy of dMi-2.  
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In summary, the results of this thesis support a model which suggests that dMi-2-RNA 
interaction causes inhibition of the remodeling function of dMi-2. This may be caused by 
eviction of dMi-2 from chromatin upon RNA interaction. At actively transcribing genes, RNA 
competes dMi-2 away from the chromatin and at repressed genes, dMi-2 has increased 
chromatin occupancy due to lack of RNA. This thesis contributes to the understanding of the 
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Chromatin wird in einem dynamischen entspannten oder unterdrückten Zustand gehalten, so 
dass DNA-Bindungsstellen für die Transkriptionsmaschinerie entweder zugänglich oder 
verschlossen sind. Auf diese Weise wird die Genexpression reguliert. Es gibt mehrere 
Chromatinregulatoren, darunter ATP-abhängige Chromatin-Remodeler, die dazu beitragen, 
die Konformation des Chromatins zu verändern oder zu modulieren, um die Genexpression 
zu unterdrücken oder zu ermöglichen. Neuere Studien haben mehrere Chromatin-Remodeler 
in die RNA-Bindung einbezogen. Die genaue Funktion dieser RNA-Bindungseigenschaft wird 
jedoch aufgrund unseres begrenzten Verständnisses der Funktion intensiv diskutiert. In 
dieser Arbeit wurde dMi-2, ein ATP-abhängiger Chromatin-Remodeler, auf seine Interaktion 
mit RNA untersucht und ein Modell für die Auswirkungen der RNA-Bindung auf seine 
Funktion vorgeschlagen, das die Hypothese unterstützt, dass die RNA-Bindung die Funktion 
von Chromatin-Remodelern moduliert. 
 
Im ersten Teil dieser Arbeit wurden die RNA-Bindungseigenschaften von dMi-2 in vitro 
charakterisiert. dMi-2 bildete biochemisch stabile Komplexe mit mehreren RNAs 
unterschiedlicher Sequenz. Dies deutete auf eine Bindung promiskuitiver Natur hin. 
Allerdings band dMi-2 einige RNAs mit höherer Affinität im Vergleich zu anderen. Weiterhin 
wurden die RNA-Bindungsregionen in dMi-2 kartiert. Die wichtigsten RNA-Bindungsregionen 
von dMi-2 befanden sich in seinem N-terminalen Teil. Die Analyse der Art der Sequenzen, an 
die dMi-2 gebunden hat, ergab eine Präferenz für G-reiche RNA. 
 
Im zweiten Teil dieser Studie wurde die in vivo RNA-Bindung von dMi-2 genomweit 
charakterisiert. Das iCLIP-Experiment (individual nucleotide-resolution crosslinking and 
immunoprecipitation) rekapitulierte die promiskuitive Natur der RNA-Bindung, die in den in 
vitro-assays gefunden wurde. iCLIP enthüllte tausende von verschiedenen dMi-2-bindenden 
RNAs. Weitere Analysen zeigten, dass dMi-2 fast ausschließlich in der Nähe des 3'-Endes 
der mRNAs interagierte. An der Vernetzungsstelle waren G-Nukleotide angereichert. 
 
Im dritten Teil dieser Arbeit wurden die Auswirkungen der RNA-Bindung auf die Funktion von 
dMi-2 untersucht. Es wurde gezeigt, dass die RNA-Bindung die Remodeling-Aktivität von 
dMi-2 hemmt. Weitere Analysen zeigten, dass die RNAs, die dMi-2 mit höherer Affinität 
banden, auch dessen Remodeling-Aktivität besser hemmten als die RNAs, die mit geringerer 
Affinität banden. Die biochemische Analyse zeigte, dassder Abbau der RNA zu einer erhöhten 
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Chromatinbesetzung von dMi-2 führte. Ebenso führte die Inhibition der Transkription in vivo 
zu einer erhöhten Chromatinbesetzung von dMi-2.  
 
Zusammenfassend unterstützen die Ergebnisse dieser Arbeit ein Modell, das nahelegt, dass 
die dMi-2-RNA-Interaktion eine Hemmung der Remodeling-Funktion von dMi-2 bewirkt. Dies 
könnte durch die Verdrängung von dMi-2 aus dem Chromatin bei RNA-Interaktion verursacht 
werden. An aktiv transkribierten Genen löst die RNA dMi-2 vom Chromatin ab und an 
repressiven Genen hat dMi-2 eine erhöhte Chromatinbesetzung aufgrund des Mangels an 
RNA. Diese Arbeit trägt zum Verständnis der Rolle der RNA-Interaktion bei der Modulation 
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Predicted secondary structures of the RNAs (A-H). The structures were predicted with 
SPOT-RNA: RNA Secondary Structure Prediction Software with optimal default settings. 




































Supplementary Figure S3.1.3:  
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#3 RNAs (100-mer single stranded RNAs) of Hsp70Aa and Pgant35a along with single 
stranded RNA size marker (A and B) are loaded on a urea denaturing polyacrylamide gel and 
electrophoresed. C) 100 base pair (bp) double stranded RNA and DNA generated from 
Hsp70Aa gene (Lanes 1 and 2, respectively) were loaded on a native polyacrylamide gel and 
electrophoresed D) ssRNA and dsRNA were untreated (Lane 1 and 2, respectively) or treated 
with RNase III (Lane 3 and 4, respectively). Each gel was stained with 1X SYBR gold and 
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Supplementary Figure S3.1.5: 
N-terminally FLAG-tagged dMi-2 Wild type (WT) and its truncation mutants were purified by 
FLAG immunopurification and eluted with FLAG peptide. The protein samples were loaded 
on SDS gels in (A), (C), (E) and (G) and electrophoresed. Molecular weight markers were 
loaded in lane 1 for each. The gels were stained with Coomassie Brilliant Blue and imaged 
with Bio-Rad Image Lab. EMSAs of dMi-2 WT and its truncation mutants in (B), (D), (F) and 
(H). In (B), 50 nanograms of Hsp70Aa #3 RNA (Figure 3A, schematics) was used for each 
reaction and 173 nanograms each of dMi-2 WT (lane 2), dMi-2 ∆N (lane 4), dMi-2 ∆C (lane 6) 
and dMi-2 (691-1271) (lane 8). In (D), 250 nanomolar Hsp70Aa #6 RNA was used for each 
reaction with titrations of dMi-2 WT or dMi-2 ∆376, as indicated. In (F), 250 nanomolar 
Hsp70Aa #6 RNA was used in each reaction and dMi-2 (1-376), lanes 2-4 or dMi-2 (377-690), 
lanes 5-7, were titrated from 0.5 to 2 micromolar (𝜇M). In (H), 250 nanomolar Hsp70Aa #6 
RNA was used in each reaction and 1.5 micromolar (𝜇M) protein each from dMi-2 (1-117) 
lane 2, (118-238) lane 3 and (239-376) lane 4. RNA only was loaded for each EMSA in lane 1. 
EMSA reactions were loaded on native polyacrylamide gels and electrophoresed. The gels 























Supplementary Figure S3.2.5: 
(A) Genes with iCLIP reads (from both replicates) are aligned at the transcription end site (TES 
= 0). In blue, cross-linking sites are indicated. On top, the cumulative cross-linking density 
for all genes is plotted. The grey shaded area from position -19 to -1 indicates a part of 
transcript where reads are extremely unlikely to be mapped due to the minimum length of 
trimmed reads of 18 nucleotides. Cross-links in this zone are mostly due to partial alignments 
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containing a poly(A) signal, very rarely read-through events or false positive mappings. Due 
to this technical constraint, iCLIP is not able to predict exact cross-linking positions in these 
last nucleotides. The colour code on the right indicates number of supporting reads for each 



































Supplementary figure S3.3.1: RNA binding inhibits dMi-2 remodelling activity 
Nucleosome remodelling assays with titrations of different 40-mer RNAs (A) (G4A4)4 RNA, (B) 
(GA)20 RNA and (C) Hsp70Aa #6 RNA. 15 nanomolar (nM) of the end-positioned nucleosomes 
with 80 base pairs (bp) of flanking DNA were used in each experiment as denoted by plus 
sign, except in controls (minus signs on the top). End-positioned nucleosome, lane 1 in each 
gel image, represented on the left (orange denotes the histone octamer positioned at the end 
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of the nucleosomal DNA denoted in blue). 50 nanomolar (nM) dMi-2 was added in each 
reaction (plus sign), except in controls (minus sign on the top). Remodelled nucleosome 
(represented on the left, orange denotes histone octamer positioned centrally on the 
nucleosomal DNA denoted in blue) can be observed in lanes 2-6 of (A) and (B) and lanes 2-
10 in (C). Free RNA in each gel can be observed at the bottom. Reactions were loaded on 
native polyacrylamide gels, electrophoresed, stained with SYBR gold and imaged with Bio-
Rad ChemiDoc system. Red arrows point out the remodelled nucleosome band and red 
asterisk marks in lanes 7-10 of (A) and (B) point out the inhibition of remodelling. Blue asterisk 
in lane 10 of (C) points out remodelled nucleosome even at the highest concentration of 
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Supplementary figure S3.3.2: RNAs that bind efficiently to dMi-2 inhibit remodelling 
Electrophoretic mobility shift assays (EMSA) of (A) (G4A4)4 RNA, (B) (GA)20 RNA and (C) 
Hsp70Aa #6 RNA. 250 nanomolar (nM) RNA was used in each reaction and dMi-2 titrated 
from 10 to 640 nanomolar (nM), lanes 2-8. Each reaction was loaded on a native 
polyacrylamide gel and electrophoresed. The gels were stained with SYBR gold and imaged 
with Bio-Rad ChemiDoc system. dMi-2 bound to RNA is denoted as bound complex. Free 
































Supplementary figure S3.3.3: Loss of RNA causes increased association of dMi-2 with 
chromatin 
RNase A treatment and western blot (A) 3.5 × 107 cells were permeabilized by treatment with 
0.05% of Tween-20 for 10 minutes at 4°C. Cells were treated with 10 milligrams per millilitre 
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(mg/ml) of RNase A. Control cells were similarly permeabilized but treated with equal amount 
of BSA (bovine serum albumin). Cells were fractionated in cytoplasmic, nuclear and 
chromatin fraction. Each fraction was loaded on an 8-12% gradient denaturing 
polyacrylamide gel and electrophoresed. Western blot analysis was performed for the 
proteins indicated. Histone H3 was used as loading control. The western blot signals were 
quantified using ImageJ software. The BSA treated control signals were set to 1 and the fold 
change in the treated samples were calculated and numbers indicated below. (B) 1 × 106 
cells per millilitre each from dMi-2-GFP and S2 cells were seeded on concanavalin A coated 
glass coverslips, permeabilized by treatment with 0.05 micrograms per microliter (𝜇g/𝜇l) of 
digitonin for 10 minutes. One set was treated with RNase A and another mock treated with 
PBS alone and cells were fixed. S2 cells were blocked with BSA, incubated with anti-MOF 
primary antibody and Alexa-547 secondary antibody. Fixed cells were stained with DAPI and 
Phalloidin stains just before mounting on a glass slide using mowiol as mounting media. Cells 
were visualized under a confocal microscope and imaged. Representative images of several 
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Table 3: dMi-2-GFP iCLIP-seq list of enriched mRNAs with Fold change > 4 and (p < 
0.05) 
FlyBase Gene Report name log2FC 
FBgn0053868 His2B:CG33868 10.8002796376212 
FBgn0052580 Muc14A 9.45703266969185 
FBgn0052320 CG32320 7.98431559774432 
FBgn0037811 CG12592 7.34205351830939 
FBgn0261836 Msp300 6.90512108738892 
FBgn0033141 CG12831 6.83376678488231 
FBgn0259110 mmd 6.48009829238807 
FBgn0034126 jtb 6.31564321070758 
FBgn0003016 osp 6.15032241570444 
FBgn0267033 mamo 6.13947123092771 
FBgn0013275 Hsp70Aa 6.01423597289303 
FBgn0042131 CG18808 5.82723197292279 
FBgn0285926 Imp 5.51261175360771 
FBgn0030914 CG6106 5.35333678436727 
FBgn0042627 FASN2 5.34698447517476 
FBgn0032683 kon 5.33454638168472 
FBgn0026206 mei-P26 5.28106560202889 
FBgn0016977 spen 5.12465549706164 
FBgn0265487 mbl 5.09354674179842 
FBgn0284408 trol 5.02973784581865 
FBgn0016976 stnA 5.02202858797867 
FBgn0016975 stnB 5.02202858797867 
FBgn0034140 Lst 5.01429266653495 
FBgn0264490 Eip93F 5.01429266653495 
FBgn0010113 hdc 4.82922645855303 
FBgn0038826 Syp 4.80554742361066 
FBgn0004652 fru 4.73165515675901 
FBgn0040765 luna 4.70726440615755 
FBgn0053554 Nipped-A 4.62241953495861 
FBgn0003165 pum 4.58493032464889 
FBgn0266696 Svil 4.56984780051999 
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FBgn0261552 ps 4.54412038731827 
FBgn0086758 chinmo 4.50048111975893 
FBgn0052113 Vps13D 4.4066220711289 
FBgn0013733 shot 4.3883913027958 
FBgn0027339 jim 4.38457515666963 
FBgn0004656 fs(1)h 4.3649173105306 
FBgn0032136 Apoltp 4.36486760035777 
FBgn0283451 br 4.33824319934438 
FBgn0033661 CG13185 4.32920287048232 
FBgn0011230 poe 4.28356352372469 
FBgn0261574 kug 4.2827128208743 
FBgn0262656 Myc 4.27141752469343 
FBgn0260400 elav 4.23457122505278 
FBgn0000479 dnc 4.20062776178223 
FBgn0265523 Smr 4.18250497919764 
FBgn0036851 CG14082 4.17569410266339 
FBgn0052296 Mrtf 4.16936958085499 
FBgn0025741 PlexA 4.12430657847216 
FBgn0010300 brat 4.07380164125748 
FBgn0036398 upSET 4.06134713863072 
FBgn0261793 Trf2 4.0403012026309 
FBgn0261797 Dhc64C 4.03134331769893 
FBgn0265045 Strn-Mlck 3.96752078846758 
FBgn0039959 CG17514 3.95073446887442 
FBgn0264975 Nrg 3.94381527946911 
FBgn0030674 CG8184 3.90684931717943 
FBgn0283521 lola 3.88370229293706 
FBgn0035142 Hipk 3.88267307312318 
FBgn0085430 CG34401 3.88106441668734 
FBgn0261617 nej 3.87889444131911 
FBgn0052767 CG32767 3.877811390303 
FBgn0011666 msi 3.85600196686996 
FBgn0260003 Dys 3.8502939063812 
FBgn0283499 InR 3.84300467611203 
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FBgn0263396 sqd 3.84026621842002 
FBgn0259170 alpha-Man-Ia 3.8302661807562 
FBgn0259789 zld 3.82192351680268 
FBgn0266557 kis 3.82151639555282 
FBgn0031107 HERC2 3.81224333164984 
FBgn0002526 LanA 3.805099444757 
FBgn0035424 Larp4B 3.8021684823626 
FBgn0085407 Pvf3 3.78230261448468 
FBgn0026869 Thd1 3.76329605650254 
FBgn0011224 heph 3.75833576673696 
FBgn0085446 CG34417 3.74416715758126 
FBgn0004435 Galphaq 3.73700919148138 
FBgn0259176 bun 3.7325444173771 
FBgn0052479 Usp10 3.7106283740648 
FBgn0029979 mahe 3.70083745707653 
FBgn0052529 Hers 3.69450431101918 
FBgn0028397 Tob 3.68980501695715 
FBgn0016694 Pdp1 3.68476402351277 
FBgn0285917 sbb 3.67453804230069 
FBgn0261802 CG42748 3.67074461112003 
FBgn0043884 mask 3.66411181002783 
FBgn0000546 EcR 3.66042646641071 
FBgn0050069 CG30069 3.64908467905196 
FBgn0040297 Nhe2 3.64055360918131 
FBgn0010905 Spn 3.6394433747121 
FBgn0263352 Unr 3.63765257248846 
FBgn0000568 Eip75B 3.63389715711136 
FBgn0040752 Prosap 3.63019268796045 
FBgn0002945 nkd 3.62847814774335 
FBgn0267912 CanA-14F 3.62012387182123 
FBgn0053100 eIF4EHP 3.61374655497384 
FBgn0085478 CG34449 3.59778213391869 
FBgn0000567 Eip74EF 3.58569829686856 
FBgn0032600 BuGZ 3.58098124511512 
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FBgn0004607 zfh2 3.5682779897614 
FBgn0003862 trx 3.56813599914016 
FBgn0263289 scrib 3.56332797796981 
FBgn0264707 RhoGEF3 3.55815203137006 
FBgn0283657 Tlk 3.55695406810382 
FBgn0267336 Glut4EF 3.53084643846658 
FBgn0023479 teq 3.52818050338941 
FBgn0036165 chrb 3.52163484398033 
FBgn0260634 eIF4G2 3.52128170385548 
FBgn0286778 CG46385 3.5142655680346 
FBgn0259745 wech 3.49010643440631 
FBgn0029114 Tollo 3.48130830860426 
FBgn0086674 Tpst 3.47650915420401 
FBgn0004198 ct 3.47225869320717 
FBgn0051998 CG31998 3.46989323416501 
FBgn0053087 LRP1 3.45453633687723 
FBgn0262160 CG9932 3.45092768873571 
FBgn0015269 Nf1 3.44876936407616 
FBgn0001122 Galphao 3.44845291492252 
FBgn0266717 Bruce 3.44492005125665 
FBgn0250754 CG42232 3.44320665275096 
FBgn0052423 shep 3.44319538672698 
FBgn0033159 Dscam1 3.44183985016598 
FBgn0261934 dikar 3.43707054163435 
FBgn0052133 Ptip 3.42728351637155 
FBgn0039920 CG11360 3.42007160617459 
FBgn0039928 Cals 3.4145470485376 
FBgn0000635 Fas2 3.40403417781517 
FBgn0266801 CG45263 3.39219887597165 
FBgn0002643 mam 3.38968029893869 
FBgn0026086 Adar 3.38883409311273 
FBgn0036004 Jarid2 3.38308793052713 
FBgn0004395 unk 3.38295557036386 
FBgn0261671 tweek 3.38226224328963 
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FBgn0085434 NaCP60E 3.38199769231437 
FBgn0261549 rdgA 3.38199769231437 
FBgn0003415 skd 3.37900372704959 
FBgn0041092 tai 3.37010573765372 
FBgn0033010 Atf6 3.35706130141735 
FBgn0014388 sty 3.35458588850229 
FBgn0286516 aqz 3.35292354750985 
FBgn0004167 kst 3.35050831229279 
FBgn0004449 Ten-m 3.34606086706945 
FBgn0261822 Bsg 3.34348060293133 
FBgn0260794 ctrip 3.34281364883831 
FBgn0025740 PlexB 3.33426992284789 
FBgn0264953 Piezo 3.33052226811085 
FBgn0262737 mub 3.32572560063108 
FBgn0003391 shg 3.32448490211995 
FBgn0029504 CHES-1-like 3.30768140409356 
FBgn0263490 mld 3.30414734457373 
FBgn0002673 twe 3.30305909078457 
FBgn0031698 Ncoa6 3.29128342704834 
FBgn0021764 sdk 3.28901098269 
FBgn0086686 l(3)L1231 3.2646294718284 
FBgn0001078 ftz-f1 3.26417477578184 
FBgn0259735 mtgo 3.2561152947444 
FBgn0039633 CG11873 3.25499268303909 
FBgn0052062 Rbfox1 3.24925612910232 
FBgn0262739 AGO1 3.24587077721261 
FBgn0000163 baz 3.24020373967179 
FBgn0262743 Fs(2)Ket 3.23950100186323 
FBgn0040388 boi 3.23656496660836 
FBgn0014163 fax 3.23627305400339 
FBgn0039209 REPTOR 3.22224426178399 
FBgn0004396 CrebA 3.22144748849293 
FBgn0033636 tou 3.21037135373029 
FBgn0039831 CG12054 3.20807220954901 
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FBgn0263929 jvl 3.20234815023948 
FBgn0029676 HIP-R 3.19393183019868 
FBgn0262975 cnc 3.18485371316302 
FBgn0265623 Su(z)2 3.1733913193136 
FBgn0039727 Vps13B 3.16963220685496 
FBgn0259168 mnb 3.16503976795187 
FBgn0085436 Not1 3.1527052537297 
FBgn0000541 E(bx) 3.13447764610696 
FBgn0261244 inaE 3.13102301524477 
FBgn0261811 pico 3.12093344475092 
FBgn0032633 Lrch 3.11701059560866 
FBgn0003301 rut 3.10769586102493 
FBgn0263706 CG43658 3.10471562946762 
FBgn0030243 CG2186 3.10095665296189 
FBgn0003525 stg 3.09940269412615 
FBgn0260965 CG42588 3.09869818486504 
FBgn0262582 cic 3.09322351281376 
FBgn0020306 dom 3.09115766849551 
FBgn0030266 CG11122 3.08189061616957 
FBgn0039590 CG10011 3.08029928355784 
FBgn0085423 GramD1B 3.07473982893751 
FBgn0003137 Ppn 3.0723859502579 
FBgn0264307 orb2 3.06586608908757 
FBgn0263346 smash 3.06506306903183 
FBgn0025936 Eph 3.04927954974251 
FBgn0004227 nonA 3.03510370990698 
FBgn0260486 Ziz 3.03464784352583 
FBgn0264324 spg 3.03091887610756 
FBgn0003048 pcx 3.03042550216857 
FBgn0266580 Gp210 3.0175721334852 
FBgn0026083 tyf 3.01615631438175 
FBgn0052000 anne 3.01385864470053 
FBgn0011817 nmo 3.0126332727389 
FBgn0036735 Edc3 3.00039518386434 
  Appendix 
 191 
FBgn0262614 pyd 2.99965147976344 
FBgn0003870 ttk 2.99758069839968 
FBgn0036374 Spt20 2.99248434088424 
FBgn0011656 Mef2 2.98779671394399 
FBgn0002645 Map205 2.98167777396056 
FBgn0259214 PMCA 2.9809277190444 
FBgn0003371 sgg 2.97996051170067 
FBgn0011837 Tis11 2.97487211307862 
FBgn0026427 Su(var)2-HP2 2.97432374037429 
FBgn0031738 CG9171 2.97369016149345 
FBgn0261854 aPKC 2.96540913913289 
FBgn0032817 CG10631 2.95539765239398 
FBgn0031118 RhoGAP19D 2.95527648174142 
FBgn0004876 cdi 2.94939203997566 
FBgn0039466 CG5521 2.94410455065222 
FBgn0000382 csw 2.93670978762071 
FBgn0036446 CG9384 2.93605771520376 
FBgn0260934 par-1 2.93306625401769 
FBgn0030766 mthl1 2.93061247024479 
FBgn0263987 spoon 2.92717972704771 
FBgn0020224 Cbl 2.91662054381818 
FBgn0036746 Crtc 2.90537352750203 
FBgn0035106 rno 2.90460279384508 
FBgn0010051 Itp-r83A 2.90273704447419 
FBgn0086655 jing 2.90201761594318 
FBgn0022764 Sin3A 2.8861920193383 
FBgn0261444 CG3638 2.8827488548919 
FBgn0261285 Ppcs 2.87971687010065 
FBgn0262730 dtn 2.87812818239281 
FBgn0001297 kay 2.86859479846172 
FBgn0262617 Nuak1 2.86490291641935 
FBgn0263006 SERCA 2.86423609190985 
FBgn0051635 CG31635 2.86403681268674 
FBgn0259212 cno 2.86154470129852 
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FBgn0005624 Psc 2.85883324097677 
FBgn0039214 puf 2.8502109345035 
FBgn0053208 Mical 2.84891808140212 
FBgn0003028 ovo 2.83065947875137 
FBgn0025726 unc-13 2.82077350836129 
FBgn0002781 mod(mdg4) 2.81813406152301 
FBgn0003345 sd 2.81601978946513 
FBgn0029903 pod1 2.81547257223379 
FBgn0085370 Pde11 2.81536571581785 
FBgn0085412 CG34383 2.80792030918454 
FBgn0015589 Apc 2.80451313895737 
FBgn0259171 Pde9 2.79648308869151 
FBgn0265998 Doa 2.79605604571792 
FBgn0030512 Nadsyn 2.78841435848043 
FBgn0034570 CG10543 2.78162934907266 
FBgn0260442 rhea 2.77761946673531 
FBgn0005631 robo1 2.7769636097824 
FBgn0264493 rdx 2.77626319561565 
FBgn0264495 gpp 2.77403839959632 
FBgn0036518 RhoGAP71E 2.76869941727135 
FBgn0051224 CG31224 2.76448256044201 
FBgn0000581 E(Pc) 2.76283691839791 
FBgn0034240 MESR4 2.76240177983413 
FBgn0263993 CG43736 2.75994931351646 
FBgn0001169 H 2.75265183573361 
FBgn0263392 Tet 2.74889286482095 
FBgn0036844 Mkp3 2.74178206088994 
FBgn0262579 Ect4 2.74164315594264 
FBgn0036576 CG5151 2.74139315638568 
FBgn0262103 Sik3 2.73460943545281 
FBgn0024921 Tnpo 2.73401091114471 
FBgn0261397 didum 2.73136070132917 
FBgn0010382 CycE 2.72974163868659 
FBgn0003507 srp 2.72093330075867 
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FBgn0286831 sov 2.71996880851096 
FBgn0024734 PRL-1 2.71857630468388 
FBgn0004370 Ptp10D 2.71685556126891 
FBgn0004838 Hrb27C 2.71502169320622 
FBgn0037705 mura 2.71442075186685 
FBgn0003502 Btk29A 2.70728325553527 
FBgn0259984 kuz 2.70218573454958 
FBgn0037902 CG5281 2.6960386883981 
FBgn0265988 mv 2.69549738552988 
FBgn0020412 JIL-1 2.693800416969 
FBgn0285955 cv-c 2.6917436091765 
FBgn0036734 CG7564 2.69087996488417 
FBgn0040324 Ephrin 2.6896366929364 
FBgn0023458 Rbcn-3A 2.6869344999041 
FBgn0266019 rudhira 2.6860473218105 
FBgn0267861 Maf1 2.68523612828502 
FBgn0016070 smg 2.68350823790166 
FBgn0000119 arr 2.68297840408335 
FBgn0061200 Nup153 2.6738236003526 
FBgn0000578 ena 2.6667129227645 
FBgn0260970 Ubr3 2.66594800603171 
FBgn0266084 Fhos 2.66511672835558 
FBgn0020251 sfl 2.66403695852226 
FBgn0263102 psq 2.6584051364151 
FBgn0011818 oaf 2.65667401747727 
FBgn0024555 flfl 2.65545777199525 
FBgn0031150 bves 2.652465254001 
FBgn0086690 Plp 2.65177408603601 
FBgn0034734 CG4554 2.64743996853497 
FBgn0259927 CG42450 2.64512369157988 
FBgn0000247 ca 2.63746346130591 
FBgn0023407 B4 2.63696519188326 
FBgn0003483 spn-E 2.63650998004523 
FBgn0265974 ttv 2.63536274112336 
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FBgn0026179 siz 2.6305123740467 
FBgn0263131 CG43373 2.62989293314375 
FBgn0266410 CG45050 2.62362727460374 
FBgn0278608 Dsp1 2.62117296723614 
FBgn0052654 Sec16 2.61928641494117 
FBgn0030049 Trf4-1 2.6155556000095 
FBgn0003416 sl 2.61534764521833 
FBgn0000464 Lar 2.61092808278158 
FBgn0003117 pnr 2.60859696767451 
FBgn0004648 svr 2.60239052390867 
FBgn0261710 nocte 2.59794022696811 
FBgn0023213 eIF4G1 2.59232114877232 
FBgn0085450 Snoo 2.59080276135639 
FBgn0262733 Src64B 2.59059455650457 
FBgn0041585 olf186-F 2.59048197961029 
FBgn0031981 Megf8 2.58720184872033 
FBgn0039419 CG12290 2.58600056303399 
FBgn0010825 Gug 2.58300976952829 
FBgn0265630 sno 2.58110539895081 
FBgn0038197 foxo 2.58101111516715 
FBgn0002905 mus308 2.57910465099039 
FBgn0051320 HEATR2 2.57883017429885 
FBgn0015778 rin 2.56931396354219 
FBgn0005640 Eip63E 2.5585194868648 
FBgn0285892 tea 2.55783249557159 
FBgn0015396 jumu 2.55534492596839 
FBgn0001624 dlg1 2.55505073146627 
FBgn0013343 Syx1A 2.5546444663924 
FBgn0028863 CG4587 2.55362847357971 
FBgn0004509 Fur1 2.55274572070552 
FBgn0000017 Abl 2.54819289960723 
FBgn0000719 fog 2.5471645343893 
FBgn0003256 rl 2.54650205299112 
FBgn0027492 wdb 2.54479447769425 
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FBgn0026376 Rgl 2.5408249384042 
FBgn0023097 bon 2.53974131454693 
FBgn0030505 NFAT 2.53535444246016 
FBgn0020309 crol 2.53285460792943 
FBgn0004875 enc 2.53037984556701 
FBgn0011826 Pp2B-14D 2.52994717269263 
FBgn0004369 Ptp99A 2.52718960839937 
FBgn0011274 Dif 2.52622928276393 
FBgn0086779 step 2.52336323716752 
FBgn0039923 MED26 2.50990106139535 
FBgn0039904 Hcf 2.50706206838391 
FBgn0026401 Nipped-B 2.50278175970482 
FBgn0000097 aop 2.50208135258897 
FBgn0024277 trio 2.49594705243386 
FBgn0087008 e(y)3 2.49484920682123 
FBgn0013263 Trl 2.47943508634996 
FBgn0260941 app 2.47812516625264 
FBgn0032821 CdGAPr 2.47595732733249 
FBgn0261556 CG42674 2.47264191444187 
FBgn0026575 hang 2.46899307225253 
FBgn0031126 Cyp6v1 2.46406990187567 
FBgn0262473 Tl 2.46093927376994 
FBgn0033194 Vps13 2.45921579032316 
FBgn0015772 Nak 2.45919160179705 
FBgn0263395 hppy 2.45772707196989 
FBgn0032395 Wdr81 2.45759753557472 
FBgn0261545 CG42663 2.45542236011173 
FBgn0001105 Gbeta13F 2.4517895390429 
FBgn0035400 CG11537 2.44217333855291 
FBgn0036451 CG9425 2.44206538210106 
FBgn0036522 CG7372 2.44041972376882 
FBgn0023510 Rbcn-3B 2.44020782129427 
FBgn0037021 CG11399 2.43649622489732 
FBgn0037248 srl 2.43635760122446 
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FBgn0036621 roq 2.42955082149738 
FBgn0004860 ph-d 2.42903756534114 
FBgn0052350 Vps11 2.42896249587558 
FBgn0041094 scyl 2.42661298409011 
FBgn0011725 twin 2.42563498489733 
FBgn0025802 Sbf 2.42397895015361 
FBgn0265082 Cdep 2.41861685099219 
FBgn0261873 sdt 2.41407758789775 
FBgn0003447 sn 2.41249859207593 
FBgn0010316 dap 2.41134446229863 
FBgn0263112 Mitf 2.40780166769646 
FBgn0039302 Nup358 2.40606703947924 
FBgn0267964 CG46244 2.40404964375311 
FBgn0002431 hyd 2.40281841637812 
FBgn0015520 nonA-l 2.40191424018986 
FBgn0037344 CG2926 2.39992487571929 
FBgn0004655 wapl 2.39989089784983 
FBgn0027603 Ulp1 2.39710915992238 
FBgn0032223 GATAd 2.39634451649019 
FBgn0016081 fry 2.39344457225599 
FBgn0259243 Pka-R1 2.39232550308458 
FBgn0000307 chif 2.39231308871872 
FBgn0264491 how 2.39118665169054 
FBgn0026375 RhoGAPp190 2.39102094244172 
FBgn0001324 kto 2.38596539533345 
FBgn0265042 Irk1 2.38297263091889 
FBgn0000273 Pka-C1 2.37696218390045 
FBgn0004390 RasGAP1 2.37486462758511 
FBgn0030680 CG8944 2.37340714143728 
FBgn0020386 Pdk1 2.3727985103154 
FBgn0050183 CG30183 2.37121829783637 
FBgn0003392 shi 2.36263125229868 
FBgn0035397 CG11486 2.36177342549171 
FBgn0036043 CG8177 2.35854757997247 
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FBgn0035959 CG4911 2.35836490466317 
FBgn0262124 uex 2.35817837980896 
FBgn0267795 Frl 2.3576825855114 
FBgn0002873 mud 2.35656922771361 
FBgn0003209 raw 2.35007959980049 
FBgn0267348 LanB2 2.34985035375732 
FBgn0004606 zfh1 2.34806397191747 
FBgn0030809 Ubr1 2.34724074399706 
FBgn0032796 CG10188 2.34437811370054 
FBgn0284225 CG46309 2.34290978191281 
FBgn0261954 east 2.33596010857812 
FBgn0039431 plum 2.33094658374251 
FBgn0283427 FASN1 2.33004623210842 
FBgn0033504 CAP 2.32523646705443 
FBgn0014141 cher 2.3219777816587 
FBgn0264895 RapGAP1 2.31861998857016 
FBgn0262734 eIF4H1 2.31825158632215 
FBgn0036032 CG16711 2.31492141777987 
FBgn0021796 Tor 2.31471774911897 
FBgn0011481 Ssdp 2.31366884885179 
FBgn0033155 Br140 2.30583949606892 
FBgn0026147 TTLL4A 2.29747302803618 
FBgn0031969 pes 2.29319594340789 
FBgn0086451 l(2)k09022 2.28979262552197 
FBgn0263232 Nxf3 2.28526622496391 
FBgn0051158 Efa6 2.28422412767222 
FBgn0032341 Reps 2.28127980299909 
FBgn0243516 Vrp1 2.28127817852858 
FBgn0036741 anchor 2.280969446207 
FBgn0029666 CG10803 2.27860660288234 
FBgn0053217 CG33217 2.27395155547263 
FBgn0031759 lid 2.27321662528559 
FBgn0032456 MRP 2.27044580631546 
FBgn0266111 ana3 2.26939379175172 
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FBgn0031885 Mnn1 2.26813095649748 
FBgn0030400 Pits 2.26460689042668 
FBgn0003118 pnt 2.26258012116944 
FBgn0037760 FBXO11 2.26117870867679 
FBgn0052756 CG32756 2.26078840174657 
FBgn0035842 CG7504 2.26078840174657 
FBgn0052103 SCaMC 2.25863951748893 
FBgn0026432 Grip163 2.25641233546752 
FBgn0033802 CG17724 2.25459669574268 
FBgn0284223 CG46307 2.24686457234522 
FBgn0050015 CG30015 2.24442575141235 
FBgn0042185 MCU 2.2427688595078 
FBgn0029123 SoxN 2.23954047974951 
FBgn0261383 IntS6 2.23657110238323 
FBgn0031990 PAPLA1 2.23542383772161 
FBgn0262740 Evi5 2.23438410598615 
FBgn0030412 Tomosyn 2.23401869685696 
FBgn0034087 clu 2.23187014960679 
FBgn0264270 Sxl 2.22632554379118 
FBgn0031187 Usp2 2.22394931577402 
FBgn0259224 CG42324 2.22133349648103 
FBgn0020257 Ppa 2.22077693249726 
FBgn0028476 Usp1 2.21974854291646 
FBgn0026189 prominin-like 2.2192287460897 
FBgn0262872 milt 2.21691085967949 
FBgn0034975 enok 2.21460531066863 
FBgn0039944 CG17162 2.21287549675706 
FBgn0015278 Pi3K68D 2.21213047307464 
FBgn0038968 CG12499 2.21086051514842 
FBgn0003463 sog 2.20832887634621 
FBgn0000721 for 2.20778344343556 
FBgn0031006 rictor 2.20585106788442 
FBgn0003721 Tm1 2.20206271537516 
FBgn0005632 faf 2.20135566073757 
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FBgn0042693 wrd 2.20078729456201 
FBgn0034158 CG5522 2.19639281222816 
FBgn0039141 spas 2.19538872246171 
FBgn0034083 lbk 2.19295808676032 
FBgn0015513 mbc 2.18909815396437 
FBgn0036534 DCP2 2.18898764101792 
FBgn0032938 CG8671 2.18733289497642 
FBgn0025455 CycT 2.18493006626074 
FBgn0004889 tws 2.18311973418013 
FBgn0029687 Vap33 2.18231528793915 
FBgn0031896 CG4502 2.17920385113533 
FBgn0263391 hts 2.17870935704716 
FBgn0000317 ck 2.17396869743185 
FBgn0058002 ND-AGGG 2.17318212077496 
FBgn0000524 dx 2.17129668624419 
FBgn0003396 shn 2.17086724359754 
FBgn0259228 C3G 2.17003674627658 
FBgn0031952 cdc14 2.16993074893325 
FBgn0005386 ash1 2.16962247455508 
FBgn0035237 CG13917 2.16835868148038 
FBgn0260938 tay 2.1658575456593 
FBgn0026181 Rok 2.16565195875127 
FBgn0015371 chn 2.16524386372645 
FBgn0261885 osa 2.16491991225475 
FBgn0004391 shtd 2.16353536538267 
FBgn0283741 prage 2.1627287689669 
FBgn0261239 Hr39 2.16198891111363 
FBgn0029825 CG12728 2.16133510381566 
FBgn0041111 lilli 2.16106057603673 
FBgn0051992 gw 2.15474998721364 
FBgn0038504 Sur-8 2.14635996182577 
FBgn0058263 MFS17 2.14419470102632 
FBgn0046692 Stlk 2.14380167504649 
FBgn0032120 CG33298 2.13264937043225 
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FBgn0039528 dsd 2.13166722662859 
FBgn0264607 CaMKII 2.13110556965004 
FBgn0261570 CG42684 2.13109214969947 
FBgn0050011 gem 2.13053274233609 
FBgn0030812 wcy 2.13052392827129 
FBgn0003310 S 2.12635222191387 
FBgn0011747 Ank 2.12513324330182 
FBgn0027548 nito 2.1242793674139 
FBgn0003892 ptc 2.12054722297233 
FBgn0003277 RpII215 2.11968763870511 
FBgn0035023 ITP 2.1190042754919 
FBgn0085443 spri 2.11854207792077 
FBgn0027948 msps 2.1181843969848 
FBgn0039945 CG17159 2.1175895390335 
FBgn0025866 CalpB 2.11711652863622 
FBgn0032006 Pvr 2.11254030945481 
FBgn0040230 dbo 2.11158906049993 
FBgn0261618 larp 2.11058275262565 
FBgn0284235 CG46319 2.11045849283883 
FBgn0040010 CG17493 2.10794201754853 
FBgn0026577 CG8677 2.1033120362932 
FBgn0063485 Lasp 2.10208243781143 
FBgn0264605 CG43954 2.10125365441681 
FBgn0015286 Rala 2.096522405419 
FBgn0003041 pbl 2.09056590123978 
FBgn0265297 pAbp 2.08901635476039 
FBgn0260789 mxc 2.08825587776901 
FBgn0001168 h 2.0865058772932 
FBgn0039907 lgs 2.08587200697008 
FBgn0266487 CG45086 2.08542670851974 
FBgn0035688 fmt 2.08494827868727 
FBgn0032363 Dlg5 2.08342146918111 
FBgn0031681 Pgant5 2.08308887874727 
FBgn0265778 PDZ-GEF 2.07757110483131 
  Appendix 
 201 
FBgn0031030 Tao 2.0757835738441 
FBgn0000183 BicD 2.07492374540185 
FBgn0029881 pigs 2.07441618807715 
FBgn0030344 Nrd1 2.0719067755965 
FBgn0266450 Kr-h1 2.0716438763146 
FBgn0033913 CG8468 2.07128296365492 
FBgn0004101 bs 2.06937035205546 
FBgn0022768 Pp2C1 2.06844328886748 
FBgn0052850 CG32850 2.06370671723186 
FBgn0014075 Uggt 2.06201824934049 
FBgn0033569 CG12942 2.05910660703589 
FBgn0261823 Asx 2.05775802305879 
FBgn0013756 Mtor 2.05608880140724 
FBgn0034046 tun 2.05606508771281 
FBgn0263108 BtbVII 2.05567475858338 
FBgn0001316 klar 2.05378415309378 
FBgn0037240 Cont 2.05319027054982 
FBgn0037720 CG8312 2.04760291043297 
FBgn0002921 Atpalpha 2.04654126515635 
FBgn0025633 CG13366 2.04524519260379 
FBgn0032123 Oatp30B 2.04459278854709 
FBgn0005617 msl-1 2.03751144023282 
FBgn0016917 Stat92E 2.03560644896501 
FBgn0037770 Art4 2.03212653592837 
FBgn0003410 sina 2.02953402706872 
FBgn0030466 CG15744 2.02715697745512 
FBgn0264560 garz 2.02588702575747 
FBgn0010309 pigeon 2.02031322334521 
FBgn0034657 LBR 2.01628140677471 
FBgn0011766 E2f1 2.01459943305984 
FBgn0052676 stx 2.01354758724351 
FBgn0002716 mei-W68 2.01141652315342 
FBgn0037831 Cap-H2 2.00752263397315 
FBgn0021760 chb 2.00709774689602 
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FBgn0033246 ACC 2.00592253890408 
FBgn0026620 tacc 2.00397501700747 
FBgn0014007 Ptp69D 2.00168898842332 
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Seminars and workshops 
Transregio 81 seminar: RNA antagonizes dMi-2/CHD4 interaction with chromatin (Marburg, 





1) Mutant p53 cooperates with SWI/SNF chromatin remodelling complex to regulate VEGFR2 
in breast cancer cells. Pfister et. al., Genes & Development 2015 (IMT, 04-08-2015) 
2) MDM2 associates with Polycomb repressor complex 2 and enhances stemness-promoting 
Chromatin modification independent of p53. Wieken et.al., Molecular Cell 2016. (IMT, 26-01-
2016) 
3) Chromatin remodelling inactivates activity genes and regulates neural coding. Yang et al., 
Science 2016 (IMT, 19-07-16) 
4) Polycomb Repressive Complex 1 generates discrete compacted domains that change during 
differentiation. Kundu et al. Molecular Cell 2017 (BMFZ, 16-02-17) 
5) Targeting of Polycomb Repressive Complex 2 to RNA by short repeats of Guanines. Wang 
et.al., Molecular Cell 2017 (BMFZ, 20-07-17) 
6) Conserved RNA-binding specificity of Polycomb repressive complex 2 is          achieved by 
dispersed amino acid patches in EZH2. Long et. al., eLife (BMFZ, 08-02-18) 
7) The interaction of PRC2 with RNA and chromatin is mutually antagonistic. Beltran et al., 
Genome Research 2016 (BMFZ, 29-11-18) 
8) Xist RNA antagonizes SWI/SNF chromatin remodeler BRG1on the inactive X-chromosome. 
Jégu et al., Nature Structural and Molecular Biology 2019 (BMFZ, 23-05-19) 
9) G-tract RNA removes Polycomb repressive complex 2 from genes. Beltran et al., Nature 
Structure and Molecular Biology 2019 (BMFZ, 14-11-19). 
10) RNA is essential for chromatin occupancy and function in human pluripotent stem cells. Long 
et al. Nature Genetics. 2020  
 





1) 5th Winter school of the collaborative research center TRR81 ‘Chromatin Changes in 
Differentiation and Malignancies’ Marburg-Gießen-Bad Nauheim-Rotterdam. dMi2 and RNA 
(Kleinwalsertal, 22-02-2015). 
2) 7th Winter school of the collaborative research center TRR81 ‘Chromatin Changes in 
Differentiation and Malignancies’ Marburg-Gießen-Bad Nauheim-Rotterdam. Recruitment 
mechanisms of dMi-2 (Klienwalsertal, 01-03-2017) 
3) 9th Winter school of the collaborative research center TRR81 ‘Chromatin Changes in 
Differentiation and Malignancies’ Marburg-Gießen-Bad Nauheim-Rotterdam. Role of dMi-2 
RNA interaction (Kleinwalsertal, 25-02-19) 
 
 (Inter)national conferences 
4th TRR81 Symposium –Chromatin Changes in Differentiation and Malignancies 18 – 20 
September 2017, Rotterdam, Netherlands. Poster Presentation - dMi-2 recruitment 
mechanism to heat shock genes (18-09-2017).  
34th Ernst Klenk Symposium in Molecular Medicine – ‘Epigenetics: Basic principles and 
clinical applications 04-06 October 2018, Cologne, Germany. Poster Presentation – Role of 
RNA in the recruitment of dMi-2 (06-10, 2020). 
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Organisation of student workshops/mini-symposia on specific topics 
- 12th TRR81 PhD Mini-Symposium ‘Advanced methods in chromatin and gene expression 
research, Marburg, Germany (08-04-2019) 
 
Internships in laboratories of the TRR81 in Rotterdam 
-   
 
Others 
- Supervised a Lab internship for a Bachelors student of Human Biology course, Marburg 
(04-08-2015) to (06-10-2015) 
- Supervised a Lab internship for a Bachelor student of Human Biology course, Marburg (15-
10-2018) to (15-12-2018) 
- Supervised the Bachelor’s Thesis for an Erasmus exchange student from Università degli 
Studi de Perugia, Italy. ‘Salt sensitivity of dMi-2 binding to RNA’. Marburg (15-04-2019) to 
(22-07-2019) 
- Supervised the Master Thesis for a student of Human Biology course ‘Characterization of 
dMi-2 RNA binding’ Marburg (01-09-2019) to (01-09-2020). 
- Supervised practical course for students of medicine, Marburg (15-06 to 24-06, 2015). 
- Supervised practical course for students of medicine, Marburg (17-06 to 22-06, 2016). 
- Supervised practical course for students of medicine, Marburg (21-06 to 27-06, 2017). 
- Supervised practical course for students of medicine, Marburg (11-06 to 13-06, 2018). 
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